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Abstract 
Clonal cell populations are known to exhibit marked phenotypic 
heterogeneity at the single cell level, a phenomenon usually masked by 
conventional population-wide analyses. Two models of yeast cell 
heterogeneity were investigated during this study. First, expression of the 
Saccharomyces cerevisiae Rad6 protein, known to facilitate DNA damage 
tolerance, was investigated. However, apparent bimodal Rad6 expression 
proved to be an artefact of a mixed-genotype culture source. The other 
model was adhesin expression heterogeneity in the opportunistic yeast 
pathogen Candida glabrata. Adherence to the host cell is an important step 
in the establishment of C. glabrata infection, mediated by adhesin proteins. 
The subtelomeric EPA family of adhesin genes encodes a large class of GPI-
anchored cell wall proteins in C. glabrata, among which Epa1 is the best 
studied. Epa1 expression is highly heterogeneous between individual C. 
glabrata cells, a factor that can dictate adherence capacity and may have 
important implications for infection. Such cell-to-cell variability was 
dependent upon strain background. Variation in cell surface Epa1 level was 
correlated with variation in EPA1 mRNA, consistent with transcriptional 
regulation of heterogeneity. Indeed Sir-dependent silencing was found to 
be a major driver of heterogeneous Epa1 expression in a strain 
demonstrating high cell-to-cell variability but not in an alternative genetic 
background demonstrating lower heterogeneity. Inefficient silencing in the 
latter strain was overcome by ectopic SIR3 expression, and was not due to 
differences in EPA1 sequence or distance from the chromosome end 
compared with the heterogeneous strain. Moreover, strain-to-strain 
variation in the silencing-dependence of EPA1 expression was observed 
across a range of clinical isolates and was found to correlate with the 
extent of Epa1 heterogeneity. Thus, marked variation in adhesin 
expression exists between cells and between strains of C. glabrata. In 
addition, the data presented shed light on the regulation of such 
heterogeneity in particular the role of Sir-dependent transcriptional 
silencing. 
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1.1 Introduction 
Conventional studies which involve the analysis of data averaged 
across whole populations of cells generally mask any variation occurring at 
the single cell level. Marked cell-to-cell variation is known to exist between 
cells derived from genetically identical populations, a phenomenon termed 
phenotypic heterogeneity. This study aimed to investigate this process 
through the use of two yeast models of cell heterogeneity. The first of 
these was investigation into bimodal expression of the S. cerevisiae 
ubiquitin conjugating enzyme Rad6. The primary role of this protein is to 
facilitate DNA damage tolerance and as such the processes involved in this 
will be introduced. Secondly, and forming a larger part of the project, 
adhesin expression heterogeneity was studied in the opportunistic yeast 
pathogen C. glabrata, which represents the most prevalent non-albicans 
Candida species causing infection in humans. This pathogen demonstrates 
an inherent resistance to azole antifungals which is accompanied by 
relatively high crude mortality (Wisplinghoff et al., 2004, Kaur et al., 
2005). Adhesion to host tissues constitutes an important step in the 
establishment of infection, heterogeneity in adhesin expression may 
therefore have important implications for virulence, particularly given that 
in theory just one virulent cell from a larger avirulent population may be 
sufficient to establish infection. C. glabrata encodes a large family of 
glycosylphosphatidylinositol-anchored cell wall proteins (GPI-CWPs) that 
function as adhesins. These adhesins, termed epithelial adhesins (Epa 
adhesins), occupy subtelomeric positions in the genome. It is unsurprising 
then that position dependent telomeric silencing has been demonstrated as 
having a role in controlling the expression of EPA adhesins (De Las Penas 
et al., 2003, Castano et al., 2005, Rosas-Hernandez et al., 2008). In 
addition to providing a general background to C. glabrata, this introduction 
aims to discuss the fungal cell wall with particular emphasis on the GPI-
anchored proteins that reside there. Furthermore owing to the subtelomeric 
location of these adhesin genes the mechanism of telomeric silencing will 
be addressed before tackling the subject of cell individuality.   
   
1.2 Classification of Fungi and the Yeasts 
The concept of grouping organisms into specific groups has existed 
VLQFH /LQQDHXV¶ WKHRU\ RI FODVVLILFDWLRQ LQ WKH HDUO\ HLJKWHHQWK FHQWXUy, 
however it was not until 1949 that the concept of fungi was first introduced 
and finally advanced into the 5 kingdom system of classification, which 
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recognises the Fungi as a separate group alongside the Monera, Protista, 
Plantae, and Animalia (Whittaker, 1959, Whittaker, 1969, Hibbett et al., 
2007). Typically known fungal species have been divided into five phyla 
consisting of; Ascomycota, Basidiomycota, Glomeromycota, Zygomycota, 
and Chytridomycota (Hedges, 2002, Scannell et al., 2007). In the last few 
years, however, a comprehensive phylogenetic classification of the fungal 
kingdom has been proposed which includes a number of changes in the 
µEDVDO IXQJDO OLQHDJHV¶ DQG GHVFULEHV one kingdom, one subkingdom and 
seven phyla. This included the recognition of 3 additional phyla; the 
Blastocladiomycota, the Neocallimastigomycota, and the Microsporidia 
along with loss of the Zygomycota (Hibbett et al., 2007).     
The yeasts reside within the largest fungal phylum; the Ascomycota, 
which diverged from the Basidiomycota around 741-1195 million years 
ago. Almost 50% of all known fungal species and 80% of pathogenic and 
opportunistic species are contained within this phylum. Shortly after the 
initial split this phylum further diverged into 2 classes; the 
Pezizomycontina, including filamentous fungi such as Neurospora crassa, 
and the Saccharomycotina (sometimes referred to as the 
hemiascomycetes), which includes budding yeasts such as S. cerevisiae. 
Recent molecular evidence, however, has raised calls for a third 
Ascomycete class; the Archiascomycotina (Taphrinomycotina), in order to 
accommodate Schizosaccharomyces pombe which has been revealed as an 
out-group to the two existing taxa (Guarro et al., 1999, Hedges, 2002, 
Hedges et al., 2004, Scannell et al., 2007). The yeasts considered within 
the scope of this thesis occupy the Saccharomycotina within which over 
1000 species have been described. Thus far all sequenced 
Saccharomycotina genomes fall into 3 clusters; the first of which, termed 
WKH µSaccharomyces FRPSOH[¶ LV SULPDULO\ FRPSRVHG RI VSHFLHV IURP WKH
genera Saccharomyces and Kluyveromyces. Within this cluster the major 
phylogenetic divergence exists between those yeasts whose common 
ancestor underwent a whole genome duplication (WGD) event and those 
that diverged prior to this. The CTG clade forms the second cluster and 
consists of species which translate CTG codons as serine rather than 
leucine, a reassignment proposed to have occurred ~170 million years ago, 
and includes many Candida species. There has been a suggestion that this 
clade could be further diverged into 2 groups relating to sexual status, thus 
separating the fully sexual species from others which at best have a cryptic 
sexual cycle (Fitzpatrick et al., 2006, Scannell et al., 2007). Finally 
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Yarrowia lipolytica is the only sequenced member of the final cluster  (Fig. 
1) (Scannell et al., 2007).    
 
1.3 Candida glabrata  
C. glabrata is a pathogenic yeast that along with other budding, 
including pathogenic, yeasts resides within the Saccharomycotina 
subphylum of the Ascomycota. Interestingly, however, this pathogenic 
yeast exists separately from the majority of other Candida species (Fig. 1), 
which are commonly found within the CTG clade, and can instead be found 
within the WGD portion of the Saccharomyces complex along with S. 
cerevisiae (Scannell et al., 2007). Historically C. glabrata was classified into 
the genus Torulopsis due to its lack of pseudohyphal growth. It was later 
determined however, that the ability to produce pseudohyphae was not a 
reliable distinguishing factor for members of the Candida genus and in 
1978 it was proposed that T. glabrata be reclassified into this genus. Thus 
the description relating to filamentous growth for the Candida genus was 
DOWHUHGIURP³SVHXGRP\FHOLDO´WR³SVHXGRK\SKDHDEVHQWUXGLPHQWDU\RU
well developed´(Fidel et al., 1999). Pseudohyphal growth has in fact now 
been observed in C. glabrata under in vitro conditions of nitrogen 
starvation (Fig. 2) (Csank and Haynes, 2000). This process appears to be 
dependent upon the transcriptional regulator Ste12, however, unlike the 
case in Candida albicans, such filamentous growth is not believed to be 
important for virulence (Calcagno et al., 2003). Indeed, to date there is no 
description of C. glabrata growing in vivo as anything other than budding 
yeast blastoconidia, typically 1-4ǋ0 LQVL]H(Fidel et al., 1999, Csank and 
Haynes, 2000). This is in stark contrast to the morphological variation 
demonstrated in vivo by C. albicans which is able to switch between yeast 
blastoconidia of ~4-ǋ0 DQG WZR IRUPV RI ILODPHQWRXV JURZWK
pseudohyphae and hyphae (Fig. 3) (Fidel et al., 1999, Sudbery et al., 
2004); a trait that is widely considered a virulence determinant in this 
organism (Lo et al., 1997). This difference may not be surprising given the 
phylogenetically distinct positions of these two pathogens, which suggests 
that the ability of C. glabrata to become associated with the mammalian 
host evolved independently from C. albicans, and indeed other Candida 
species. C. glabrata is in-fact more closely related to the non-pathogenic S. 
cerevisiae (Fig. 1) (Kaur et al., 2005, Roetzer et al., 2011).  An 
independent evolutionary route for C. glabrata is highlighted by its clear  
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Figure 1 ± Phylogenetic tree representing evolution of the Saccharomycotina. C. 
glabrata is identified within the same cluster as S. cerevisiae while C. albicans is 
phylogenetically distinct from these 2 organisms and is located within the CTG 
clade. Slightly modified from (Roetzer et al., 2011). 
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Figure 3 ± Yeast (A), pseudohyphal (B), and hyphal (C) morphologies 
exhibited by C. albicans. Taken from (Sudbery et al., 2004).  
Figure 2 ± Demonstration of C. glabrata pseudohyphal formation following 
growth on nitrogen starvation solid medium (SLAD). (A) Illustrates a polarized 
colony, (B) Pseudohyphal chains from the perimeter of the colony seen in (A). 
Taken from (Csank and Haynes, 2000) 
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separation from the CTG clade within which many other Candida species 
reside. 
1.3.1 The Genomics of C. glabrata 
The C. glabrata type strain CBS138/ATCC2001, which was originally 
isolated from human faeces, has been sequenced as part of the 
genolevures project (http://www.genolevures.org/cagl.html) to provide 
subtelomere-to-subtelomere data for all 13 chromosomes (A-M). Upon 
exclusion of rDNA, which is organised into two distinct loci on 
chromosomes 12 and 13, this haploid genome totals 12.3Mb, encoding 
approximately 5283 coding genes and 207 tRNA genes (Sherman et al., 
2006). The C. glabrata genome shows a high degree of similarity with S. 
cerevisiae, sharing on average 65% amino acid identity between protein 
orthologues. Nevertheless, and likely due to its close association with the 
mammalian host, C. glabrata demonstrates a significantly greater degree 
of gene loss compared to S. cerevisiae resulting in regressive evolution. For 
instance, C. glabrata has streamlined its metabolic capacity with the loss of 
genes involved in galactose and sucrose assimilation, phosphate, nitrogen 
and sulphur metabolism and, thiamine, pyridoxine and nicotinic acid 
biosynthesis (Domergue et al., 2005, Kaur et al., 2005, Sherman et al., 
2006).  
 Although no sexual cycle has been observed in C. glabrata the 
genome has been shown to encode, like S. cerevisiae, three mating type-
like loci (MTL); MTL1, MTL2, and MTL3, in addition to many of the genes 
required for mating, meiosis and sporulation (Srikantha et al., 2003, 
Ramirez-Zavaleta et al., 2010). Interestingly, unlike S. cerevisiae, the 
three loci do not exist on the same chromosome. Rather, MTL1 resides at 
an internal location on chromosome B (II) with MTL3 10.5kb from the left 
end of this chromosome. MTL2 however is located 29.4kb from the left end 
of chromosome E (V). In further contrast to S. cerevisiae, only one locus, 
MTL3, is subject to silencing, this requires Sir2 to -4, yKu70, yKu80, and 
Rif1, while both the MTL1 and MTL2 loci are transcriptionally active (Muller 
et al., 2008, Ramirez-Zavaleta et al., 2010). Nevertheless C. glabrata is 
able to maintain distinct a- and alpha- haploid mating types with MTL1 
thought to function as equivalent to the S. cerevisiae MAT locus. Both the 
alpha-1 and alpha-2 genes have been found to be expressed in a mating 
type specific manner, however, the a1 gene can be detected in strains of 
each mating type. Further analysis of the a1 gene led to the proposition 
that mating type identity is maintained to some extent by incomplete 
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splicing of the transcript (Muller et al., 2008). Such a1 splicing is locus 
specific, fully processed a1 transcript is undetectable when expressed from 
MTL2, while both functional processed and non-functional unprocessed, in 
addition to partially processed forms can be detected following expression 
from MTL1 (Ramirez-Zavaleta et al., 2010). Despite apparently maintaining 
a mating type identity, genes determined as either a-, alpha-, or haploid-
specific based on their expression in S. cerevisiae are expressed 
irrespective of mating type information in C. glabrata. Thus cell-type 
specific genes are not regulated in the same way that S. cerevisiae 
regulates such genes and this likely leads to a lack of cell type identity in 
C. glabrata. Moreover it is not known if the a1, alpha1, and alpha2 proteins 
are actually functional in C. glabrata. It has been suggested that C. 
glabrata may have undergone a rewiring of these mating type regulators 
such that they do not control sexual reproduction or the cell-type identity 
genes at all. Rather they may control processes important for survival 
within the mammalian host such as the pheromone response pathway 
which is known to play a role in C. glabrata virulence (Ramirez-Zavaleta et 
al., 2010). Interestingly mating type switching from a- to alpha- has been 
reported to occur in vivo for this pathogen (Muller et al., 2008) further 
suggesting that there may be a role for these genes in virulence.  
 Finally C. glabrata exhibits significant genome plasticity with 
marked variations in chromosome structure evident upon karyotype 
analysis of different isolates.  Large chromosomal size polymorphisms were 
identified and have been associated with both reciprocal and non-reciprocal 
translocations of chromosome arms, and the translocation of 
interchromosomal duplications ranging from 40-700kb in size (Polakova et 
al., 2009). Furthermore minisatellites, including unusually long elements 
termed megasatellites, have been identified in the genome and are largely 
found in genes regulating cell-to-cell adhesion. The presence and length of 
such repeated motifs has been shown to differ between C. glabrata strains 
(Frieman et al., 2002, Thierry et al., 2008).  Another effect of this genome 
plasticity is the formation of small novel chromosomes composed of large 
120- to 200kb segmental duplications that include a centromere region and 
which have acquired telomeres. In addition chimeric chromosome fusions 
have been identified (Muller et al., 2009, Polakova et al., 2009). 
Aneuploidy in S. cerevisiae is associated with a proliferative disadvantage 
(Torres et al., 2007). This and other changes in chromosome structure are 
generally associated with pathological events in other eukaryotes and are 
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not compatible with a sexual lifecycle (Delneri et al., 2003, Polakova et al., 
2009). Elevated chromosome dynamics may however be beneficial for 
adaptation to changing environments such that may be encountered by C. 
glabrata during host infection with the suggestion that a sexual cycle has 
EHHQ ³VDFULILFHG´ to better tolerate such genome alterations (Polakova et 
al., 2009).  
1.3.2 Clinical Relevance and Incidence of C. glabrata Infections  
Several Candida species, including C. albicans and C. glabrata 
generally exist as harmless commensals of the gastrointestinal and 
genitourinary tracts and can be isolated from the mucosa of normally 
healthy asymptomatic individuals (Kaur et al., 2005). Indeed, C. glabrata 
infections are frequently thought to arise from the hosts endogenous 
microflora in response to illness or a reduction in immune defences (Fidel 
et al., 1999, Safdar et al., 2002). Despite being phylogenetically distinct, 
as discussed section in 1.1, both pathogens cause a similar range of painful 
superficial mucosal infections such as vaginitis in otherwise healthy 
women, and more severe surface oropharyngeal and esophageal 
candidiasis in HIV patients. Upon entering the bloodstream more life 
threatening systemic infections occur especially among vulnerable intensive 
care patients, particularly those undergoing cancer chemotherapy or 
immunosuppressive therapy following bone marrow or organ 
transplantation (Fidel et al., 1999, Sudbery et al., 2004, Kaur et al., 2005). 
Furthermore, many Candida infections involve the formation of biofilms on 
implanted devices such as prosthetic heart valves and particularly 
indwelling catheters, and are thus almost certainly agents of nosocomial 
infection (Fig. 4). Importantly biofilms are less susceptible to anti-fungal 
agents, primarily by limiting substance penetration through the biofilm 
matrix. Thus implant infections are notoriously difficult to treat and 
eradicate without removal of the device (Douglas, 2003, Iraqui et al., 
2005, Silva et al., 2011). 
Together Candida species are currently considered to be the  fourth 
leading cause of nosocomial bloodstream infections in the USA, estimated 
to account for 8-10% of such infections, and are associated with a crude 
mortality rate of ~39% (Pfaller and Diekema, 2004, Wisplinghoff et al., 
2004, Choi et al., 2009, Horn et al., 2009). In fact in the USA alone it is 
estimated that Candida infections are responsible for ~10,000 deaths a  
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Figure 4 ± Both (A), taken from (Silva et al., 2011) and (B), taken from 
(Iraqui et al., 2005) illustrate C. glabrata biofilms.  
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year with Medicare costs exceeding $1 billion (Miller et al., 2001, Sudbery 
et al., 2004). Thus, Candida infections clearly constitute a major public 
health concern. C. albicans is known to be the predominant cause of 
candidemia worldwide, as demonstrated by a study of 6082 bloodstream 
infection (BSI) isolates of Candida spp over a 10 year period (Pfaller and 
Diekema, 2004). Nevertheless non-albicans Candida spp are often isolated 
from infected individuals (Haynes, 2001). Indeed, recent analysis of 
isolates from 2019 patients with proven candidemia demonstrated that 
together the non-albicans Candida spp were more frequently isolated than 
C. albicans accounting for 54.4% of infection collectively (Horn et al., 
2009). Such non-albicans Candida spp include C. parapsilosis, C. tropicalis, 
and C. krusei. C. glabrata, however,  has emerged as the most prevalent 
non-albicans yeast pathogen in humans (Pfaller and Diekema, 2004, 
Wisplinghoff et al., 2004, Horn et al., 2009), being responsible for roughly 
26% of Candida bloodstream infections in the USA (Horn et al., 2009). In 
addition the frequency of C. glabrata %6,¶VKDs been seen to increase from 
13% to 24%, from 11% to 13%, and from 14% to 18% in Canada, Europe, 
and the USA respectively over a 10 year period (Pfaller and Diekema, 
2004). C. glabrata %6,¶V also demonstrate a strikingly high crude mortality 
rate of 50.1% compared with the 36.6% that is observed for C. albicans 
(Wisplinghoff et al., 2004). Inherent resistance to a number of antifungals 
may contribute to the increased prevalence and higher mortality rates seen 
for C. glabrata (Kaur et al., 2005).  
1.3.3 Treatment and Azole Resistance of Candida glabrata 
Infections 
Candidemic patients that remain untreated have been shown to 
demonstrate significantly higher mortality rates; 61% and 50% in adults 
and children respectively, versus those undergoing antifungal therapy, 
leading to the recommendation that all such patients receive antifungal 
therapy (Pappas et al., 2003). Consequently this has been accompanied by 
increased demand for existing and novel antifungal agents with the 
triazoles becoming the primary mode of treating Candida infections (Grant 
and Clissold, 1990, Pfaller and Diekema, 2004). Prior to the discovery of 
azoles the polyene antifungal amphotericin B (AmpB) was considered the 
³gold standard´ in treatment of systemic Candida infections (Wingard, 
1994). AmpB is thought to act by creating pores in the yeast cell 
membrane due to formation of an AmpB-ergosterol complex, this causes 
leakage of vital cytoplasmic components and ultimately leads to cell death. 
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It has been suggested however that a poor ability of AmpB to effectively 
differentiate between yeast ergosterol and mammalian cholesterol may 
lead to drug toxicity (Ghannoum and Rice, 1999). Renal toxicity has been 
described as a major drawback of AmpB therapy (Chen et al., 2011). Such 
toxicity problems have undoubtedly contributed to the triazoles becoming 
increasingly utilised against fungal infections, although, drug-drug 
interaction and hepatotoxicity problems have been reported for some of 
the newer azoles (Chen et al., 2011). Triazoles act by targeting the 
cytochrome P-450-dependent C14 lanosterol demethylase, encoded by 
ERG11, which is an essential enzyme in the fungal ergosterol biosynthesis 
pathway. Inhibition of this enzyme is proposed to induce both depletion of 
plasma membrane ergosterol along with intracellular accumulation of toxic 
14Ƚ-methylated intermediates. Ultimately this results in growth arrest but 
not cell death; azole antifungals are generally considered to be fungistatic 
rather than fungicidal (Henry et al., 2000, Kaur et al., 2004). Fluconazole 
has emerged as the most commonly prescribed triazole likely owing to its 
oral availability, high efficiency, and low toxicity (Grant and Clissold, 1990, 
Pappas et al., 2003).   
During such treatment C. glabrata has emerged as being of 
particular concern due to an innate resistance to azole antifungals (Kaur et 
al., 2005). In addition azole susceptible C. glabrata isolates can generate 
azole-resistance clones at a surprisingly high frequency upon exposure to 
fluconazole in vitro (Sanglard et al., 2001). Both factors likely contribute to 
the increased prevalence of C. glabrata infections in countries with high 
fluconazole use (Kaur et al., 2005), and to the relatively high mortality rate 
observed for this yeast. Indeed the introduction and widespread use of 
fluconazole has coincided with a significant decrease in the incidence of C. 
albicans BSI¶V, while C. glabrata %6,¶V notably increased during the same 
10 year period (1989-1999) in the USA (Trick et al., 2002). Furthermore 
 RI C. glabrata BSI isolates may be highly resistant to fluconazole 
(Pfaller and Diekema, 2004), and it is often isolated as a replacement 
species in individuals undergoing fluconazole treatment (Kaur et al., 2004). 
A number of factors have been implicated in fluconazole resistance 
including; up-regulation of the multidrug transporters CDR1 and CDR2 
(Sanglard et al., 2001, Kaur et al., 2005), calcium uptake and signalling 
(Kaur et al., 2004), up-regulation of the ERG11 encoded target enzyme 
(Henry et al., 2000), mitochondrial competence or loss (Sanglard et al., 
18 
 
2001, Kaur et al., 2004), and the presence of a novel minichromosome 
(Polakova et al., 2009).       
In recent years the echinocandins, including caspofungin, 
micafungin and anidulafungin, have become a first-line treatment for many 
cases of mucosal and systemic Candida infections. These drugs inhibit 1,3-
ǃ-D-glucan synthase and thus prevent synthesis of the essential cell wall 
component 1,3-ǃ-glucan. Importantly they exhibit potent in vitro and in 
vivo fungicidal activity against Candida spp including those that 
demonstrate azole resistance such as C. glabrata. Moreover adverse effects 
and drug-drug interactions appear to be minimal. Anidulafungin may be 
particularly relevant in the treatment of C. glabrata infections as there has 
been some indication that the minimum inhibitory concentration (MIC) 
required is especially low (Chen et al., 2011).  In addition all three 
echinocandins have been shown to be effective against Candida biofilms 
(Morace et al., 2009, Chen et al., 2011). Clinical resistance to the 
echinocandins does appear to be rare, although a number of case reports 
have identified caspofungin resistance in several Candida spp including C. 
glabrata. Resistance has been associated with mutations in FKS1 and its 
homologue FKS2, which encode subunits of 1,3-ǃ-D-glucan synthase 
(Krogh-Madsen et al., 2006, Thompson et al., 2008, Chen et al., 2011).   
The relative resistance of C. glabrata to antifungals, in particular 
fluconazole, along with the rising incidence of infection has important 
implications for therapy. Although the introduction of echinocandins has 
provided promising results, with resistance rare, resistance has 
nevertheless been reported in clinical isolates of C. glabrata. This, 
alongside the demonstrated genome plasticity, and subsequent 
implications for virulence, of this pathogen highlight the need for 
continuous development of novel antifungals and drug targets. 
 
1.4 The Fungal Cell Wall 
The fungal cell wall is an essential and highly dynamic structure that 
provides shape and physical strength to the fungal cell while allowing 
enough elasticity to stabilise internal osmotic conditions without rupture of 
the plasma membrane. In addition, stress-bearing cell wall polysaccharides 
function as a skeletal scaffold to an external layer of glycoproteins. 
Collectively such glycoproteins, in particular their N-linked carbohydrate 
side chains, are important for limiting permeability and therefore protect 
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the skeletal polysaccharides from hostile degrading enzymes present in the 
environment. Similarly this protein scaffold may limit the escape of soluble 
cell wall intermediates and function in the retention of periplasmic proteins 
(Klis et al., 2006, de Groot et al., 2008). Further to these more general cell 
wall functions additional functions are conferred via the specific activities of 
individual cell wall proteins &:3¶V&:3¶V allow yeast cells to flocculate 
and adhere either to each other or to a surface. Indeed, being the first 
point of host-pathogen contact, the cell wall has an important role in 
numerous host-fungus interactions during the establishment of infection. 
For instance, cell wall components not only mediate adherence but also, 
tissue invasion and subsequent proteolytic damage, they provide protection 
against host defence mechanisms, are involved in biofilm formation, trigger 
the host immune response, and may also confer resistance to antifungal 
drugs. In addition they enable recognition of mating partners, offer 
protection against oxidative stress, facilitate iron acquisition and aid sterol 
uptake. (Klis et al., 2006, de Groot et al., 2008, Yin et al., 2008, Levitz, 
2010). 
1.4.1 Cell Wall Structure 
Cell wall construction is a tightly controlled process coordinated with 
the cell cycle and dependent upon environmental conditions (Klis et al., 
2006, Lesage and Bussey, 2006). The major components of the fungal 
cell wall, based on studies in a number of yeasts including S. cerevisiae, C. 
albicans, and C. glabrata, are WKH SRO\VDFFKDULGHV  ǃ-glucan,  ǃ-
glucan, and chitin and covalently incorporated cell wall glycoproteins (Fig. 
5A). All three organisms conform to the same bi-layered architectural 
model with the various proteins and polysaccharides being localised to the 
same regions via the same linkages (Fig. 5A and B) (de Groot et al., 2004, 
Weig et al., 2004, de Groot et al., 2008, Klis et al., 2010). Nevertheless, 
there are specific differences in the contribution of the individual 
components (Table. 1) (de Groot et al., 2004, Weig et al., 2004, de Groot 
et al., 2008). A great deal of metabolic energy is likely invested in cell wall 
biosynthesis since both S. cerevisiae and C. glabrata cell walls, typically 
100-200nm in thickness, account for roughly 20% of the cells¶ dry weight 
(de Groot et al., 2008, Klis et al., 2010). The highly elastic and load 
bearing inner portion of the cell wall is constructed from a continuous 
QHWZRUNRIǃ-glucan created through the interaction of side chains via 
hydrogen bonds. The flexible helical structure of  ǃ-glucan molecules, 
which can exist at various stages of extension, aids in creating such  
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Figure 5 ± (A) Schematic representation of cell wall molecular architecture for 
S. cerevisiae, C. albicans, and C. glabrata (Kapteyn et al., 2000).  (B) Lateral 
view of the C. glabrata cell wall. CW, cell wall; ASL, alkali sensitive linkage: EC, 
extracellular environment; PM, plasma membrane; C, cytosol (de Groot et al., 
2008). 
Table 1 ± Cell wall composition of C. glabrata in comparison to S. cerevisiae 
and C. albicans (de Groot et al., 2008) 
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elasticity. As alluded to earlier, this allows the inner network to become 
considerably extended and aids in the prevention of cell rupture when 
surrounded by hypotonic conditions. Equally it enables the cell, which can 
lose up to 60% of its volume when placed in hypertonic solutions, to shrink 
reversibly (Klis et al., 2006).  
The non-reducing ends of  ǃ-glucan molecules can act as sites 
for the covalent attachment of additional polysaccharides (Fig. 5A). 
Internal to WKH  ǃ-glucan layer these covalent interactions result in 
attachment of chitin chains and extension of the inner wall. By contrast the 
ǃ-glucan layer is extended towards the cells external face by chains of 
higKO\EUDQFKHGǃ-glucan. These branched chains are often covalently 
attached to GPI-anchored cell wall mannoproteins, chitin can also become 
attached to ǃ-glucan. Additionally a smaller group of cell wall proteins 
containing internal repeats, the Pir protein family, can be directly linked to 
WKH  ǃ-glucan network via an alkali sensitive linkage (ASL) and are 
distributed throughout the cell wall (de Groot et al., 2004, Weig et al., 
2004, Klis et al., 2006, de Groot et al., 2008).  
There has been suggestion that the consensus sequence (DGQJQ) 
within such Pir internal repeats is involved in direct attachment to 1,3 ǃ-
glucan. Consequently it is thought conceivable that Pir-&:3¶VPD\DFW WR
LQWHUFRQQHFW VHYHUDO  ǃ-glucan molecules thus adding considerable 
strength to the wall (Klis et al., 2006). Consistent with this a strong up-
regulation of PIR genes upon cell wall stress is observed. It was thought 
this may also go some way to explaining the apparent essentiality of the 
only protein to contain Pir repeats in C. albicans, Pir1 (Klis et al., 2010), 
however, this protein has now been successfully deleted (Noble et al., 
2010). Proteins can also become attached to the wall in a reducing agent 
sensitive manner, often via disulphide bridges to other proteins (de Groot 
et al., 2004, Klis et al., 2006, Ruiz-Herrera et al., 2006), or via non-
covalent ionic bonds due to the many negative charges present at the cell 
wall (Yin et al., 2008).  
Estimations based upon exponentially growing S. cerevisiae cells in 
rich medium suggest that the number of covalently linked proteins per cell 
LVaPLOOLRQZLWKDSURWHLQGHQVLW\RIPROHFXOHVǋP2 (Klis et al., 
2010). Interestingly this number is likely increased in C. glabrata which has 
been identified as having 50% higher mannoprotein content than either S. 
cerevisiae or C. albicans. This is accompanied, as expected, by a higher cell 
wall mannan component, as such the relative level of glucan is decreased 
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and the mannose: glucose ratio is seen to increase. Furthermore lower 
levels of alkali-insoluble glucans, relative to both total wall mass and total 
glucan, compared to S. cerevisiae and C. albicans suggests that fewer 
cross-links between glucan and chitin exist in the cell wall of this pathogen 
(Table. 1).  There is some suggestion that a mannoprotein dense outer 
OD\HUPD\DLGLQPDVNLQJǃ-glucans, known to be potent proinflammatory 
molecules, from host immune recognition more effectively than is observed 
for C. albicans.  This may increase the propensity of the pathogen to cause 
disease (Wheeler and Fink, 2006, de Groot et al., 2008).   
As an essential structure, constructed of components largely absent 
from mammalian cells, fungal cell walls provide an excellent reservoir for 
the detection of potential drug targets and the development of novel 
antifungals. The identification of fungal constituents to serve as new drug 
targets may in future go some way to aid the emerging problem of 
antifungal resistance in C. glabrata clinical isolates. 
1.4.2 GPI-Anchored Cell Wall Proteins 
Covalently linked CWPs have been identified in numerous fungi and 
the cell walls of S. cerevisiae, C. albicans and C. glabrata can contain > 20 
different types of these CWPs of differing functions at any time. As 
discussed earlier, the cell wall mannoproteins can be divided into two 
groups the largest of which comprises proteins that are modified by 
addition of a GPI anchor and can be specifically released from the cell wall 
by treatment with HF-pyridine (de Groot et al., 2008, Klis et al., 2010). S. 
cerevisiae, C. albicans, and C. glabrata have been found to contain 66, 
115, and 106 putative GPI proteins respectively (De Groot et al., 2003, 
Richard and Plaine, 2007, de Groot et al., 2008, Klis et al., 2009). GPI-
anchored cell wall proteins undergo a maturation process involving a 
number of post-translational modifications during which the proteins 
become fully glycosylated (Klis et al., 2010). Such GPI modifications can be 
identified in roughly ~0.5% of all eukaryotic proteins (Eisenhaber et al., 
2001). Proteins destined for GPI-anchor addition share a number of 
conserved features including an N-terminal hydrophobic signal sequence, 
which targets the nascent polypeptide to the endoplasmic reticulum (ER), 
and a C-terminal GPI anchor addition signal sequence which is replaced by 
a GPI anchor during the maturation process (Fig. 6). The two signal 
peptides are separated by a functional domain and a ser/thr rich spacer 
domain (De Groot et al., 2005, Klis et al., 2006, Klis et al., 2009).  
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Figure 6 ± Structure of the GPI-anchored protein precursor demonstrating the 
hydrophobic cleavable signal sequences and the enzymes involved, the GPI 
addition site and spacer sequence. The GPI-anchor core structure is also shown 
illustrating the components and sites at which further modification can occur, 
DAG-diacylglycerol (Mayor and Riezman, 2004).  
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Following targeting to the ER, the entry point to the secretory 
pathway for newly synthesised proteins, the N-terminal signal peptide is 
removed by a signal peptidase complex. Similarly, via the action of a GPI 
transamidase, the C-terminal signal sequence is recognised and cleaved 
before attachment of a preassembled GPI anchor at the C-terminal GPI-
DQFKRU DWWDFKPHQW VLWH ǔ-site) (Ikezawa, 2002, Mayor and Riezman, 
2004, Pittet and Conzelmann, 2007, Klis et al., 2009). Amino acid residues 
N-terminal to the ǔ-VLWHDUHWHUPHGǔ-minus whilst those C-terminal to the 
DWWDFKPHQWVLWHDUHGHVLJQDWHGǔ-plus. Studies into this region have been 
predominately undertaken using S. cerevisiae and the GPI-anchor signal 
sequence is known to have a number of general features. These begin with 
D VWUHWFK RIa SRODU DPLQR DFLGV ǔ- WRǔ-1) which forms a flexible 
linker region. The GPI attachment site itself is the first of three contiguous 
DPLQR DFLGV WKDW SUHFHGH D PRGHUDWHO\ SRODU VSDFHU VHTXHQFH ǔ-to-
ǔ ZKLFK LV ILQally followed by a hydrophobic sequence of variable 
length up to the C-terminal end (Fig. 6) (Mayor and Riezman, 2004, Orlean 
and Menon, 2007, Pittet and Conzelmann, 2007). The anchored protein is 
rapidly attached to the ER membrane where it exists as a tail-anchored 
membrane glycoprotein (de Groot et al., 2008, Klis et al., 2010). 
The structure of the GPI anchor is common amongst all species and 
consists of ethanolamine phosphate, through which an amide bond is 
FUHDWHG ZLWK WKH QHZO\ JHQHUDWHG FDUER[\O JURXS DW WKH ǔ-site following 
protein cleavage, a trimannosyl core, glucosamine and phosphatidylinositol 
(Fig. 6). An acyl-chain present on the inositol ring is thought to be required 
for efficient biosynthesis and attachment of the anchor. Yeast also contains 
an essential fourth mannose (Man) residue attached to the core 
trimannoside via Man-3. This fourth mannose is necessary for the addition 
of the Man-3 ethanolamine phosphate which subsequently becomes protein 
linked. Man-1 and Man-2 initially contain ethanolamine side chains, 
however, it is unclear if these side chains are retained by fully mature GPI-
anchored proteins at the cell surface (Orlean and Menon, 2007, Pittet and 
Conzelmann, 2007, Fujita and Kinoshita, 2010). Indeed following addition 
to the protein the GPI anchor is subject to various modifications within the 
ER and Golgi during transport to its final destination. Such modifications 
include inositol deacylation and remodelling of the glycan and lipid 
components (Fujita and Kinoshita, 2010). Interestingly, in S. cerevisiae, 
newly synthesised GPI-anchored proteins are separated from other 
secretory transmembrane proteins upon exit from the ER, this is in stark 
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contrast to the lack of segregation observed for mammalian GPI-anchored 
proteins. The proteins are then transported to the Golgi in coat protein 
complex II (COPII) coated vesicles and continue their maturation process 
(Muniz et al., 2001, Castillon et al., 2009, Rivier et al., 2010).  
Fungal GPI proteins follow the secretory pathway until they reach 
the plasma membrane where some are retained and termed GPI plasma 
membrane proteins (PMPs) whilst others continue on and are incorporated 
into the cell wall (GPI-CWPs). Nevertheless other mature GPI proteins have 
been identified in substantial amounts at both locations and it seem likely 
that this is the case for both S. cerevisiae and C. albicans (Mao et al., 
2008, Klis et al., 2009). 7KHVHTXHQFHVLPPHGLDWHO\EHIRUHWKHǔ-site are 
known to be important for determining the final destination of such fungal 
*3, SURWHLQV 3DUWLFXODUO\ D GLEDVLF PRWLI DW ǔ- DQG ǔ-2 has been 
implicated in directing a greater proportion of protein to the membrane. 
CWPs lack this dibasic motif and rather K\GURSKRELFUHVLGXHVDWǔ-DQGǔ-
5 are more influential in directing a greater amount of protein to the cell 
wall. Furthermore all wall-directed proteins contain a substantial 
hydrophobic region of four to eight residues N-WHUPLQDO WR WKHǔ-site. By 
contrast proteins destined for the membrane demonstrate a hydrophobic 
residue exclusion zone wLWKLQaUHVLGXHVRI WKHǔ-site. Additionally the 
characteristic ser/thr rich domains of the proteins are thought to favour cell 
wall targeting to such an extent that the membrane retaining effect of the 
dibasic motif may be overridden (Frieman and Cormack, 2004, Dranginis et 
al., 2007, Mao et al., 2008). Cell wall attachment in ascomycetous yeast is 
known to require processing of the GPI-anchor, (De Groot et al., 2005). 
Arriving at the plasma membrane the lipid moiety of the GPI anchor is 
UHPRYHGDQGWKHSURWHLQVEHFRPHWDLODQFKRUHGWRǃ-glucan in the cell 
wall via a trimmed GPI structure (GPIt). Consequently the N-terminal 
region extends out into the external environment (Klis et al., 2010).  
1.4.2.1 GPI-Anchored Adhesins 
The cell walls of human pathogens act as the first point of contact 
with the human host and thus govern the initial host-pathogen interactions 
that underlie the establishment of fungal infections. Adhesion is one of the 
first such interactions to occur and is an important initial step in the 
infection process. Thus the proteins often referred to collectively as 
adhesins, that mediate these interactions are of interest as virulence 
factors. Candida adhesins tend to be grouped into large gene families 
which include the eight-member ALS (agglutinin-like sequence) gene family 
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in C. albicans, (Zhao et al., 2004, Hoyer et al., 2008), and the EPA 
(epithelial adhesin) family in C. glabrata of which there are at least 17 
members in the sequenced CBS138 strain (Kaur et al., 2005). When 
expressed heterologously in S. cerevisiae, members of both adhesin 
families enable this normally non-adherent organism to adhere to 
mammalian cells (Cormack et al., 1999, Frieman et al., 2002, Sheppard et 
al., 2004). S. cerevisiae itself encodes the FLO (flocculin) family of 
adhesins which confer adherence to agar, plastics and other yeast cells 
(Halme et al., 2004). C. glabrata has been reported to contain 106 putative 
GPI proteins, around 50% of which have adhesin like properties and can 
thus be potentially implicated in fungal-host interactions or biofilm 
formation during the development of infection (Weig et al., 2004). Further 
investigation, XVLQJDGLUHFWFHOOZDOO ³VKDYLQJ´PHWKRG and tandem mass 
spectrometry, however, identified just 23 proteins to be covalently 
incorporated into the cell wall (de Groot et al., 2008). Adhesin structure 
and maturation conforms to that observed for other GPI-anchored proteins 
(1.4.2), with the N-terminal functional domain being involved in ligand 
binding and projected from the wall surface by the ser/thr rich region 
(Frieman et al., 2002, Dranginis et al., 2007). Analysis of the glycan 
specificity of the C. glabrata EPA adhesin family members; Epa1, Epa6, and 
Epa7, revealed that all three bind to glycans containing a terminal 
galactose residue. Glycan specificity, however, does vary with Epa6 having 
a broader substrate range than either Epa1 or Epa7. Interestingly, other 
pathogenic organisms are known to bind to the same galactosides as have 
been identified for the Epa proteins (Zupancic et al., 2008). The difference 
in Epa specificity has been attributed to a 5-amino acid hypervariable 
region within a surface loop of the PA14 (anthrax toxin protective antigen) 
domain in the N-terminus (Zupancic et al., 2008). An additional 
hypervariable region within the PA14 domain corresponds to an adjacent 
surface loop and has also been implicated in ligand binding (Fig. 7) 
(Zupancic et al., 2008). The PA14 domain has previously been suggested 
to contribute to carbohydrate binding (Rigden et al., 2004) and can also be 
identified in all additional currently known members of the C. glabrata Epa 
family and within the Flo family of S. cerevisiae. The Als adhesins of C. 
albicans do not display the lectin-like properties of the Epa and Flo families, 
and instead are known to bind peptides. Consistent with this, the PA14 
domain has not been identified in these proteins (Dranginis et al., 2007, de 
Groot and Klis, 2008).  
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Figure 7 ± Cartoon and space filling model of the PA14 domain taken from 
(Zupancic et al., 2008). The 5 amino acid hypervariable region that 
determines sugar specificity is shown in purple while the additional 
hypervariable region also implicated in ligand binding is highlighted in orange.  
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Given the important role of adhesins in host-pathogen interactions 
and in the establishment of infection, further investigation into such 
molecules may be important to advance understanding of host colonization 
by pathogenic yeasts. Furthermore the pathways responsible for their 
expression, biosynthesis, and cell wall assembly may provide a potential 
reservoir of new drug targets. Interestingly members of both the C. 
glabrata EPA and S. cerevisiae FLO adhesin families are predominantly 
located in subtelomeric regions. Consequently these adhesin families are 
known to be subjects of transcriptional silencing (De Las Penas et al., 
2003, Halme et al., 2004, Castano et al., 2005, Rosas-Hernandez et al., 
2008). Moreover, transcriptional silencing appears to have an important 
role in controlling gene expression variation between individual cells 
(Halme et al., 2004, Verstrepen and Fink, 2009), and may thus be of 
importance during the investigation into EPA heterogeneity during this 
study. 
 
1.5 Sir-Dependent Transcriptional Silencing in Yeasts  
One of the best studied examples of transcriptional silencing can be 
found in S. cerevisiae where silencing occurs at telomeres, the silent 
mating type loci and within the ribosomal DNA (rDNA) repeats (Rusche et 
al., 2003). As such, and owing to the close relationship between S. 
cerevisiae and C. glabrata, information obtained from this well researched 
budding yeast will provide the basis of this section. Despite different 
mechanisms, the behaviour of silent chromatin and the pathways that 
assemble it appear to be strikingly similar in the fission yeast S. pombe 
and involve orchestrated changes in chromatin modifications (Rusche et 
al., 2003, Buhler and Gasser, 2009).  Transcriptional silencing involves the 
establishment of a specialised chromatin structure, similar to the 
heterochromatin of higher organisms, which is less accessible to restriction 
enzymes and DNA methylases, and exhibits repressed gene expression 
within the silenced domain. A major factor underlying the regulation of 
such silencing is histone modification which includes processes such as 
acetylation, methylation and monoubiquitination. Acetylation is probably 
the best understood of these modifications, however the role of 
methylation is also becoming more prominent. Indeed active regions of 
chromatin are associated with both acetylation and methylation whereas 
deacetylated and demethylated histones are associated with silenced 
regions (Rusche et al., 2003, Shilatifard, 2006, Shahbazian and Grunstein, 
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2007, Yang et al., 2008, Verzijlbergen et al., 2009, Takahashi et al., 2011). 
Silent information regulator (Sir) proteins are important regulators of this 
silencing, with chromatin immunoprecipitation studies revealing them to be 
spread inward from telomeres and distributed throughout the HMR and 
HML loci to form a distinct chromatin structure (Rusche et al., 2003). The 
Sir2 protein of S. cerevisiae was the first discovered member of the class 
III histone deacetylases (HDACs), also referred to as sirtuins. The class III 
+'$&¶V are found in organisms ranging from bacteria to humans and are 
orthologs of the yeast transcriptional repressor Sir2 (North and Verdin, 
2004, Tong and Denu, 2010, McGuinness et al., 2011). By contrast class I 
and II HDACs are orthologs of the yeast deacetylases Rpd3 and Hda1 
respectively and demonstrate no sequence similarity to the class III 
HDACs. They do however share significant similarity to each other in their 
catalytic cores (de Ruijter et al., 2003, Verdin et al., 2003).  
 Sir2 catalyses NAD+-dependent deacetylation of histone tail lysines, 
and is essential, but not sufficient, for transcriptional silencing at all sites in 
yeast with deacetylation of histone H4 Lys-16 appearing to be of particular 
importance. Although Sir2 is required at all silenced regions different 
multiprotein complexes are utilised at these different genomic sites. 
Silencing at both telomeres and the mating type loci is regulated by the Sir 
complex which consists of Sir2, Sir3 and Sir4, whereas Sir2-dependent 
silencing at rDNA is mediated by the regulator of nucleolar silencing and 
telophase exit (RENT) complex, containing Sir2, Net1, and the telophase-
regulating phosphatase Cdc14 (Rusche et al., 2003, North and Verdin, 
2004, Shahbazian and Grunstein, 2007, Tong and Denu, 2010). The 
enzymatic activity initially associated with sirtuins was ADP-
ribosyltransferase requiring NAD+, and indeed some sirtuins may mediate 
such a process, however histone deacetylation was later revealed as the 
primary activity. This efficient histone deacetylation reaction is coupled to 
formation of the novel acetyl-ADP ribose product O-acetyl-ADP ribose 
(OAADPr). During the reaction one molecule NAD+ and acetyl-lysine are 
readily converted to one molecule of deacetylated lysine, nicotinamide, and 
OAADPr LQ SDUWLFXODU WKH ¶-O-acetyl-ADP ribose isomer. Ultimately this 
occurs by transfer of the removed acetyl group to the ADP-ribose moiety of 
NAD+ (Fig. 8) (Smith et al., 2008, Tong and Denu, 2010). Deacetylation of 
histone H4 Lys-16 via the action of Sir2 as mentioned earlier is of 
particular importance in gene silencing, however Hos2 mediated 
deacetylation of this same residue actually has a role in gene activation. It 
3
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Figure 8 ± NAD+-dependent histone deacetylation catalysed by the activity of Sir2. The reaction leads to deacetylation of the histone tail along with 
formation of nicotinamide and the novel metabolite OAADPr. Taken from (Tong and Denu, 2010).  
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is thought such differing roles for the same modification may be due to the 
context of histone acetylation of surrounding residues.  Deacetylation of H4 
Lys-16 with acetylation at other sites is important for activation, while in 
the context of other unacetylated residues, as found at heterochromatin, 
the modification is important for the establishment of transcriptional 
silencing (Rusche et al., 2003, Shahbazian and Grunstein, 2007, Buhler 
and Gasser, 2009). It is interesting to note that the class I and II 
deacetylases have lost this energetically expensive mechanism and do not 
require NAD+ as a cofactor. Accumulating evidence implicating OAADPr in 
numerous downstream cellular functions, including the ability to synergize 
or antagonize sirtuin biological activity may go some way to explain 
retention of the process (Tong and Denu, 2010). 
1.5.1 Telomeric Silencing 
Telomeres were first identified by the observation that x-ray 
induced chromosomal rearrangements never included loss of the terminal 
chromosome regions. This was in contrast to the terminal region loss seen 
at chromosomal breaks. Consequently telomeres were identified as non-
nucleosomal VWUXFWXUHV WKDW IXQFWLRQ DV µFDSV¶ SURWHFWLQJ WKH HQGV RI
chromosomes from DNA repair and degradation. More recently, however, a 
number of additional properties of the chromosome ends have been 
identified including roles in aging and senescence, transcriptional silencing 
and chromatin structure, segregation, cell cycle control, chromosome 
movement, and nuclear architecture (Pryde and Louis, 1997, Louis and 
Vershinin, 2005).    
Telomeric DNA sequences are strongly conserved between a 
number of divergent species and generally exhibit a single stranded G-rich 
¶ RYHUKDQJ DQG double stranded telomeric repeats transitioning into the 
sub-telomere (Louis and Vershinin, 2005, Buhler and Gasser, 2009). The 
telomere sequences of S. cerevisiae consist of a variable repeat of TG1-3 
that can extend to ~300bp in length (Buhler and Gasser, 2009). The size of 
such repeat regions exhibit remarkable variation between species, ranging 
from 20bp in the ciliate Oxytricha to ~150kb per telomere in laboratory 
mouse strains, tobacco and wheat (Louis and Vershinin, 2005). The 
telomeric repeats of C. glabrata are suggested to range from 400-700bp 
(Kachouri-Lafond et al., 2009). Specific synthesis of these telomeric 
repeats and thus maintenance of the telomere is ensured by the enzyme 
telomerase, with telomerase deficient mutants demonstrating a progressive 
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telomere shortening in the VR FDOOHG ³HYHU VKRUWHU WHORPHUH´ SKHQRW\SH
(Pryde and Louis, 1997, Kachouri-Lafond et al., 2009).  
Moving away from the chromosome ends, subtelomeric regions 
follow on from the telomeres and in S. cerevisiae are composed of a 
number of subtelomeric elements that can vary between ends and strains. 
$WPDQ\HQGVWKLVLQFOXGHVWKHKLJKO\FRQVHUYHG<¶HOHPHQW, of which there 
can be up to four copies. All ends have core X element, most of which 
contain a core-X repeat, and can range in size from 300bp to 3kb. The 
core-X is centromere-proxLPDO WR WKH<¶HOHPHQWDQG WKH WZR regions are 
VHSDUDWHG E\ VPDOOHU VHTXHQFHV WHUPHG VXEWHORPHULF UHSHDWV 675¶V 
(Pryde and Louis, 1999, Louis and Vershinin, 2005, Zhu and Gustafsson, 
2009). In contrast to the telomeres themselves, subtelomeres are known 
to encode several gene families including the S. cerevisiae FLO family of 
adhesins (Halme et al., 2004), and the EPA family of adhesins in C. 
glabrata, which constitute the major focus of this study. Consequently both 
adhesins families are subject to telomeric silencing (De Las Penas et al., 
2003, Halme et al., 2004, Castano et al., 2005, Rosas-Hernandez et al., 
2008).  
1.5.1.1 Assembly and Propagation of the Telomeric Sir 
Complex 
 In S. cerevisiae, assembly of the Sir complex at telomeric regions 
begins by an initial interaction of Rap1, a sequence-specific DNA binding 
protein also involved in the regulation of telomere length, with telomeric 
repeats (Conrad et al., 1990, Pryde and Louis, 1997, Castano et al., 2005, 
Buhler and Gasser, 2009). Rap1 binding sites exist roughly every 20bp in 
the telomeric repeat sequences (Pryde and Louis, 1997). The observation 
that Sir4 is able to bind Rap1 independently of other silencing factors at 
regions close to the telomeres of S. cerevisiae, while all silencing factors 
are required for the same interaction at telomere distal regions (0.5kb and 
beyond) (Luo et al., 2002) led to the following model for Sir complex 
assembly and propagation. After binding to the telomeric repeats Rap1 
recruits Sir4 to the telomere, an interaction that initiates further sequential 
recruitment of additional Sir proteins. Sir2 associates via interaction with 
both Sir4 and histone H4 at the nucleosome adjacent to the Rap1 binding 
sites. Sir2-mediated deacetylation, particularly at histone H4 Lys-16, then 
enables Sir3 and Sir4 binding to histone tails (Fig. 9) (Luo et al., 2002, 
Liou et al., 2005, Talbert and Henikoff, 2006). The yKu70/yKu80 hetero-  
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Figure 9 - Representation of Sir complex assembly at the telomeres of budding 
yeast. Taken from  (Blasco, 2007). Rap1 binds to double stranded telomeric 
repeats and subsequently recruits Sir2, Sir3, and Sir4 in addition to the Rif 
proteins which compete with the Sir complex for binding. Subsequent histone 
deacetylation enables further recruitment and spreading of the Sir complex into 
subtelomeric regions. The G-strand overhang is bound by Cdc13.   
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dimer is also required for silencing and predominantly associates with 
telomeres via direct DNA end binding. The heterodimer promotes 
recruitment of Sir4 to the subtelomere possibly by counteracting the action 
of Rif1, a Rap1 binding protein that inhibits Rap1-Sir4 association (Mishra 
and Shore, 1999, Lopez et al., 2011). Interestingly Sir4 appears important 
in the recruitment of yKu70/yKu80 to the subtelomere likely due to the 
interaction between yKu80 and Sir4 (Lopez et al., 2011). Spreading of 
silent chromatin then occurs as Sir3 recruits additional Sir4, which in turn 
binds Sir2 and allows further deacetylation and binding of more Sir3 and 
Sir4 to histone tails (Luo et al., 2002, Liou et al., 2005, Talbert and 
Henikoff, 2006). 
More recent studies have increasingly identified methylation as 
having an important role in the maintenance of silent chromatin with levels 
of this modification being reduced in silent regions. In particular Dot1 
dependent methylation at histone H3 Lys79 and Set1 dependent 
methylation of H3 Lys4 have been proposed to act as boundary elements, 
efficiently targeting silencing components to unmethlyated 
heterochromatin. Loss of methylation at these residues does indeed lead to 
redistribution of Sir proteins across the genome and silencing defects. 
Histone acetylation appears to have a similar role and such observations 
demonstrate the ability of histone modifiers to make positive and negative 
contributions to heterochromatin formation (Verzijlbergen et al., 2009, 
Norris and Boeke, 2010, Takahashi et al., 2011). Consequently 
heterochromatin formation and spreading is proposed to be determined by 
competition between binding of the Sir complex and the action of histone 
modifying enzymes. For instance Sir3 and Dot1 are thought to compete for 
the methylation state of H3 Lys-79 while Sir2 competes with the 
acetyltransferase Sas2 for the acetylation state of histone H4 Lys-16 
(Verzijlbergen et al., 2009, Norris and Boeke, 2010).  
Transcriptional silencing can be propagated to distances of 4- to 8-
kb within the subtelomeric regions of S. cerevisiae. By contrast, 20- to 25-
kb of the subtelomeric region within C. glabrata can be subject to this so 
called telomere position effect (TPE) gene silencing (Rosas-Hernandez et 
al., 2008). In each instance, however, the strength of silencing has 
generally been demonstrated to decrease with increased distance from the 
telomere (Renauld et al., 1993, De Las Penas et al., 2003, Castano et al., 
2005, Rosas-Hernandez et al., 2008). Promoter weakening, the presence of 
a 6.7NE VXEWHORPHULF <¶ HOHPHQW DQG RYHUH[SUHVVLRQ RI 6LU H[WHQG WKH
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distance across which silencing can occur (Renauld et al., 1993), the latter 
being associated with increased propagation of Sir3 from the telomeric 
regions into adjacent chromatin. Interestingly, the detection of both Sir2 
and Sir4 is decreased at such regions suggesting that Sir3 can function 
independently (Renauld et al., 1993, Hecht et al., 1996, Strahl-Bolsinger et 
al., 1997). Indeed incubation of purified full length Sir3 with naked DNA, 
nucleosome core particles, or defined nucleosomal arrays created 
condensed chromatin fibers (McBryant et al., 2008). 
Initial ideas of repression spreading continuously from the telomere 
and ever diminishing in strength (Renauld et al., 1993) may be rather too 
simplistic, particularly with the observation that silencing at the native ends 
of S. cerevisiae chromosomes is actually discontinuous and can vary 
significantly in intensity between ends (Pryde and Louis, 1999, Zhu and 
Gustafsson, 2009) <¶ HOHPHQWV DUH KLJKO\ HQULFKHG LQ QXFOHRVRPHV DQG
resistant to silencing along the majority of their length. Consistent with 
active chromatin they lack the classical hallmarks of heterochromatin such 
as low H4 Lys-16 acetylation, and high Sir3 and Rap1 occupancy. Maximal 
repression is actually observed within the centromere-proximal 
subtelomeric core X element which is devoid of nucleosomes and bound by 
Rap1 and Sir3 (Zhu and Gustafsson, 2009). Repression peaks at a site 
adjacent to the ARS consensus sequence within core X, before decreasing 
precipitously towards the centromere (Fig. 10). Such X element repression 
requires proximity to the telomere and remains dependent upon the Sir 
and Ku proteins (Pryde and Louis, 1999, Louis and Vershinin, 2005, Zhu 
and Gustafsson, 2009).  Resistance of the <¶ HOHPHQW to silencing is 
VXJJHVWHGWREHGXHWRORRSLQJRXWRIWKH<¶HOHPHQWIROORZLQJLQWHUDFWLRQ
between the terminus and the core X element, possibly due to the 
interaction of Rap1 and Sir proteins at the TG1-3 repeats with the Rap1/Sir 
protein structure at core X (Fig. 10) (Pryde and Louis, 1999, Zhu and 
Gustafsson, 2009). Alternatively the presence of subtelomeric anti-
silencing regions (STARs) DQGUHOD\HOHPHQWVZLWKLQ;DQG<¶HOHPHQWVPD\
discontinuously impede and re-establish silencing respectively (Fourel et 
al., 1999, Louis and Vershinin, 2005). Either way these observations 
illustrate that repressive chromatin can assemble centromere-proximal to a 
region that is expressed and indicate that transcriptional silencing does not 
depend on exact distance to the chromosome end. The precise locations of 
;DQG<¶HOHPHQWVDUHLPSRUWDQWLQGHWHUPLQLQJ chromosome specific sub-  
 
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 ± The looping model of discontinuous telomeric silencing during 
ZKLFK WKH <¶ HOHPHQW LV SURWHFWHG IURP VLOHQFLQJ ZLWK PD[LPDO UHSUHVVLRQ
occurring within the core X element. Taken from (Pryde and Louis, 1999), the 
core X element has subsequently been found to be histone deficient.   
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telomere organisation and indeed silencing at individual chromosome ends 
(Zhu and Gustafsson, 2009). 
The influence of subteORPHULF <¶ HOHPHQWV RQ WUDQVFULSWLRQDO
silencing is not likely a factor that requires consideration within the C. 
glabrata portion of this study as the pathogenic \HDVW ODFNV FRQVHUYHG<¶
elements within subtelomeres (Kachouri-Lafond et al., 2009). Even so, 
silencing in C. glabrata is not thought to purely be a product of distance 
from the telomere. Furthermore, the telomeres of this pathogen are not 
equivalent, with silencing requirements differing between ends. Position 
dependent silencer elements have been implicated in this. Variation in TPE 
between different telomeres is an observation mirrored in S. cerevisiae 
(Rosas-Hernandez et al., 2008). Additional factors, such as the negative 
regulators of sirtuin activity recently identified in S. cerevisiae, may also 
contribute to differences in telomeric silencing observed between different 
ends (Raisner and Madhani, 2008). 
Ultimately, telomeric silencing appears to be an extremely complex 
process with various possible modes of regulation. Further understanding 
of the process will be of particular use in the study of subtelomeric gene 
families, many of which encode pathogenic virulence factors and have 
important implications for host infection.   
  
1.6 DNA Damage Tolerance in Yeast 
Genetic material contained within cells is constantly subjected to 
various exogenous and endogenous agents that can lead to a wide variety 
of different types of DNA damage and/or lesions.  The consequences of 
such damage are, as a result, also extremely diverse and include; 
obstruction of DNA replication, irreversible mutations contributing to 
oncogenesis, blockage of transcription and cell death.  In reaction to the 
broad spectrum of DNA damage that can occur cells have developed a 
number of repair mechanisms. Although no single repair system can cope 
with all types of DNA damage, together they counter most types of 
oxidative and spontaneous DNA damage (Hoeijmakers, 2001, Ulrich, 
2005), and have overlapping roles (Doetsch et al., 2001). Most repair 
mechanisms rely on the excision of damaged DNA regions followed by 
subsequent resynthesis based on information encoded by the 
complementary strand. A requirement for the complementary strand 
renders these excision repair systems unable to act on regions of damaged 
single stranded DNA as these arise during genome replication. 
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(Hoeijmakers, 2001, Salmon et al., 2004, Ulrich, 2005). Replication of 
cellular DNA is often blocked by such damage causing replication forks to 
stall, thus risking their collapse. The resulting cell cycle arrest would 
eventually lead to cell death. Consequently DNA damage tolerance, which 
enables bypass of such DNA lesions without actually removing the damage, 
has evolved to enable completion of replication under such circumstances 
(Fig. 11). These processes play an integral role in cell survival following 
exposure to genotoxic agents (Ulrich, 2005, Branzei and Foiani, 2007, 
Andersen et al., 2008). Two pathways of DNA damage tolerance exist and 
have been termed the error free pathway and the error prone or 
translesion synthesis pathway (TLS) (Fig. 11). Both pathways are induced 
by DNA damage or replication stress and, although they perform damage 
tolerance through two different mechanisms, they both require the 
ubiquitin conjugating enzyme (E2) Rad6 and its binding partner, the 
ubiquitin ligase (E3) Rad18, the former of which will be discussed further in 
chapter 3. The DNA polymerase processivity clamp, proliferating cell 
nuclear antigen (PCNA), acts as the ubiquitination target for both damage 
tolerance pathways (Ulrich, 2005, Ulrich, 2009). 
1.6.1 Translesion Synthesis 
As alluded to above, TLS is a major damage tolerance pathway allowing 
DNA replication to continue at damaged templates via bypass of DNA 
damage lesions (Fig. 11). As a result TLS provides resistance to DNA-
damaging agents, and the ability to restart stalled replication forks or to fill 
ssDNA gaps containing lesions following DNA damage (Waters et al., 
2009). The classical replicative polymerases, consisting of Pol1(Ƚ3ROİ
DQG 3ROį LQ \Hast, are highly accurate and specific to an unperturbed 
template and primer terminus. Advancing replication is generally stalled at 
DNA lesions due to an inability of these high fidelity replicative polymerases 
to accommodate modified nucleotides into their active sites (Hubscher et 
al., 2002, Andersen et al., 2008, Waters et al., 2009). However, a class of 
alternative polymerases, termed the TLS polymerases, exist that are able 
to insert nucleotides opposite a variety of abnormal structures and are 
utilised during this method of DNA damage tolerance. In eukaryotes TLS is 
generally thought to occur by the action of two such polymerases, typically 
one of the Y family polymerases, consisting of Rev1 and Poln in S. 
cerevisiae, DQG3ROǅD%IDPLO\SRO\PHUDVHDOVRSUHVHQWLQS. cerevisiae and  
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Figure 11 ± Mechanisms of DNA damage tolerance. Translesion synthesis 
(TLS) utilises specialised damage tolerant polymerases to by-pass DNA lesions. 
Error free damage tolerance is proposed to occur by two mechanisms, 
replication fork regression or strand invasion.  Upon encountering DNA damage 
(A), template strand switching to the undamaged, newly synthesised sister 
chromatid occurs (B) by either fork regression or strand invasion. Replication 
takes place utilising genetic information encoded by the sister chromatid to 
bypass the damage (C), before reversion back to the original template strand 
(D). Taken from (Unk et al., 2010).  
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consisting of Rev3 and Rev7 subunits  (Ulrich, 2005, Waters et al., 2009, 
de Groote et al., 2011). Rev1 is notable among the TLS polymerases since 
its catalytic activity is limited primarily to inserting a dCMP in particular 
opposite abasic sites and a variety of different adducted guanines. 
Furthermore the polymerase activity of Rev1 is not essential for the Rev1-
mediated bypass of many lesions. Rather a model is proposed whereby 
Rev1 mediates the majority of its function in TLS by recruiting and 
coordinating DNA damage tolerance factors to the site of lesions rather 
than bypassing them directly. Indeed S. cerevisiae Rev1 is able to interact 
with botKWKH5HYDQG5HYVXEXQLWVRI3ROǅDQGZLWK3ROQ(Waters et al., 
2009). In addition mammalian and yeast Rev1 has been shown to bind to a 
recessed, ¶ SKRVSKRU\ODWHG primer-template junction DQG WR WKH ¶ 2+
terminus of the gap (de Groote et al., 2011).   
The active site of the TLS polymerases is generally more open 
compared to the replicative polymerases. This allows better 
accommodation of bulky adducts present on damaged DNA. Other 
members have more constrained active sites but even so are specialized to 
accommodate particular classes of DNA lesions referred to as their cognate 
lesion (Waters et al., 2009, de Groote et al., 2011). The more relaxed 
FDWDO\WLF VLWH DORQJ ZLWK ODFN RI D SURRIUHDGLQJ ¶-to-¶ GRPDLQ DQG WKH
limited contacts made between the template base and incoming nucleotide, 
mean the TLS polymerases tend to act with decreased replication fidelity. 
As such they confer a potentially mutagenic activity within the cell. Indeed 
most mutations generated by genotoxic agents are believed to be as a 
result of replication from these damage tolerant polymerases rather than 
from the actual damage. The process has therefore become known as error 
prone damage tolerance (Ulrich, 2005, Waters et al., 2009).  
To date there is compelling evidence that TLS polymerases act via 
two models to bypass DNA lesions, these being the polymerase switching 
model and the gap filling model (Fig. 12). It is likely that TLS polymerases 
act in a manner consistent with both models when appropriate, for 
instance, according to the context of the lesion or phase of the cell cycle 
(Waters et al., 2009).  The polymerase switching model is proposed to act 
at stalled replication forks and involves a switch from the stalled replicative 
polymerase at the primer-template-terminus to one or more TLS 
polymerases (Fig. 12A). A final switch then takes place restoring the 
replicative polymerase and enabling accurate DNA synthesis to resume 
(Pages and Fuchs, 2002, Waters et al., 2009). Indeed the majority of TLS  
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Figure 12 ± Bypass of DNA lesions by TLS is proposed to occur by, (A) the 
polymerase switching model, and (B) the gap filling model.  
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polymerases demonstrate very low processivity a factor that may help to 
minimise the chance of mutation (Ulrich, 2005). Following DNA damage the 
Rad6/Rad18 heterodimer is recruited to sites of DNA damage. Although 
Rad18 exhibits DNA binding activity, essential for its in vivo role, there is 
increasing evidence that this recruitment is facilitated by the interaction of 
Rad18 with the ssDNA binding replication protein A (RPA) in S. cerevisiae 
(Ulrich, 2009). The Rad6/Rad18 heterodimer subsequently 
monoubiquitinates PCNA at Lys-164, this stage has been shown to be 
essential for TLS in yeast and is suggested to require PCNA to be loaded 
onto DNA (Andersen et al., 2008, Pages et al., 2009, Ulrich, 2009, Waters 
et al., 2009). Although the specific role of PCNA monoubiquitination is not 
entirely clear the modification directly enhances the affinity of TLS 
SRO\PHUDVHV 5HY DQG 3ROǆ IRU 3&1$ 7KLV FDQ EH DWWULEXWHG WR WKH
ubiquitin binding domains of such enzymes. Strengthening of this 
interaction may then promote the switch between a replicative and a TLS 
polymerase. Following extension across the lesion a second switch occurs 
back to the replicative polymerase possibly mediated by the 
deubiquitination of PCNA (Pages and Fuchs, 2002, Ulrich, 2009, Waters et 
al., 2009). 
The gap filling model is thought to mediate TLS damage bypass at 
ssDNA gaps outside the context of the replication fork during G1 or G2/M 
phase and likely during late S phase (Lopes et al., 2006, Waters et al., 
2009). A recent study does indicate that TLS functions effectively after 
chromosomal replication, outside of S-phase (Karras and Jentsch, 2010).  
Gaps can occur due to repriming of the replication machinery downstream 
from the blocking lesion, processing of closely spaced lesions on opposite 
DNA strands, or by the processing of interstrand cross-links. Upon 
identification of the need for lesion bypass the TLS polymerase is thought 
to be directed to the ssDNA gap by many of the same factors involved in 
the switching model (Fig. 12B). Handovers between the replicative and TLS 
polymerases are not thought to play a significant role in the gap filling 
model however may come into play if the remaining gap following lesion 
bypass is sufficiently large (Lopes et al., 2006, Waters and Walker, 2006, 
Waters et al., 2009). Following the completion of replication or filling of 
ssDNA gaps, via successful TLS, the lesion can be removed by DNA repair 
pathways possibly before the next round of replication (Waters and Walker, 
2006, Waters et al., 2009).    
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How the most appropriate TLS polymerase is selected to bypass a 
particular lesion remains one of the most intriguing questions regarding 
TLS.  A trial and error method has been suggested to occur whereby 
several polymerases may associate at the primer terminus sequentially 
until the best suited for bypass of the specific lesion is encountered. During 
such a time, and also possibly in the absence of damage, PCNA may act as 
a tether for several polymerases thus enabling rapid switching. It is likely, 
however, that numerous factors play a role in determining which 
polymerases have access to the primer terminus. For instance, the 
apparent cell cycle regulation of Rev1, and the ubiquitin state of PCNA and 
the polymerases themselves (Pages and Fuchs, 2002, Waters et al., 2009).  
 
1.6.2 Error Free Damage Tolerance 
An alternative pathway of DNA damage tolerance also exists. This 
additional pathway does not utilise the damaged region of DNA as a 
template and is thus deemed error free. Rad6/Rad18 mediated 
monoubiquitination of PCNA at Lys-164 can be extended by the 
Ubc13/Mms2 ubiquitin conjugating complex, in cooperation with the 
ubiquitin ligase Rad5, to a Lys-63-linked polyubiquitin chain. This 
polyubiquitination of PCNA is a requirement for error free DNA damage 
tolerance. The mechanism behind how error free lesion bypass is achieved 
remains to be fully established but is thought to, temporarily, utilise the 
newly synthesised, undamaged, sister chromatid as a template (Andersen 
et al., 2008, Ulrich, 2009).  At ssDNA gaps this has been suggested to 
occur via a template strand switch, via strand invasion, leading to the 
formation of a sister chromatin junction (SCJ) intermediate, in a manner 
similar to a homologous recombination reaction (Fig. 11) (Andersen et al., 
2008, Branzei et al., 2008). This process seems to require SUMOylation of 
PCNA and may cooperate with Rad51-dependent homologous 
recombination events. Indeed in the absence of PCNA SUMOylation, SCJ 
formation can occur and requires Rad51-dependent homologous 
recombination events which act independently of Rad18 (Branzei et al., 
2008). It is suggested that PCNA SUMOylation acts to suppress SCJs 
occurring by homologous recombination alone. This may be achieved 
through the interaction of SUMOylated PCNA with the Srs2 helicase which 
seems to prevent unscheduled recombination events at replication forks 
(Branzei et al., 2008, Ulrich, 2009).   
44 
 
An alternative model of error free damage tolerance has been 
suggested, this involves reversion of the replication fork as facilitated by 
the helicase activity of Rad5 (Fig. 11). It has been proposed that 
regression of the replication fork is accompanied by pairing of the two 
nascent strands while the original template strands re-anneal creating a 
chicken foot structure. Elongation can then continue from the stalled 
primer terminus using the nascent sister chromatid as a template (Zhang 
and Lawrence, 2005, Andersen et al., 2008). By contrast it has been 
suggested that the DNA damage checkpoint acts to prevent regression of 
the replication fork while error free DNA damage tolerance occurs by the 
template switching model discussed above (Andersen et al., 2008). 
Ultimately debate still exists as to the mechanism by which the error free 
damage tolerance pathway exerts its effect.  
 
1.6.3 Conservation of DNA Damage Tolerance from Yeast to 
Humans 
The above two pathways of DNA damage tolerance are highly 
conserved in eukaryotes, ranging from yeast to humans, in terms of both 
the components and the proposed mechanisms utilised (Andersen et al., 
2008, Ulrich, 2009, Waters et al., 2009). This includes monoubiquitination 
of PCNA by Rad6/Rad18 which occurs at the same Lys-164 residue in 
yeasts and higher eukaryotes, including humans (Hoege et al., 2002). 
Indeed the ability of this modification to enhance affinity of TLS 
polymerases for PCNA and thus promote switching between was first 
LGHQWLILHG IRU KXPDQ 3ROǆ (Ulrich, 2009). Although slightly more 
controversial, Lys-63 linked PCNA polyubiquitination has now been shown 
to occur in a number of separate human cell lines, following UV irradiation, 
to promote the error free pathway. This is dependent upon both Rad18, 
suggesting that monoubiquitination is first required, and Ubc13. In addition 
Mms2 along with two Rad5 homologues, SHPRH and HLTF, have been 
identified in human cells (Chiu et al., 2006, Langie et al., 2007, Unk et al., 
2010). Both human Rad5 homologues exhibit ubiquitin ligase activity for 
Ubc13/Mms2 dependent Lys-63 linked polyubiquitination of PCNA and HLTF 
in particular has been implicated as having a Rad5-like role in damage 
tolerance (Unk et al., 2010). Unlike in yeast, however, Mms2 appears to 
serve a redundant role suggesting the presence of an alternative Mms2 
variant or complex that can compensate for its loss (Brun et al., 2008).   
45 
 
The significance of DNA damage tolerance in maintaining genomic 
stability along with such conservation highlights how the study of such 
pathways may have important implications in the development of novel 
strategies to combat cancer (Ulrich, 2005, Andersen et al., 2008, Waters et 
al., 2009).  The mutagenic nature of error prone DNA damage tolerance 
may in itself create detrimental changes in genetic information and must 
therefore be maintained under tight control (Ulrich, 2005, Andersen et al., 
2008). Indeed, yeast cells defective for error free damage tolerance can 
demonstrate spontaneous mutation rates elevated by 30-fold (Andersen et 
al., 2008). Furthermore, the Rad5 homologues, HLTF and SHPRH, proposed 
to function in the error free pathway of damage tolerance, have been 
implicated in tumour suppression, however further studies are required to 
clarify their specific roles (Unk et al., 2010).  
The majority of current cancer treatments involve the selective 
killing of malignant cells through the use of radiation or cytotoxic chemicals 
that interfere with DNA replication, either by the introduction of lesions or 
interfering with enzymes involved in DNA metabolism. Elimination of 
damage tolerance pathways, which aid survival under such conditions, 
should increase the efficiency of such treatments (Ulrich, 2005). In 
addition, the development of secondary tumours due to DNA damage 
created by conventional cancer treatments represents one of their greatest 
risks. Suppression of damage bypass polymerases that enable mutagenic 
lesion bypass may help to minimize these detrimental consequences 
(Ulrich, 2005). Ultimately more research is required to establish the roles 
of DNA damage tolerance in tumorigenesis and carcinogenesis. 
 
1.7 Microbial Cell Individuality   
Individual cells from clonal microbial populations are known to 
exhibit marked phenotypic heterogeneity in a wide variety of functions that 
are often vital for survival and development. These have been shown to 
include, for example, variable degrees of virulence in pathogenic 
microorganisms, different levels of resistance to environmental stressors 
and variation in cellular and colony morphology (Avery, 2006). Phenotypic 
heterogeneity at the single cell level is generally masked by conventional 
studies which use population averaged data often from across thousands or 
millions of cells. Increased appreciation for the importance of cellular 
heterogeneity, along with a surge of interest in the processes that govern 
such cell-to-cell variability, has driven the development of new tools and 
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techniques to study individual cells and brought the issue of cell 
individuality to the fore in recent years.  
 7KHWHUPµEHWKHGJLQJ¶ILUVWLQWURGXFHGE\6ODWNin in 1974, is often 
used to described phenotypic heterogeneity as a risk-spreading strategy 
that may help to ensure survival of at least a subset of the isogenic 
population in whichever environmental condition is encountered (de Jong et 
al., 2011). Indeed, it is generally considered that phenotypic heterogeneity 
provides a dynamic source of diversity in addition to the heritable 
genotypic variation created by sequence changes such as mutation and 
genome rearrangements. Microbial populations are proposed to benefit 
from the existence of phenotypic heterogeneity due to the creation of 
variant subpopulations that are pre-equipped to persist better during times 
of stress and exploit new niches, thus aiding survival during times of 
environmental fluctuation (Avery, 2006). In support of this, heterogeneous 
populations can demonstrate increased fitness and, under high states of 
stress, out-survive a more homogeneous microbial community likely due to 
the availability of alternative adaptive strategies (Bishop et al., 2007, 
Smith et al., 2007, Acar et al., 2008). Importantly, and in contrast to 
variation created by sequence changes, phenotypic heterogeneity does not 
result in an irreversible commitment to the new cell state, rather individual 
cells can rapidly revert to their original status if required (Avery, 2006). 
Representations of this non-genotypic cell-cell heterogeneity exist 
throughout the microbial world and include such examples as; pili switching 
in Escherichia coli (Wolf and Arkin, 2002), morphology switching in 
pathogenic Candida species, and the presence of dormant persister cells 
within bacterial populations (Lewis, 2007).     
In principle, the initiation of an infection may require just a few 
variant virulent cells from within a larger avirulent population. 
Consequently phenotypic heterogeneity may be of particular importance for 
virulence, enabling pathogens to survive the changing environments that 
may be encountered during infection of a mammalian host and colonisation 
of various niches. Indeed genome rearrangement-driven variation in the 
expression of virulence genes has been linked to pathogenesis in certain 
protozoa and bacteria (Scherf et al., 2008, Bayliss, 2009). It is possible to 
link heterogeneity to stochastic fluctuations, at the molecular level, in the 
processes that control transcription and translation with subsequent mRNA 
and protein degradation also subject to similar molecular noise. Such 
processes result from binding events, such as transcription factor binding 
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to a promoter, which occur randomly and are therefore inherently 
stochastic. Even small fluctuations of this type can lead to substantial 
differences as the effect is amplified through subsequent stages (Kaern et 
al., 2005, Avery, 2006, Kaufmann and van Oudenaarden, 2007). The 
stochastic process of transcriptional bursting is known to generate 
increased cell-to-cell variability and can confer advantages in the face of 
environmental stress (Blake et al., 2006). In addition to the contribution of 
stochastic gene expression, various other generic drivers of heterogeneity 
in microbial populations have been uncovered. These include; progression 
through the cell cycle and oscillatory changes in the physiological state of 
the cell that may accompany this (biological rhythms), aging, metastably 
inherited epigenetic modifications, mitochondrial activity, and individual cell 
growth rates (Avery, 2006). For instance, the cell cycle- and age-
dependent activity of Sod1 (Sumner et al., 2003), as well as metabolic 
oscillations (ultradian rhythms) which modulate single cell redox status 
(Smith et al., 2007) are implicated in the stress resistance of individual 
yeast cells. Epigenetic regulation of gene expression also appears to have a 
particularly prominent role in the induction of cell-to-cell variability. Indeed 
epigenetic silencing effects due to changes in chromatin structure near 
telomeres constitute a major source of variation in the expression of genes 
located in the subtelomere, many of which encode cell surface proteins and 
adhesins (Halme et al., 2004, Verstrepen and Fink, 2009). To date, the 
relevance of cell-to-cell gene expression heterogeneity to virulence of yeast 
pathogens, such as Candida spp, has not been examined. 
 
1.7.1 Cell Surface Variation 
Many microorganisms have developed mechanisms to generate 
variability at their cell surface thus producing differential adherence, 
evasion of the immune system and environmental adaptation strategies 
(Verstrepen and Fink, 2009). In both yeast and protozoa much of this 
variation is reliant upon epigenetically regulated processes including 
transcriptional silencing and differential gene expression (Avery, 2006, 
Verstrepen and Fink, 2009).  
1.7.1.1 Protozoan Cell Surface Variation  
Some of the best studied examples of cell surface variation can be 
found within protozoan parasites, such as the trypanosomes, and the 
malaria parasite Plasmodium falciparum. The African trypanosome 
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Trypanosoma brucei is well known for its antigenic variation at the cell 
surface. T. brucei is an extracellular parasite carried in the bloodstream of 
infected hosts and is responsible for African sleeping sickness with 
transmission occurring via the tsetse fly. The extracellular nature of this 
parasite renders it fully exposed to the host¶s immune response, against 
which a dense glycoprotein coat provides protection and masks other 
potentially immunogenic cell surface proteins (Barrett et al., 2003, 
Verstrepen and Fink, 2009). Continual evasion of the immune response is 
achieved by switching the composition of this outer coat to antigenically 
distinct glycoproteins from a large repertoire of >1500 so called variant 
surface glycoprotein (VSG) genes and pseudogenes which are largely 
located in the subtelomeres (Horn and Barry, 2005, Avery, 2006, Horn and 
McCulloch, 2010). Each cell expresses only one VSG at a time, a process to 
which a number of mechanisms may contribute (Fig. 13) and that can 
create cell- to-cell variation. Firstly and indeed the prominent mechanism 
from which antigenic variation originates involves duplication of a silent 
VSG gene into a single active expression site and deletion of the previous 
VSG resident at that site (Robinson et al., 1999). Such DNA recombination 
events are believed to be initiated by double strand breaks within the 70bp 
repeats upstream of the actively transcribed VSG gene (Boothroyd et al., 
2009). Secondly, activation of new VSG genes can be achieved by an in 
situ switch involving activation of a silent expression VSG site coupled to 
repression of the  previously active site (Alsford et al., 2009). Reciprocal 
translocation, including telomere exchange, is also known to be a method 
of VSG antigenic switching (Boothroyd et al., 2009, Verstrepen and Fink, 
2009). Transcriptional silencing is instrumental in maintaining monoallelic 
VSG expression from among the 10-20 telomeric expression sites that exist 
and as such protects the integrity of the evasion strategy (Horn and 
McCulloch, 2010). A direct role for telomeric silencing in the form of 
telomere position effect however remains controversial. Additional factors 
suggested to influence such monoallelic expression include chromatin 
remodelling, DNA modification or a unique transcriptional/elongation 
apparatus (Horn and Barry, 2005). That many 96*¶Vexist as pseudogenes 
provides another possible source of antigenic variation and the generation 
of novel combinations. Such pseudogenes must partially recombine with 
the active VSG resident in order to reconstitute a functional gene thus 
creating a chimeric product. This ability further aids evasion of the immune 
system by increasing the potential VSG reservoir (Pays, 2005).   
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Figure 13 ± The mechanisms by which VSG switching of a silent gene or 
pseudogene in to the VSG active expression site (ES) can occur. The 
majority of mechanisms involve either reciprocal or duplicative 
translocations whilst the final mechanism involves an in situ switch to a 
different expression site (ES).  Taken from (Verstrepen and Fink, 2009). 
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A second trypanosome exhibiting cell surface variability is 
Trypanosoma cruzi. This parasite is spread by reduviid bugs and causes 
Chagas disease, which constitutes the most important parasitic infection in 
Latin America with many areas being endemic (Barrett et al., 2003, Dias, 
2009). The major surface glycoproteins at the cell surface of this parasite 
are the mucin-like proteins. The mucin coat protects the parasite from host 
derived defence mechanisms while enabling correct targeting to specific 
cells or tissues (Buscaglia et al., 2006). The T. cruzi genome encodes ~850 
members of these mucin-like proteins, within the TcMUC subfamily, the 
products of which demonstrate many similarities to fungal cell surface 
adhesins (El-Sayed et al., 2005, Verstrepen and Fink, 2009). A second 
mucin subfamily is also encoded by the T. cruzi genome, TcSMUG, and 
consists of a small subset of relatively homogenous members that are 
generally expressed while the parasite resides within its insect vector (El-
Sayed et al., 2005, Buscaglia et al., 2006). By contrast the TcMUC family 
encodes a large number of members which demonstrate substantial 
variability and dominate expression upon entry to the mammalian host 
(Buscaglia et al., 2004). Thus, the transition from insect to mammal 
occupation corresponds with a switch to a different set of mucin genes, the 
vast majority of which are silenced by an as-yet-unknown mechanism in 
the insect vector. This results in a switch from a mucin coat of rather 
homogeneous polypeptide composition to one that is highly heterogeneous. 
Studies have not yet revealed whether mammal-dwelling mucin variability 
is due to the expression of multiple mucins on the cell surface of each 
parasite or if, as has been seen for the T. brucei VSG genes, each parasite 
is able to express a single but different mucin molecule thus generating 
cell-to-cell variation and ultimately subpopulations of parasites with 
different TcMUC expression (Buscaglia et al., 2006, Verstrepen and Fink, 
2009). In addition, cells rely on post-transcriptional mechanisms such as 
the control of RNA stability to regulate gene expression making it less 
straightforward to investigate which mucins are expressed (Verstrepen and 
Fink, 2009). 
The malaria parasite P. falciparum also employs an immune 
response evasion strategy which involves transcriptional switching among 
members of the highly diverse ~60 member VAR family which encode the 
PfEMP1 (P. falciparum erythrocyte membrane protein 1) surface antigens 
(Verstrepen and Fink, 2009). The majority of genes of this antigen-
encoding family reside at subtelomeric locations in the genome. Individual 
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parasites within clonal populations generally transcribe only one dominant 
VAR gene thus creating cell-to-cell variation. Furthermore VAR switching 
allows individual parasites within such populations to demonstrate different 
antigenic and phenotypic characteristics at different times (Ralph and 
Scherf, 2005). The VAR genes can be partitioned into either slow or fast 
switching phenotypes. This partitioning is suggested to be associated with 
chromosomal position since genes at more internal locations demonstrate 
intrinsically slower off rates than those exhibited by their subtelomeric 
family members (Frank et al., 2007).  A model to describe the pattern of 
switching that occurs in individual parasites has recently been described. 
This model suggests utilisation of a single-many-single (sms) switching 
pathway whereby an initial unbiased switch, away from the starting 
dominant transcript, occurs towards a subset of variants. Each variant in 
the subset has a high off rate and transcription ultimately becomes biased 
towards a single new variant within this subset which subsequently gains 
dominance (Recker et al., 2011). Such a mechanism is believed to have 
evolved due to the propensity of P. falciparum to infect non-naive 
individuals where discordance between the parasite and the immune 
repertoire cannot be guaranteed. The initial diversification process may 
greatly improve the chances of evading pre-existing immune responses 
since many variants become accessible, while the subsequent contraction 
protects the remaining repertoire from further exposure. Thus, this 
mechanism demonstrates a higher level of flexibility than observed for 
other organisms such as T. brucei, where a direct switch is employed, while 
still remaining structured. It has been suggested that the initial switch 
occurs to a set of antigenetically similar variants which are then effectively 
removed by short-lived cross reacting antibody responses, thereby allowing 
such variants to be recycled at later stages of the infection (Recker et al., 
2011).  
The above model describes the pattern by which VAR gene 
switching occurs, however the molecular mechanisms that drive such 
switching and determine the gene to be expressed in individual parasites, 
ultimately leading to cell-to-cell variation, remain far from being fully 
understood. To date the process of VAR gene switching is known to be 
under epigenetic control (Recker et al., 2011), DNA rearrangements such 
as those observed in T. brucei are known not to be required (Ralph and 
Scherf, 2005, Verstrepen and Fink, 2009), which is unsurprising given the 
proposed sms switching model. Rather, a number of other factors including 
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changes in intracellular location, chromatin state, and the presence of 
promoter containing introns have been implicated in the switching 
mechanism (Verstrepen and Fink, 2009). Position dependent silencing 
appears to be of particular note and the P. falciparum Sir2 homologue 
(PfSir2) has been shown to bind at regions close to inactive VAR genes, an 
interaction correlated with hypoacetylation and silencing at these regions 
(Deitsch et al., 1999, Duraisingh et al., 2005, Freitas-Junior et al., 2005, 
Verstrepen and Fink, 2009). Furthermore subtelomeric VAR genes have 
been observed to occupy different nuclear positions at the nuclear 
periphery depending on their activation state (Duraisingh et al., 2005, 
Verstrepen and Fink, 2009). Such organisation into different subnuclear 
clusters appears to function as another level of epigenetic regulation for 
these genes. The P. falciparum nuclear periphery consists primarily of silent 
heterochromatin, however, the nucleus of each parasite contains at least 
one distinct heterochromatin free region at its periphery which may 
indicate a transcriptionally active zone (Dzikowski and Deitsch, 2009). A 
model has been proposed whereby silenced subtelomeric VAR genes are 
associated with telomeric clusters at heterochromatin regions of the 
nuclear periphery. Upon activation, VAR genes exit this site to a 
transcriptionally active region of the nuclear periphery (Fig. 14). It is, 
however, unknown if transcription at the active site is a consequence of the 
new nuclear position or if transcriptional activation itself results in 
positional displacement (Ralph et al., 2005, Dzikowski and Deitsch, 2009). 
Along with upstream regulatory regions, the promoter-containing intron, 
present in all bar one of the VAR genes, has been implicated in silencing at 
inactive VAR loci, additionally these introns are thought to have a role in 
VAR gene recognition by the mechanism that controls mutually exclusive 
expression (Calderwood et al., 2003, Gannoun-Zaki et al., 2005, Dzikowski 
and Deitsch, 2009, Verstrepen and Fink, 2009). It has been proposed that 
VAR introns act as heterochromatin boundary elements maintaining 
repression of adjacent VAR genes at the same subtelomere as the active 
locus, such barrier activity may also require interactions with the nuclear 
pore complex and may go some way to explaining the nuclear periphery 
sublocalisation (Ralph and Scherf, 2005, Ralph et al., 2005). In a rare 
stochastic event intronic promoter activity is able to outcompete the active 
VAR promoter for the transcription initiation complex. This produces a non-
coding RNA species that tags the active locus for histone modification,  
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Figure 14 ± Model for the activation of VAR genes according to nuclear 
localisation. (a) VAR genes present in subtelomeric clusters are subject to 
transcriptional repression due to high levels of silencing factors such as PfSir2. 
(b) The active VAR locus then move away from these silenced clusters towards a 
transcriptionally active region of the nuclear periphery. (c) VAR gene intron 
barrier activity, a process that may require interaction with the nuclear pore, 
preventing the spread of silenced chromatin into the active locus.  
Taken from (Ralph and Scherf, 2005).  
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heterochromatin formation and subsequent silencing (Ralph and Scherf, 
2005). Activation of a new VAR promoter, however, appears sufficient to 
initiate a switch in cell surface antigenicity (Voss et al., 2006).  
 
1.7.1.2 Yeast Cell Surface Variation 
A number of aspects of protozoan cell surface variation discussed 
above such as subtelomeric location and epigenetic transcriptional silencing 
may also contribute to adhesin variation at the fungal cell surface. The cell 
wall adhesins produced by many fungi mediate flocculation, adherence to 
both inert surfaces and mammalian tissues and biofilm formation 
(Verstrepen et al., 2004). An important survival strategy for yeast cells is 
the ability to adapt to new conditions which may often require adhesion to 
a new substrate or, in the case of pathogenic yeast, to different host 
tissues in order for infection to occur. 
 As mentioned briefly in earlier sections the S. cerevisiae FLO gene 
family is a group of adhesins that are able to confer attachment to agar, 
solid surfaces and other yeast cells (flocculation). There are only five 
known members of the FLO gene family; FLO1, 5, 9, and 10, which reside 
adjacent to their respective telomeres and FLO11 which is neither adjacent 
to a telomere or centromere. The subtelomeric FLO genes confer varying 
degrees of flocculation, with FLO1 providing the strongest level of cell-to-
cell adhesion. By contrast expression of FLO11 is more relevant for 
adhesion to abiotic surfaces and for haploid invasive or diploid filamentous 
growth (Guo et al., 2000, Verstrepen et al., 2004, Soares, 2011). However, 
FLO10 has been observed to compensate for loss of FLO11 function and 
induce filamentation, thus generating phenotypes which overlap those of 
FLO1 and FLO11 (Guo et al., 2000).   
Cell-to-cell variation in expression of the FLO10 and FLO11 genes is 
known to have an epigenetic basis (Fig. 15). The propensity of diploid S. 
cerevisiae to filament under conditions of nitrogen starvation has been 
shown to vary between individual cells. While some cells are seen to grow 
as filamentous pseudohyphae others, within the same population, remain 
in the yeast form. This morphological heterogeneity is dependent upon 
metastable silencing of the FLO11 gene. This gene is known to be silent 
while cells reside in the yeast form but is expressed to produce filamentous 
growth, an expression state that can be inherited for >10 generations. 
Transcriptional silencing from the FLO11 promoter is dependent upon its 
chromosomal position. However, in contrast to conventional telomere  
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Figure 15 ± Schematic representations of the positional- and promoter 
dependant mechanisms that mediate heterogeneous expression of (A) FLO11 
and (B) FLO10. Taken from (Halme et al., 2004) 
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silencing, repression of FLO11 is also promoter specific (Halme et al., 
2004). The transcriptional repressor Sfl1, for which DNA binding is inhibited 
by protein kinase A (PKA) activity, works antagonistically with the Flo8 
activator to regulate expression of FLO11 via a common promoter element 
(Conlan and Tzamarias, 2001, Pan and Heitman, 2002). As such Sfl1 has 
been implicated as a possible candidate for regulation of the promoter 
specific portion of FLO11 silencing and has indeed been identified as 
necessary for such repression (Halme et al., 2004). In addition Hda1p is 
believed to be associated with deacetylation within regions that encompass 
the FLO11 locus. Such deacetylation is restricted to specific areas of the 
genome and is thus believed to be responsible for the position dependent 
fraction of FLO11 silencing (Halme et al., 2004). Hda1p is recruited to 
specific promoters by Tup1 (Wu et al., 2001), which is thought to be 
recruited to the FLO11 promoter by Sfl1p (Conlan and Tzamarias, 2001), 
thus suggesting a strategy by which both promoter dependent and position 
dependent factors co-operate to silence FLO11. Indeed deletion of either 
regulatory factor (Sfl1p or Hda1p) leads to constitutive expression of 
FLO11 and loss of cell-to-cell variability in the expression of this adhesin 
(Halme et al., 2004). Interestingly, the Sfl1p component of this regulation 
occurs independently of the FLO transcriptional activator Flo8 (Conlan and 
Tzamarias, 2001). The above strategy therefore provides a novel 
regulatory pathway for FLO11 expression. 
A subsequent study utilised a dual-reporter assay system to 
demonstrate the slow transition rates between on and off associated with 
epigenetic silencing at the FLO11 promoter. In diploid cells, these switches 
create four possible expression states: both ON, both OFF, ON/OFF, and 
OFF/ON. Such independent switching may represent an additional 
mechanism in the generation of variation. In addition three classes of 
global trans activators including Msn1p, Tec1p, and Flo8p were found to 
have roles in governing either epigenetic (slow, Class II), conventional 
(fast, Class I), or both forms (Class III) of regulation, respectively. 
Distribution in the control of transition rates may enable individual cells 
within isogenic populations to shape the diversity of FLO11 expression 
through the utilisation of various combinations of such regulators (Octavio 
et al., 2009).     
Access to the remaining reservoir of S. cerevisiae FLO genes is 
governed by a mutational mechanism involving high frequency mutations 
(~103) in the genetically unstable IRA1 or IRA2 genes, which encode the 
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yeast Ras GTPase activation proteins. In haploid cells which do not undergo 
filamentation, such mutation leads to hyperinvasive growth and increased 
flocculance. The novel adhesive phenotypes exhibited by such mutants are 
mainly the result of increased FLO10 expression. This transcriptional 
activation is dependent upon both the MAP kinase and cAMP regulated PKA 
pathways and is suggested to occur due to increased Ras activity in IRA 
mutants. As with FLO11, FLO10 expression was identified as being 
heterogeneous between individual cells. Such variation is again due to 
metastable epigenetic silencing, influenced by both promoter and position 
specific mechanisms by the actions of Sfl1. Sfl1 is thought to inhibit the 
Flo8 activator and recruit the Sir2 homologues, Hst1 and Hst2, to the 
FLO10 promoter.  The telomeric Sir3 and Ku proteins are also involved in 
FLO10 silencing, although it is unclear whether these proteins act through 
Hst1 and/or Hst2 or independently (Halme et al., 2004). Such results 
demonstrate the ability of gene expression to vary between individual cells 
of a genetically identical population following environmental stimulus. 
Ultimately this is able to generate subpopulations that vary in their ability 
to filament, invade and adhere. It seems logical to speculate that should 
similar events occur within pathogenic yeast, such as C. glabrata, there 
would be important implications for virulence. 
 
1.8 Aims of the Current Work 
The pathogenic yeast C. glabrata encodes a family of GPI-anchored 
cell wall adhesins termed the EPA (epithelial adhesin) family. The 
predominant aim of this study was to investigate the possibility of 
heterogeneous expression of Epa1 in this pathogenic yeast. Mediating one 
of the initial host-pathogen interactions to occur during infection, such 
adhesins play an integral role in the establishment of host infection and are 
an important virulence factor. It is possible that heterogeneity in the 
expression of these adhesins is able to confer a selective advantage during 
host colonization. Consequently further understanding of the mechanisms 
and regulatory elements involved in controlling cell-to-cell variability will be 
important in further understanding how this pathogen interacts with its 
host, possibly pointing to new drug targets. This may be particularly 
pertinent for C. glabrata due to its rising prevalence, high mortality, and 
antifungal resistance. Such regulatory processes may encompass 
transcriptional silencing, owing to the subtelomeric nature of these genes. 
Indeed a number of EPA genes are known to be subject to sir-mediated 
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silencing (De Las Penas et al., 2003, Castano et al., 2005, Rosas-
Hernandez et al., 2008).  Post-translational effects occurring during the 
process of GPI-CWP maturation, placement at the cell wall, and subsequent 
removal must also be considered as possible points at which expression 
heterogeneity can occur. 
A smaller aim of this study was to investigate the regulatory 
proteins, in particular Sir2 and Swi6, which may control heterogeneous 
expression of Rad6 in S. cerevisiae. Preliminary data from the laboratory 
prior to this project suggested that expression of Rad6, a protein involved 
in DNA damage tolerance regulation, was bimodal. Such an observation 
may have important implications for stress resistance and again aid 
survival under different environmental conditions. 
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Chapter 2 - Materials and 
Methods 
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2.1 Strains and Plasmids 
Candida glabrata BG2 (Cormack et al., 1999) and the type strain 
GHULYDWLYH &* +78Ʃ (his3Ʃtrp1Ʃura3Ʃ) (Kitada et al., 1995), the 
latter being kindly donated by Ken Haynes (University of Exeter), were the 
wild type backgrounds from which other strains were derived. C. glabrata 
BG2 and derivatives ura3Ʃ (BG14), epa1Ʃ (BG64) and an EPA1-GFP 
transcriptional fusion strain (BG198), which is also deleted for URA3 were 
gifts from Brendan Cormack (Johns Hopkins University). A yps7Ʃ deletion 
strain in the ATCC2001 background was also kindly provided by Ken 
Haynes. The triple HA-tagged strain, BG2-Epa1-HA, was constructed prior 
to the initiation of this study (M.C. Smith), using the ura3Ʃ BG2 derivative, 
BG14, by the same method described for CG2001-Epa1-HA below. Clinical 
isolates of C. glabrata were provided by Michael Petrou, from the collection 
at the Department of Medicine, Imperial College London. C. glabrata 
NCYC388 was from the NCYC, Norwich. Single copy C. glabrata plasmids, 
pCgACH-3 and pCgACH-14 (Kitada et al., 1996), were donated by Ken 
Haynes. Maps of the plasmids discussed and constructed below can be 
found in (Fig. 16) with the exception of plasmids used in S. cerevisiae, 
which are discussed in chapter 3. Primers (Table. 5) and protocols utilised 
in the construction of strains and plasmids can be found in the ensuing 
sections of this chapter. 
2.1.1 Construction of CG2001-Epa1-HA 
To construct strains expressing hemagglutinin (HA)-tagged EPA1, a 
fragment containing triple HA-tagged EPA1 under the control of its own 
promoter and containing extended regions of genomic sequence around 
EPA1(-3HA), together with the internal URA3 marker, was excised as a 
~6.8kb fragment from pMS15 by digestion with XbaI and PacI and 
transformed in to C. glabrata using a modified lithium acetate method 
(Castano et al., 2003). Ura+ transformants were selected on YNB plates 
lacking uracil. Appropriate integration of the transforming fragment was 
verified with diagnostic PCR using genomic DNA and primers WIEPA1-
FWD/HAtag-FWD and EPA1-REV-OSHOM. Primers WIEPA1-FWD and EPA1-
REV-OSHOM indicated successful integration by generation of a ~4.5kb 
band compared to a ~3.4kb band produced in untagged strains. Primers 
HAtag-FWD and EPA1-REV-OSHOM confirmed the presence of 3HA-EPA1 by 
generation of a ~5.8kb band while no band was produced in untagged 
transformants. This is illustrated further in chapter 4 (4.2.3).  
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Figure 16 ± Maps of plasmids utilised during this study. pMS15, pMS26, and 
pMS27 were generated prior to the start of this project (M.C. Smith). 
pCgACH-3, and pCgACT-14 (Kitada et al., 1996), were kindly donated by Ken 
Haynes (University of Exeter). Plasmids constructed and utilised during this 
study included pMS26-HIS, pCgACT-14-SIR3, and pYPS1-HIS.  
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The plasmid, pMS15, was generated prior to the initiation of this 
project and contained 3HA-tagged EPA1 from pBC214 (from B. Cormack) 
(Frieman et al., 2002) under EPA1 promoter control due to the presence of 
~1kb of upstream EPA1 sequence. The URA3 marker (from pHOBST-URA3 
(Payne, 2007)) is present after the EPA1 followed by a ~1kb region of 
sequence found immediately downstream of the EPA1 ORF.  
2.1.2 Construction of sir3Ʃ Strains 
 BG2-sir3Ʃ, CG2001-sir3Ʃ, and BG2-EPA1-GFP sir3Ʃ strains were 
constructed in the ura3Ʃ EDFNJURXQGVRI%*&*+78ƩDQGEPA1-
GFP (BG198), respectively, by the same method. This involved the use of 
plasmid pMS27, which had been constructed prior to the initiation of this 
study (M.C. Smith). Briefly this had involved amplification of C. glabrata 
SIR3 from BG2 genomic DNA and subsequent ligation into the NsiI and 
SphI sites of pGEM7 (Promega) to initially generate pMS26 (M.C. Smith). 
The URA3 selection marker (from pMS15) was then ligated into MscI-cut 
pMS26 in order to disrupt SIR3 and ultimately generate pMS27 (M.C. 
Smith). Digestion of pMS27 with BamHI and HpaI released a ~3.8kb 
sir3::URA3 fragment which was transformed into the relevant C. glabrata 
strains mentioned above. Ura+ transformants were selected for on YNB 
plates lacking Uracil. Appropriate integration of the transforming fragment 
was verified by diagnostic PCR with genomic DNA using primers MS-SIR3-
FWD and MS-SIR3-REV, both of which recognise regions outside of the 
transforming fragment. Successful disruption of SIR3 was confirmed by the 
generation of a ~4.4kb fragment compared to a ~3.2kb band produced in 
untransformed cells using these primers.  
To disrupt SIR3 in Ura+ CG2001-Epa1-HA cells, a HIS3 marker 
excised by XhoI digestion of pCgACH-3 (Kitada et al., 1996), was ligated in 
to the XhoI site of pMS26 to disrupt the SIR3 ORF within this plasmid 
generating pMS26-HIS. Digestion of this plasmid with MscI and PmlI 
released a ~2.2kb sir3::HIS3 fragment for SIR3 disruption via homologous 
recombination. Successful transformants were selected for on YNB plates 
lacking histidine and further confirmed by diagnostic PCR with genomic 
DNA, again using primers MS-SIR3-FWD and MS-SIR3-REV which both 
recognise regions outside of the transforming fragment. Successful 
integration of the transforming fragment was indicated by a band size of 
~4.2kb, by contrast a band of ~3.2kb was obtained from strains containing 
wild type SIR3.    
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2.1.3 Construction of pCgACT-14-SIR3 Single Copy Plasmid 
 Expression of C. glabrata SIR3 from a single copy plasmid was 
achieved by amplification of the SIR3 ORF, together with ~800bp each of 
the upstream and downstream genomic sequence, as a ~4.8kb SacI 
fragment using the primers, SIR3-FWD-SacI and SIR3-REV-SacI.  This 
fragment was subsequently digested with SacI and ligated into the 
similarly digested single copy C. glabrata plasmid pCgACT-14 (Kitada et al., 
1996), to create pCgACT-14-SIR3. Successful ligation was first indicated by 
diagnostic colony PCR, following transformation into Escherichia coli XLI 
blue and selection on LB ampicillin plates, using primers SIR3-FWD-SacI 
and SIR3-REV-SacI to identify the presence of C. glabrata SIR3. Correct 
ligation was further confirmed by digestion of plasmid DNA with BamHI to 
produce bands of ~8.5kb and ~0.8kb, and with HpaI to produce bands of 
~6kb and ~3.3kb. The BamHI digestion was also able to indicate the 
orientation of the ligated fragment owing to the fact that one site resides 
within the pCgACT-14 vector while the other is in the SIR3 fragment. 
Transformation of pCgACT-14-SIR3 into C. glabrata CG2001-Epa1-HA cells 
followed, with successful transformants selected for on YNB agar lacking 
tryptophan. Further confirmation was obtained by isolation of plasmid DNA 
from transformed yeast followed by diagnostic restriction digests as 
described above. 
2.1.4 Construction of yps7Ʃ and yps1yps7Ʃ Mutant Strains     
 The yps7Ʃ deletion strain in an ATCC2001 background, provided by 
Ken Haynes, was utilised during the generation of these mutants. A 
deletion cassette was amplified from this strain as a ~3.2kb fragment, 
encompassing the NATR marker together with flanking sequences 
corresponding to ~1kb upstream and downstream of the YPS7 ORF, using 
YPS7-FWD and YPS7-REV primers. This fragment transformed into 
CG2001-Epa1-HA cells in order to generate an Epa1-HA tagged strain in 
which YPS7 was deleted (CG2001-Epa1-HA yps7Ʃ). Transformants were 
selected for successful integration by growth on YPD medium 
supplemented with nourseothricin. Successful integration of the deletion 
cassette was further confirmed by diagnostic PCR utilising genomic DNA 
and primers YPS7-FWD-OSHOM and YPS7-REV which recognise regions 
outside and within the transforming fragment respectively. Transformants 
in which YPS7 was successfully deleted produced a band of ~3.4kb, by 
contrast wild type YPS7 generated a band of ~4kb.  
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To delete YPS1 in the CG2001-Epa1-HA yps7Ʃ strain, the YPS1 ORF 
was amplified, along with 1kb flanking sequences, as a ~3.8kb SacI 
fragment with primers YPS1-FWD-SacI and YPS1-REV-SacI. The amplified 
fragment was inserted into the pJET2.1 vector (Fermentas Life Sciences). 
The HIS3 marker from pCgACH-3 was amplified as a BamHI/NheI fragment 
using the primers Cg-HIS-FWD-BamHI and Cg-HIS-REV-NheI and, 
following appropriate digestion, inserted in to the above plasmid creating 
pYPS1-HIS3. Digestion of this plasmid with SacI released a ~2.3kb 
fragment for transformation to produce yps1Ʃ cells. Successful 
transformants were selected for on YNB plates lacking histidine and further 
confirmed by diagnostic PCR with genomic DNA and primers YPS1-FWD-
OSHOM and YPS1-REV-SacI which produced a band of ~2.7kb to 
demonstrate correct integration. By contrast cells containing wild type 
YPS1 produce a band of 4.1kb.  
 
2.1.5 S. cerevisiae Strains and Plasmids 
 S. cerevisiae BY4741 (MATahis3Ʃleu2Ʃmet15Ʃura3Ʃ) and a Rad6-
GFP translational fusion (MATaleu2Ʃmet15Ʃura3Ʃ), in the BY4741 
background (Invitrogen) were the wild type backgrounds from which other 
strains were derived. S. cerevisiae strains and plasmids constructed during 
this study are discussed further in Chapter 3.  
 A RAD6-GFP transcriptional fusion was constructed by amplification 
of the GFP cassette from pSVA12, which includes the HIS3 selection 
marker (Avery et al., 2000), using primers RAD6GFP-TF-FWD and 
RAD6GFP-TF-REV, which each contain 50bp of flanking RAD6 homology. 
The resulting ~2.2kb fragment was transformed in to S. cerevisiae BY4741 
and selected for on YNB agar lacking histidine, and correct integration 
confirmed by diagnostic PCR utilising primers RAD6-FWD and RAD6-REV. 
These diagnostic PCR primers recognise regions outside of the transforming 
fragment and produce a band of ~3.5kb in RAD6-GFP transcriptional fusion 
strains while untagged RAD6 results in a band of only ~1.8kb 
 In order to construct a Rad6-GFP translational fusion the Rad6-GFP 
cassette was amplified from the Invitrogen Rad6-GFP translational fusion 
strain using primers, RAD6-TLF-FWD and RAD6-TLF-REV. These primers 
amplify a region that includes the HIS3 selection marker and following 
transformation of the resulting ~2.4kb fragment was transformed into S. 
cerevisiae BY4741 with successful integration being selected for on YNB 
agar lacking histidine. Further confirmation of integration was achieved via 
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diagnostic PCR utilising the primers RAD6-FWD and RAD6-REV which 
recognise regions outside of the transforming fragment produce a band of 
~4kb to indicate successful transformation.   
 Expression of S. cerevisiae SIR2 and SWI6 from single copy 
plasmids was achieved by amplification of the SIR2 and SWI6 ORFs, along 
with their own promoters and terminators, from genomic DNA. Primers 
SIR2-FWD-PstI and SIR2-REV-XbaI amplify SIR2 along with ~1kb and 
~0.25kb upstream and downstream sequences respectively, as a PstI-XbaI 
fragment (~3.2kb). SWI6-FWD-BamHI and SWI6-REV-SacII enabled 
amplification of SWI6 as a BamHI-SacII fragment (~3.2kb), this included 
~0.66kb and 0.25kb of upstream and downstream sequence respectively 
(~3.3kb). These fragments were subsequently digested with the 
appropriate combination of restriction enzymes and ligated into the 
similarly digested single copy S. cerevisiae plasmid pRS315, to create 
pRS315-SIR2 and pRS315-SWI6. Following transformation into Escherichia 
coli XLI blue and selection on LB ampicillin plates, successful ligation was 
further confirmed by digestion of pRS315-SIR2 plasmid DNA with BamHI to 
produce bands of ~8.7kb and ~0.5kb. Correct ligation of pRS315-SWI6 
was demonstrated by digestion of plasmid DNA with XhoI to produce bands 
of ~8.6kb and ~0.7kb. Transformation of pRS315-SIR2 and pRS315-SWI6 
into Rad6-GFP sir2Ʃ and Rad6-GFP swi6Ʃ, respectively, was followed by 
selection for successful transformants by growth on YNB agar lacking 
Leucine. Further confirmation was obtained by isolation of plasmid DNA 
from transformed yeast and diagnostic restriction digests using BamHI and 
XhoI as described above.   
  
2.2 Growth Conditions for Experiments and Storage 
 Organisms were routinely maintained on yeast extract peptone 
dextrose (YPD) (yeast extract 10gL-1, peptone 20gL-1, 2% glucose, with 16 
gL-1 agar for plates), agar and, unless otherwise stated grown, with 
shaking at 120rev.min-1 and 30°C, overnight to stationary phase in 
standard YPD broth, before dilution into fresh medium and further growth 
for 3 hours before experimental use (Holland and Avery, 2009). When 
growth at 37°C was required, the above culturing steps were performed at 
the alternate temperature. Synthetic complete (SC) medium was used for 
experiments involving nicotinic acid (NA) limitation, comprising yeast 
nitrogen base (YNB) without amino acids and NA (Formedium), and 
supplemented with SC amino acid mixture (Formedium) and 2% glucose. 
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The medium was supplemented ZLWKǋ0RUǋ0RI
the normal SC nicotinic acid concentration. Cultures grown overnight at 5% 
or 100% NA were diluted in the same medium and grown for a further 3 
hours. For experiments where nitrogen was limited, SC medium comprised 
of YNB without amino acids and ammonium sulphate ((NH4)2SO4) 
(Formedium), supplemented with SC amino acid mixture and 2% glucose 
was used. The medium was supplemented with 5% (1.9mM) or 100% 
(37.8mM) of the normal SC (NH4)2SO4 concentration. Cultures grown 
overnight at 5% or 100% (NH4)2SO4 were diluted in the same medium and 
grown for a further 3 hours.  C. glabrata cells were grown at different 
ambient S+¶VLQ3DQ)XQJDO0HGLXP3)0ZKLFKZDVEXIIHUHGWRS+RU
pH8 with 100mM Tris-HCL, or to pH4 with 100mM glycolic acid (Schmidt et 
al., 2008). Cells were grown overnight at the pH of interest before dilution 
into the same medium and growth for a further 3 hours. Myriocin and 
ketoconazole (Sigma) were dissolved in methanol and added to YPD at final 
concentrations RIǋ0 DQGǋ0UHVSHFWLYHO\3K\WRVSKLQJRVLQH6LJPD
ZDVGLVVROYHGLQHWKDQRODQGDGGHGWR<3'DWDILQDOFRQFHQWUDWLRQRIǋ0
(Martin and Konopka, 2004). In all cases cells were grown overnight in YPD 
broth supplemented with the appropriate combination of myriocin, 
ketoconazole, or phytosphingosine before dilution into similarly prepared 
YPD medium and growth for a further 3 hours.  
Selection of yeast colonies following transformation (2.9.1) was 
performed on YPD agar supplemented with nourseothricin (Shen et al., 
2005, Ferrari et al., 2009), or when required hygromycin (Table. 2). 
Alternately colonies were selected on YNB without amino acids 
(Formedium) agar (16 gL-1 agar) supplemented with, the appropriate 
amino acids (Table. 2) and 2% glucose. If 5-FOA selection was required SC 
agar was supplemented with 5-)2$DWDILQDOFRQFHQWUDWLRQRIǋJPO-1. 
Maintenance of the transformed plasmid, pCgACT-14-SIR3, by cells was 
insured through the use of YNB (without amino acids) agar and broth 
supplemented with 2% glucose and the appropriate amino acids, but 
lacking tryptophan.     
In all cases E. coli XLI blue strains were maintained on Luria Bertani 
(LB) (Bertani, 1951) (10gL-1 tryptone, 5 gL-1 yeast extract, 10 gL-1 NaCl, 
pH7, with 15 gL-1 agar for plates), agar supplemented with ampicillin 
(Table. 2) and grown with shaking at 200rev.min-1, 37°C, overnight in LB 
broth, supplemented with ampicillin (Table. 2), prior to experimental use. 
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In order to create electro-competent (2.9.2.1) E. coli XLI blue was grown in 
LB broth supplemented with tetracycline (Table. 2).    
Short term storage of all yeast and bacterial strains took place at 
4°C on the appropriate agar plates. For long term storage glycerol stocks 
were produced with 25% glycerol and kept at -80°C.  
 
Table 2 - Amino Acid and Antibiotic Concentrations 
Amino Acid  
or 
 Antibiotic 
Stock   
Concentration 
 (mg ml-1)* 
C. glabrata 
Working 
Concentration 
(µg ml-1) 
E. coli Working 
Concentration 
(µg ml-1) 
Histidine 10 20 - 
Tryptophan 10 20 - 
Uracil 2 20 - 
Ampicillin 50 - 50 
Tetracycline 5 - 50 
Nourseothricin 200 200 - 
Hygromycin 50 500 - 
* Tetracycline stock solution was made in ethanol. In all other cases, stock 
solutions were made to the concentrations indicated in dH2O and filter 
sterilised. Amino acid stock solutions were stored at 4°C and antibiotic 
stock solutions were stored at -20°C with the exception of hygromycin 
which was kept at 4°C.   
2.3 Isolation of DNA 
In all cases isolated genomic and plasmid DNA was stored at -20°C 
2.3.1 Genomic DNA Isolation from Yeast 
Yeast were grown overnight at 30°C. 1.5ml of culture was pelleted 
and resuspended in 250µl 0.5M sorbitol containing 100µg RNAse A and 
100U lyticase (L4025 Sigma). Samples were incubated for 1.5h at 37°C, 
with a gentle inversion at 45 minutes to remix the solution. SDS ǋORI
10% (w/v)) was added and samples were mixed gently by pipetting before 
incubation at 65°C for 20 min. A 200µl aliquot of 5M potassium acetate 
was added to the mixture, tubes were inverted to mix and incubated on ice 
for 10 min. Cell debris was pelleted by centrifugation at 13000g for 10 min, 
450µl of the supernatant was then transferred to a new 1.5ml microfuge 
tube containing 450µl isopropanol. Samples were incubated on ice for 5 
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min followed by a second 10 minute centrifugation at 13000g. The 
supernatant was removed and discarded and the remaining pellet washed 
in 200µl of (v/v) 70% ethanol by centrifugation for 1 min at 13000g. 
Ethanol was removed and the pellet allowed to air dry for 5-10 min. The 
pellet was resuspended in 100µl dH2O and incubated at 65°C for 5 min in 
order to dissolve the DNA.  
2.3.2 Plasmid Isolation from E. coli 
 E. coli plasmid DNA was isolated from overnight liquid cultures in LB 
broth containing ampicillin for plasmid selection (Table. 2). Mini 
preparations of plasmid DNA were with the ZyppyTM Plasmid Miniprep Kit 
(Zymo Research Corp) as follows: Lysis Buffer (100µl) was added directly 
to 600µl of overnight culture or alternatively to 600µl of cells resuspended 
in sterile dH2O following centrifugation (1 min, 13000g) of up to 3ml 
bacterial culture. Samples were mixed by inversion four-six times at which 
point the colour should change from opaque to clear blue indicating 
complete lysis. An aliquot (350µl) of cold Neutralization Buffer was added 
and samples mixed by inversion, resulting in a colour change to yellow and 
formation of a yellow precipitate. Samples were inverted a further two-
three times to ensure complete neutralisation followed by centrifugation at 
13000g for 4 min. The supernatant, (~900µl), was carefully transferred to 
a Zymo-SpinTM IIN column. The column was placed in a collection tube and 
centrifuged for 15 sec at 13000g, the flow through was discarded and the 
column placed back in the same collection tube. Endo-Wash Buffer (200 µl) 
was added to the column. Samples were centrifuged at 13000g for 15 sec 
followed by the addition of 400µl ZyppyTM Wash Buffer. A slightly longer 30 
sec centrifugation at 13000g was then performed to ensure complete 
removal of ethanol from the column. Columns were transferred to new 
1.5ml microfuge tubes and plasmid DNA was eluted by adding 30µl of 
ZyppyTM Elution Buffer directly to the column matrix. Samples were allowed 
to stand at room temperature for 1 min, and finally centrifuged at 13000g 
for 15 seconds. 
2.3.3 Plasmid Isolation from C. glabrata and S. cerevisiae 
Yeast colonies were picked into a 5ml sterile tubes containing 500µl 
of the appropriate YNB selection medium and vortexed for 1 min. Cultures 
were left to grow overnight at 30°C, 120rev.min-1 before cells were 
transferred to 1.5ml microfuge tubes and pelleted by centrifugation at 
13000g for 5 min. The supernatant was removed by pouring and the pellet 
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UHVXVSHQGHG LQ WKH UHVLGXDO OLTXLG aO /\WLFDVH ǋO DW 8O ZDV
added and the samples mixed thoroughly by pipetting before being 
incubated at 37°C, 200rev.min-1 for 1h. Sodium dodecyl sulfate (SDS) 
ǋORIZYZDVDGGHGWRWKHVDPSOHVZKLFKZHUHWKHQYRUWH[HG
for 1 min and frozen at -20°C. Samples were thawed and made up to 600µl 
with sterile dH2O. The protocol for plasmid isolation from E. coli (2.3.2) was 
WKHQIROORZHGIURPWKHSRLQWRIDGGLQJ/\VLV%XIIHUǋO 
 
2.4 Polymerase Chain Reaction (PCR) 
 PCR reactions were performed using a Techhne TC-512 gradient 
thermal cycler with Phusion® high-fidelity polymerase (Finzymes) (2.4.1, 
Table. 3) when high accuracy was required or Taq DNA polymerase (New 
England Biolabs Inc) (2.4.2, Table. 4) for diagnostic PCR reactions. PCR 
reactions using genomic/plasmid DNA and colony PCR (2.4.3, 2.4.4) 
reactions were carried out in a total volume of 50µl in 0.2ml PCR tubes 
(Star Lab). The amplification products were analysed by agarose gel 
electrophoresis (2.6) in the appropriate strength gel. Any PCR products 
required for additional use were excised from the gel and the DNA was 
purified by gel extraction (2.7). 
2.4.1 Phusion® High-Fidelity Polymerase PCR Reaction 
 The standard reaction mixture for PCR reactions utilising Phusion® 
high-fidelity polymerase is detailed in (Table. 3). Cycling conditions for 
these reactions were: initial denaturation at 98°C for 30 sec, followed by 
30 cycles of 10 sec at 98°C, 30 sec at (*)°C, and 30 sec kb-1 of the desired 
product at 72°C; the 30 cycles were followed by a 10 min extension at 
72°C before a final hold at 4°C 
* Tm values were calculated using the nearest neighbor method. 
Primers >20nt were annealed at a temperature +3°C of the lower Tm 
SULPHU )RU SULPHUVQW DQ DQQHDOLQJ WHPSHUDWXUH HTXDO WR WKH 7P RI
the lower Tm primer was used. 
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Table 3 - Phusion® High-Fidelity Polymerase PCR Reaction 
Mixture 
 
Component 50µl Reaction 
5x Phusion® HF Buffer  10µl (1x) 
10mM dNTPs 1µl (200µM final conc.) 
Forward Primer 0.5µM 
Reverse Primer 0.5µM 
Template DNA 50-250ng 
DMSO (100%)  1.5µl  
Phusion® DNA Polymerase  1 unit 
dH2O Make up to 50µl final 
volume 
 
 2.4.2 Taq DNA Polymerase PCR Reaction 
 The standard reaction mixture for PCR reactions utilising Taq DNA 
polymerase is detailed in (Table. 4). Cycling conditions for these reactions 
were: initial denaturation at 95°C for 30 sec, followed by 30 cycles of 15 
sec at 95°C, 30 sec at (*)°C, and 1 min kb-1 of the desired product at 
68°C; the 30 cycles were followed by a 10 min extension at 68°C before a 
final hold at 4°C 
* Tm values were calculated using the nearest neighbor method. 
Primers >20nt were annealed at a temperature +3°C of the lower Tm 
SULPHU )RU SULPHUVQW DQ DQQHDOLQJ WHPSHUDWXUH HTXDO WR WKH 7P RI
the lower Tm primer was used. 
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Table 4 - Taq DNA Polymerase PCR Reaction Mixture 
 
Component 50µl Reaction 
10x Standard Taq or ThermoPol Buffer  5µl (1x) 
10mM dNTPs 1µl (200µl final conc.) 
Forward Primer 0.5µM 
Reverse Primer 0.5µM 
Template DNA 50-500ng 
Taq DNA Polymerase  1.25 units 
dH2O Make up to 50µl final 
volume 
 
2.4.3 Yeast Colony PCR 
A stock solution of lyticase was diluted to 5U µl-1 and aliquoted in to 
50µl quantities. C. glabrata or S. cerevisiae colonies were picked using 
either, a sterile wooden cocktail stick or pipette tip and added to the 50µl 
lyticase aliquots (1 colony per aliquot). Samples were then agitated by 
pipetting and incubated at 30°C for 30 min. After incubation at 95°C for 10 
min, 5µl of each sample was used as template in a 50µl Taq DNA 
polymerase PCR reaction (2.4.2, Table. 4).   
2.4.4 Bacterial Colony PCR 
 Colonies ZHUHSLFNHGDVLQDQGDGGHGWRǋO dH2O. Samples 
were incubated at 95°C for 10 min, and then tubes were briefly spun to 
collect any condensation. The whole 5µl was then used as template in a 
50µl Taq DNA polymerase PCR reaction (2.4.2, Table. 4). 
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Table 5 ± PCR Primers 
Primer Name Sequence ¶-¶ 
WIEPA1-FWD GTCTTACATCGTATTCTATCTCTC 
HAtag-FWD CCGGACTATGCAGGATCCTATC 
EPA1-REV-OSHOM GATATATACTGCTTTACTGAATATCAATC 
MS-SIR3-FWD CTGAGCTTATAAAAGACCTGGAAGG 
MS-SIR3-REV TCTATTCGGTGAGACACGATTGGATCC 
SIR3-FWD-SacI GATCGAGCTCCCAGGATCGATACTCGCAGTAG 
SIR3-FWD-SacI GATCGAGCTCGGAATGCAATTCTGGAAAACAACC 
YPS7-FWD CGCGTATGAGGTGCTGGTGG 
YPS7-REV CGTCTAGCTTGTCGATGGTATCC 
YPS7-FWD-OSHOM GCGTTGACGTTGTGCTGCTG 
YPS1-FWD-SacI AAAAGAGCTCGTGGATCGTCGATCTGCGCAAG 
YPS1-REV-SacI AAAAGAGCTCCGTGTCCCTACCTCTATCTGGG 
Cg-HIS-FWD-BamHI GATCGGATCCGTGCCACCTGACGTCCTCGAG 
Cg-HIS-REV-NheI GATCGCTAGCGTGCCACCTGACGTCCTCGAG 
YPS1-FWD-OSHOM GCCATTACATATCATGTTTGTATAAG 
RAD6GFP-TF-FWD GAATTCCAAAGATTATTTTTAGGCAGACAGAGACTAAA 
AGATAAAGCGTCATGTCTAAAGGTGAAGAATTATTC * 
RAD6GFP-TF-REV CGAATTCATAATATCGGCTCGGCATTCATCATTAAGAT 
TCTTTTGATTTTTCTTAAACTGGATGGCGGCGTTAG * 
RAD6-FWD AGCCAGTGAGGAATCTCAAAAATTTATCC 
RAD6-REV AAGATACGGGTATCGGCAGTTATAACCG 
ADH1-term-REV GTGTGGTCAATAAGAGCGAC 
RAD6-TLF-FWD GGACGATATGGACGATGATGATGATGATGATGACGAC 
GACGACGACGACGAAGCAGAC 
RAD6-TLF-REV GTAATCGAATTCATAATATCGGCTCGGCATTCATCATT 
AAGATTCTTTTGATTTTTC 
SIR2-FWD-PstI AAAACTGCAGCGAAGATGACCAGTTGGATTTCCATTCA 
TACTGTATG 
SIR2-REV-XbaI CTAGTCTAGAGATTTGAATTTGCTGTTCCACCTGCCCT 
TCTTACATTAAG 
SWI6-FWD-BamHI AAAAGGATCCGTAAAATGCATGAAAATAAATCAATACA 
ACACCAAAG 
SWI6-REV-SacII AAAACCGCGGGCTTAAGATCTTGTAGAAGGACACATA 
AACAATATTTTTGG 
Underlined sequence corresponds to restriction sites.  
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*Italics correspond to homology to the GFP cassette from pSVA12 
2.5 DNA Sequencing 
 High sensitivity DNA sequencing reactions were performed by the 
University of Nottingham, Medical School Sequencing laboratory, utilising 
BigDye v3.1. Analysis was performed using a 3130x1 PRISM Genetic 
Analyser. Primers used for sequencing are shown in (Table. 6) 
 
Table 6 ± Sequencing Primers 
Primer 6HTXHQFH¶-¶ 
RAD6-SEQ1 CAATTAGATAAAGTGTGAGC 
RAD6-SEQ2 GATGATGATGACGACGACGAC 
RAD6-SEQ3 CTATATTTTTCAAAGATGAC 
RAD6-SEQ4 GCGAATTTCTTATGATTTATG 
 
2.6 Digestion of DNA with Restriction Enzymes 
Restriction enzymes, were purchased from New England Biolabs Inc, 
DQG XVHG LQ DFFRUGDQFH ZLWK PDQXIDFWXUHU¶V LQVWUXFWLRQV $OO UHVWULFWLRQ
digestion reactions were performed in a total volume of 50µl. Digestion 
products were separated by electrophoresis on the appropriate percentage 
agarose gel (2.7). Where specific digestion products were required for 
further use (e.g. cloning) the corresponding band was excised from the gel 
and the DNA purified by gel extraction (2.8). 
 
2.7 Agarose Gel Electrophoresis 
 Nucleic acids were separated out according to size by 
electrophoresis using high melting temperature agarose gels. Gels of 
various concentrations, typically between 0.8-1.5% (w/v) were used 
depending on the size of nucleic acid fragments to be resolved. Gels were 
routinely prepared using the appropriate amount of agarose (Seakem® LE 
Agarose) in 1x TAE buffer followed by heating in a microwave until the 
agarose had dissolved. The solution was left to cool for approximately 10 
minutes at which point ethidium bromide was added to a final 
concentration of 0.5µg ml-1 to allow visualisation of separated DNA. The 
solution was then poured into a mould and allowed to set for ~20 min to 
form a solid gel. Gels were placed into the appropriate size electrophoresis 
tank filled with 1x TAE buffer. Bromophenol blue DNA loading dye was 
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added to samples at a final concentration of 1x and they were loaded onto 
the gel along with either a 1kb or 100bp DNA ladder (NEB UK) (Fig. 17). 
Gels were run for 30-60 minutes at 80-100V using a Biorad Power-Pac 300.  
Following electrophoresis, separated DNA was visualised using a Biorad Gel 
Doc 2000. 
 
2.8 Purification of DNA from Agarose Gels 
Gel extractions were performed using the Geneflow Q-Spin gel 
Extraction/PCR Purification Kit (GENEFLOW). For DNA extraction from 
agarose gels, the appropriate fragment was excised and transferred to a 
1.5ml microfuge tube. The gel fragment was weighed and an equivalent 
(w/v) amount of Binding Buffer was added. For agarose gels above 1.5% 
(w/v) twice the volume of Binding Buffer was used. Samples were 
incubated at 50°C with occasional vortexing until the gel had completely 
dissolved. The resulting solution was transferred to a spin column and 
allowed to stand at room temperature for 2 min. Spin columns were 
centrifuged for 1 min at 11000g and flow through in the collecting tube 
discarded. Wash Solution I ǋO ZDV DGGHG WR HDFK FROXPQ EHIRUH
centrifugation for 15 sec at 11000g and the flow through discarded. This 
wash step was then repeated. A longer centrifugation step of 1 min at 
11000g removed any residual Wash Solution I. Columns were then 
transferred to new 1.5ml collection tubes and 30-50µl of Elution Buffer 
added directly to the spin column membrane. Columns were allowed to 
stand at room temperature for 2 min before DNA was eluted by 
centrifugation for 1 min at 11000g. All DNA purified in this way was stored 
at -20°C. 
 
2.9 DNA Ligations 
 Prior to ligation, DNA fragments were purified from their either PCR 
(2.4) or restriction digest (2.6) enzymatic reactions. The CloneJETTM PCR 
Cloning Kit (K1231 Fermentas Life Sciences) was used for cloning of blunt 
ended Phusion® high-fidelity polymerase (Finzymes) PCR products into the 
pJET1.2 blunt cloning vector. For this, 50ng of pJET1.2 blunt cloning vector 
were used per ligation reaction. Ligations not involving pJET1.2 were 
performed using 100-200ng of the appropriate vector per ligation reaction. 
All DNA was quantified using a Nano-Drop spectrophotometer (NanoDrop 
Technologies). When required, vector DNA was treated with Antarctic 
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Figure 17 ± 1kb and 100bp DNA ladders used in agarose gel electrophoresis 
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phosphatase (M0289S NEB UK) prior to ligation. All DNA ligations were 
performed at room temperature using T4 DNA Ligase (M0202S NEB UK or 
supplied with the CloneJETTM) after which ligated DNA was prepared for 
transformation (2.10) by ethanol precipitation (2.9.1). All enzymes were 
XVHGLQDFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV$WRWDOYROXPHQR
greater than 30µl and an insert to vector fragment ratio of 3:1 was used in 
all cases. In order to calculate the appropriate amount of insert to include 
in the ligation reaction the following equation was used; 
 
 
 
2.9.1 Ethanol Precipitation 
 Ethanol precipitation was performed on ligated DNA, in microfuge 
tubes, prior to transformation. Initially 3M sodium acetate was added at 
1/10 the volume of the sample being treated followed by 3x the sample 
volume of 100% (v/v) ethanol. Samples were then mixed by inversion and 
centrifuged at 13000g for 10 min creating a DNA pellet. The Supernatant 
was carefully removed so as not to disturb the pellet which was then 
washed with 70% (v/v) ethanol by centrifugation at 13000g for 1 min. 
Ethanol was removed and DNA pellets air-dried, before being resuspended 
LQǋOG+2O.  All samples were stored at -20°C.  
 
2.10 Transformations 
2.10.1 Yeast Transformation 
A slightly modified version of the traditional lithium acetate (LiAc) 
method was used for all C. glabrata and S. cerevisiae transformations 
(Castano et al., 2003). Cells were grown to OD600~1 in 50ml YPD medium 
(2.2), harvested and washed with the same volume (50ml) of dH2O. Cells 
were resuspended in 500µl of 100mM LiAc and 50µl aliquots, each 
containing roughly 5x107 cells, were used for each transformation. To each 
50µl sample a transformation mix containing 240µl 50% polyethylene 
glycol 3350 (PEG), 36µl of 1M LiAc, 50ug of heat-denatured salmon sperm 
DNA (Sigma) and the DNA to be transformed dissolved in 50µl of sterile 
dH2O. Typically 5-10ug of transforming DNA, quantified using a Nano-Drop 
spectrophotometer (NanoDrop Technologies), was used. Once all 
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components had been added the sample was mixed by pipetting and 
incubated at 30°C for 30 min. Subsequently, 45µl of DMSO was added and 
samples were mixed by inversion and immediately heat shocked at 42°C 
for 15 min.  For selection using an auxotrophic marker the transformation 
mix was centrifuged at 5000g for 20 sec to pellet the cells. Cells were 
resuspended in 1ml of sterile dH2O and allowed to recover for 5 min at 
room temperature before plating on selective YNB medium (2.2). For 
selection with antibiotic cells were allowed to recover in 5ml YPD for 1h at 
30°C with shaking at 120 rev min-1, after which they were pelleted and 
resuspended in 1ml sterile dH2O before plating on antibiotic supplemented 
YPD agar (2.2). 
2.10.2 Bacterial Transformation 
All bacterial transformations were performed by electroporation of 
XL-1 blue E. coli cells. Electro-competent XLI EOXHFHOOVǋOsee below 
2.10.2.1) were added to transforming DNA dissolved in 10µl sterile dH2O 
and gently mixed by pipetting. This mixture was transferred to an 
HOHFWURSRUDWLRQFXYHWWHDQGWKHVDPSOHHOHFWURSRUDWHGDWN9DQG
25µF capacitance using a Biorad electroporater. Super optimal broth with 
catabolite repression (SOC) medium (2% tryptone, 0.5% yeast extract, 
10mM NaCl, 2.5mM KCl, 10mM MgCl2, 10mM MgSO4, 20mM glucose) (1ml) 
was then immediately added to the electroporation cuvette and cells 
resuspended before being transferred to a 20ml sterile tube. Cells were 
allowed to recover for 1 hour at 37°C with shaking at 200 rev min-1. The 
transformation mixture was subsequently plated onto LB agar 
VXSSOHPHQWHGZLWKDPSLFLOOLQǋJPO-1). 
2.10.2.1 Preparation of Electro-competent E. coli XLI Blue 
Cells 
 E. coli XLI blue cells were grown overnight in 10ml LB broth 
supplemented with tetracycline (2.2, Table. 2). This culture was then 
added to 1L LB broth supplemented with tetracycline and grown to an 
OD600 ~0.5-0.8. Cells were transferred to sterile centrifuge tubes and 
harvested by centrifugation at 8000g, 4°C for 15 min. The supernatant was 
removed and cells resuspended in 1L of sterile ice-cold 1mM HEPES. Cells 
were centrifuged at 10000g, 4°C for 15 min and again pellets were 
resuspended in 1L sterile, ice-cold 1mM HEPES. Resuspendend cells were 
centrifuged at 10000g, 4°C for 15 min before removal of the supernatant 
and resuspension in 100ml of sterile, ice-cold 1mM HEPES with 10% 
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glycerol. A final centrifugation at 10000g, 4°C for 15 min was performed 
and cells resuspended in 1ml sterile, ice-cold HEPES with 10% glycerol. 
$OLTXRWV ǋO RI FHOOV ZHUH WUDQVIHUUHG WR VWHULOH VFUHZ-cap microfuge 
tubes and frozen on dry ice. Cells were then stored at -80°C until use. 
 
2.11 Cell Staining/Probing 
Freshly harvested cells (1.5 x 106) were used for all staining 
procedures, after 5min incubation at 30°C with 50mM EDTA to prevent cell 
aggregation. Cells were collected by centrifugation (8000 g, 2 min) and 
pellets resuspended in 300ǋO phosphate buffered saline (PBS). The 
appropriate staining procedure (below) was then applied.  
2.11.1 Probing for Epa1 
 Hemagglutinin (HA)-tagged Epa1 was probed with anti-HA, Alexa 
Fluor® 488 conjugate (Molecular Probes, Invitrogen) by incubation of 1.5 x 
106 with 3.5ǋg ml-1 antibody for 30 min at 4°C. Samples were washed 
twice with 300ǋO3%6 (8000 g, 2 min) before analysis. 
An anti-Epa1 rabbit polyclonal antibody (Kaur et al., 2007), was a 
gift from Brendan Cormack. To avoid cross-reactivity, the antibody was 
pre-absorbed against C. glabrata epa1Ʃ cells before use: cultures were 
grown in SC, 5% NA medium (2.2) to induce EPA gene expression 
(Domergue et al., 2005). Cells (1 x 108) were suspended in 500ǋO3%6DQG
preabsorption performed through 10 x 1 h incubations on ice with antibody 
(1/5 dilution), each incubation with a fresh batch of cells. The final 
supernatant was confirmed to have Epa1-specific reactivity by probing wild 
type and epa1Ʃ cells, grown in SC, 5% NA medium, with analysis by flow 
cytometry (2.12). This antibody was used to probe Epa1 by incubating 1.5 
x 106 cells for 30 min at 4°C in the presence of antibody (1/5,000 dilution). 
Cells were washed twice with PBS (8000 g, 2 min) and resuspended in 
ǋO3%6EHIRUHLQFXEDWLRQZLWKǋJPO-1 anti-rabbit Alexa Fluor® 488 
conjugate secondary antibody (Molecular Probes, Invitrogen). After 20 min 
at 4°C, cells were washed twice with PBS (8000 g, 2 min) before analysis. 
2.11.2 Probing for Mannoprotein 
Cells (1.5 x 106) were probed for cell surface mannoprotein by 
staining with concanavalin A, Alexa Fluor® 647 conjugate (Molecular 
Probes, Invitrogen). A 5mg ml-1 stock solution of the conjugate in 0.1M 
sodium bicarbonate was added to cell samples to give a final conjugate 
concentration of 70µg ml-1. Samples were then incubated for 30 min at 4°C 
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before being washed twice in 300µl PBS (8000 g, 2 min) and used for 
analysis by flow cytometry (2.12). 
2.11.3 Filipin Staining 
 Prior to staining cells were resuspended in 1ml PBS. A filipin stock 
solution (5mg ml-1 LQ'062ZDVDGGHGDWDILQDOFRQFHQWUDWLRQRIǋJPO-1, 
samples mixed, and cells analysed by fluorescence microscopy (2.13) 
within 5 min.  
2.11.4 Dual Staining 
When dual staining of cells was required with anti-HA, Alexa Fluor® 
488 conjugate and concanavalin A, Alexa Fluor® 647 conjugate staining 
was performed simultaneously as described above (2.11.1, 2.11.2). For 
dual staining with anti-HA, Alexa Fluor® 488 conjugate and filipin, staining 
was performed first with anti-HA, Alexa Fluor® 488 conjugate (2.11.1) 
followed by filipin just before analysis (2.11.3).  
2.11.5 Actin Staining 
 Cells were fixed with formaldehyde (4% v/v) with inversion at 30°C 
for 15 min before being pelleted by centrifugation at 8000g for 1 min and 
resuspended in PBS. Samples were then incubated with 4% (v/v) 
formaldehyde for a further 1h at room temperature. The fixed cells were 
washed 5 times in PBS DQGUHVXVSHQGHGLQǋO3%6$QǋODOLTXRWof cells 
ZDV UHPRYHG DQG ǋO RI $OH[D )OXRU® 488 phalloidin (Invitrogen) added, 
before incubation in the dark at room temperature with vortexing every 15 
min for 90 min. Samples were washed 5 times in PBS prior to analysis. 
 
2.12 Flow Cytometry and Fluorescence Activated Cell 
Sorting (FACS) 
Analysis by flow cytometry was with a BD FACSCanto instrument, 
equipped with a 488 nm argon-ion laser (BD Biosciences). After staining 
(2.11) cell samples were suspended in 300ǋO3%6LQIORZF\tometry tubes 
(BD Biosciences). Alexa Fluor® 488 fluorescence was measured via a FITC 
filter and Alexa Fluor® 647 fluorescence via an APC-A filter. Data was 
recorded for 10,000 cells per sample, at  5000 cells sec-1. When 
quantification of fluorescence for dual stained cells was required 
compensation controls, which take and fluorescence overlap into account, 
were set for each fluorochrome using single stained cells. Data were stored 
and analyzed using FacsDIVA (BD Biosciences), with additional analysis 
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using Weasel software (the Walter and Eliza Hall Institute of Medical 
Research, Australia). Fluorescence measurements with the FACSCanto 
were normalized for cell size, by forward scatter (FSC-A) correction. Unless 
indicated otherwise (Newman et al., 2006), these normalized data were 
used to determine Coefficients of Variation (CV), excluding the outlying top 
and bottom 0.1% of data. When an alternate method of CV calculation was 
utilised this was as described by Newman et al (2006). Cell sorting (FACS) 
was performed with a Coulter Altra flow cytometer. Similar sized cells, as 
determined by FSC-A values, were gated into the lowest- or highest- 13% 
of Epa1-HA fluorescence. Cells from each subpopulation (1x106) were 
sorted directly onto ice prior to RNA extraction (2.15). 
2.13 Fluorescence Microscopy 
Cells were examined through a 100x objective lens with a Nikon 
Eclipse Ti microscope equipped with a DS-Qil camera and temperature 
controlled chamber. Image acquisition was with NIS elements Br Software 
(Nikon). Following staining (2.11), cells were pelleted by centrifugation at 
J IRUPLQDQGUHVXVSHQGHG LQǋO3%6$QDOLTXRWǋORIVWDLQHG
cells was added to a microscope slide and covered with a coverslip prior to 
imaging. Imaging was performed using the bright field filter for all cells. 
Alexa Fluor® 488 fluorescence was imaged using the FITC filter while filipin 
fluorescence was observed using the DAPI filter. Cell fluorescence was 
quantified per unit cell area with Image J software, using the region of 
interest (ROI) tool.  
2.13.1 Time Lapse Microscopy 
For time lapse studies 5x106 freshly harvested cells, incubated for 
5min at 30°C with 50mM EDTA to prevent cell aggregation, were used for 
(HA)-tagged Epa1 probing with anti-HA, Alexa Fluor® 488 conjugate 
(2.11). Stained cells were resuspended in 1ml PBS and added to glass 
chambers (WAKI), pre-coated with 1 mg ml-1 concanavalin-A and air dried, 
where they were allowed to adhere for 20 min at 4°C. The supernatant 
above adhered cells was removed and the chamber washed gently with 1 
ml PBS to remove nonadherent cells, before adding 1ml of pre-warmed 
(30°C) YNB broth with appropriate amino acid supplements (2.2). The time 
course was started immediately with the temperature controlled chamber 
pre-heated to 30°C. Bright field and fluorescence images, using the FITC 
channel, were captured at 10 min intervals. 
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2.14 Adherence Assay 
HEp-2 epithelial cells were grown (5% CO2, 37°C) to confluence in 
'XOEHFFR¶V Modified Eagles medium (DMEM) supplemented with 10% (v/v) 
fetal calf serum, 100U ml-1 penicillin, 0.1 mg ml-1 streptomycin, and 2mM 
L-glutamine before splitting with 0.25% (w/v) trypsin, 0.53mM EDTA. After 
incubation for 24±48 h in DMEM, 24-well tissue culture plates (Nunclon®) 
were seeded with 1 x 104 cells ml-1 in DMEM and incubated at 37°C for 2 
G &RQIOXHQW PRQROD\HUV ZHUH ZDVKHG WZLFH ZLWK +DQN¶V Buffered Salt 
Solution (HBSS, Sigma) and fixed for 10 min in 4% (v/v) 
paraformaldehyde, before three 5-min washes with PBS. C. glabrata cells 
grown to exponential phase at 30°C and at 37°C in YPD broth (2.2) were 
diluted to 2,000 cells ml-1 in HBSS before 1 ml of cells was added to 
individual wells containing the HEp-2 monolayers. Plates were centrifuged 
(500 g, 1 min) and incubated at 37°C for 30 min to allow adherence. 
Supernatant was removed by pipetting, followed by three washes with 
500ǋO+%66 WR UHPRYHXQERXQG FHOOV0RQROD\HUV and bound C. glabrata 
cells were released by incubation at 37°&IRUPLQZLWKǋl 2% (w/v) 
trypsin in PBS. After addition of 10ǋl of 10% (v/v) Triton X-100, 50ǋO 
100mM EDTA DQGǋO<(3'EURWKUHOHDVHGFHOOVZHUHSODWHGLQUHSOLFDWH
on YEPD agar and incubated at 30°C for at least 2d. Colonies were counted 
to determine adherent cell numbers. 
 
2.15 RNA Extraction 
Total RNA was isolated using an RNeasy® Mini Kit (Qiagen) either 
from 1 x106 (after FACS, 2.12) or 1 x 107 cells on all other occasions. This 
kit utilizes the selective binding properties of a silica based membrane 
within RNeasy® mini spin columns. If not indicated otherwise all 
centrifugation steps were performed at room temperature, 8000g. Cell 
samples were centrifuged for 5 min, 1000g at 4°C. Cell pellets were 
resuspended in 100µl of freshly prepared buffer Y1 (1M sorbitol, 0.1M 
EDTA. pH7.4, just before use 0.1YYǃ-mercaptoethanol and lyticase 
(50U per 1x107 cells) were added), containing 50U of lyticase and 
incubated for 10 min at 30°C with gentle shaking to generate spheroplasts. 
Buffer RLT ǋO was added and the samples vortexed vigorously to lyse 
the spheroplasts, after which 250µl of 100% ethanol was added and mixed 
by pipetting. The homogenized lysate was transferred to an RNeasy® mini 
spin column, placed in a 2ml collection tube, and centrifuged for 15 sec. 
Flow-through was discarded and 700µl Buffer RW1 added before spinning 
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for 15 sec. The flow through was again discarded and the column washed 
with 500µl Buffer RPE by centrifugation for 15 sec. This step was repeated 
with centrifugation for 2 min. An additional centrifugation step at 13000g 
for 1 min ensured complete removal of Buffer RPE. The columns were 
transferred to new 1.5ml collection tubes and 30-50µl of RNase free water, 
added to the spin column membrane. RNA was finally eluted by 
centrifugation for 1 min and stored at -20°C. All RNA was quantified using 
a Nano-Drop spectrophotometer (NanoDrop Technologies) 
 
2.16 Reverse Transcription 
Reverse transcription was performed using SuperScript III 
Reverse Transcriptase (RT), and Oligo(dT)20 Primer (Invitrogen) according 
to the PDQXIDFWXUHU¶V instructions. RNase free conditions were maintained 
ZLWK51DVH287 Recombinant RNase Inhibitor (Invitrogen) and nuclease-
free microcentrifuge tubes were used throughout. Initially 1µl of oligo(dT)20 
(50µM) was added to a microfuge tube, this was followed by 10pg-5µg 
total RNA and 1µl of 10mM dNTP mix. If required sterile dH2O was added 
up to a volume of 13µl. Samples were heated to 65°C for 5 min followed by 
at least a 1 min incubation on ice. The contents of the microfuge tubes 
were collected by a brief centrifugation before addition of; 4µl 5X First 
Strand Buffer, 1µl of 0.1M dithiothreitol (DTT) O RI 51DVH287
5HFRPELQDQW 51DVH ,QKLELWRU DQG O RI 6XSHU6FULSW ,,, 57 8O
The samples were mixed by gentle pipetting and incubated at 50°C for 1h 
after which the reaction was inactivated by heating to 70°C for 15 min. The 
resulting cDNA was then prepared by PCR purification using the Geneflow 
Q-Spin gel Extraction/PCR Purification Kit (GENEFLOW). In this instance an 
equivalent volume of Binding Buffer was added to cDNA samples and the 
solutions mixed. Samples were then incubated at room temperature for 1 
min before being transferred to a spin column after which all steps were 
performed as described for gel extraction in (2.8). All cDNA purified in this 
way was quantified with a Nano-Drop spectrophotometer (NanoDrop 
Technologies) and subsequently used for quantitative RT-PCR (qRT-PCR) 
(2.17). Samples were stored at -20°C.   
 
2.17 Quantitative RT-PCR (qRT-PCR) 
qRT-PCR was performed in triplicate reactions, each comprising 
30ng cDNA, 100nM of each gene specific primer (Table. 7), and 1X Fast 
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SYBR® Green master mix (Applied BiosystePV PDGH XS WR ǋl with 
RNase free water. Reactions were performed in sealed 96-well plates and 
monitored with a 7500 Fast Real Time PCR System (Applied Biosystems) 
using 7500 software v2.0.4 (Applied Biosystems). The most appropriate 
annealing temperatures were chosen based on gradient PCR reactions 
using Taq DNA polymerase (2.4.2), and the relevant primers with genomic 
DNA and were as follows: 56°C for EPA1, EPA6, and EPA7; 59°C for Ƚ2, 
58°C for ACT1, and 67°C for SIR3. For annealing temperatures below 60°C 
a three-step 40 cycle protocol of, 3 sec at 95°C, 30 sec at the appropriate 
annealing temperature, 30 sec at 60°C. When annealing temperatures 
were above 60°C a two-step protocol was utilised with reactions being run 
for 40 cycles of 3 sec at 95°C, 30 sec at the appropriate annealing 
temperature. In all cases a melt curve was included after the amplification 
stage to check for the detection of just one product. Amplification was 
quantified from a standard curve constructed from reactions with defined 
copy number of the expected PCR product (2.17.1). Results were analysed 
with 7500 software v2.0.4.   
2.17.1 Calculation of DNA Copy Number for qRT-PCR Standard 
Curves 
 Determination of copy number for the PCR products to be used in 
the construction of standard curves was achieved by calculation of the 
molecular weight (MW) (g mol-1) of dsDNA PCR products and subsequent 
determination of the number of molecules in 1ng of DNA. The MW of 
dsDNA PCR products for use in standard curve reactions were calculated 
using the following equation: 
 
MW (g mol-1) = (Size of DNA (bp) x 607.4) + 157.9 
 
The resulting MW (g mol-1) value was used to determine the number 
RIPROHVSUHVHQW LQJRIPDWHULDO8VLQJ$YRJDGUR¶VQXPEHU[23 
molecules mole-1), the number of template molecules g-1 can be calculated: 
 
Molecules g-1 = moles g-1 [$YRJDGUR¶VQXPEHUPROHFXOHVPROH-1) 
The resulting values can be converted to ng to give the number of 
molecules (copy number) in 1ng of template DNA.  
The template PCR products were quantified using a Nano-Drop 
spectrophotometer (NanoDrop Technologies) and diluted to 1ng ml-1 before 
four further serial 10-IROG GLOXWLRQV ǋO RI HDFK GLOXWLRQ ZDV XWLOLVHG LQ
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standard curve reactions. Consequently a standard curve could be 
constructed from reactions with defined copy number of the expected PCR 
product.  
 
Table 7 ± qRT-PCR Primers 
Primer Name Sequence ¶-¶ 
EPA1-RT-FWD GGGCTCAAAAACAGCTAAAG 
EPA1-RT-REV TAACAGTGTTTTCGTTTGAT 
EPA6-RT-FWD GGGTTCTCAAACAGCTAAGG 
EPA6-RT-REV GTACTTCGCTGTTTGATACA 
EPA7-RT-FWD TACGGAAGAATGGTTCGTAC 
EPA7-RT-REV GCTTGCCGGTAAATGATCT Ƚ2-RT-FWD GAAATCAAGAATTAGTATTACGCATC Ƚ2-RT-REV GGGTAAACTGGAACACAATGATATAAGT 
ACT1-RT-FWD CGCCGGTGACGATGCTCC 
ACT1-RT-REV CTTGGATTGAGCTTCGTC 
SIR3-RT-FWD CGGTCTGCTCGCGATTTTGAG 
SIR3-RT-FWD TTACAGTATTGTCGGTATCCTCAGCC 
 
2.18 Digestion, Separation and Probing of EPA1-
containing High Molecular Weight DNA 
2.18.1 Isolation of High Molecular Weight DNA in Agarose 
Plugs 
 To preserve high molecular weight DNA fragments, genomic DNA 
was isolated in low melting temperature agarose plugs. C. glabrata cultures 
were grown overnight in YPD at 30°C (2.2), pelleted by centrifugation for 5 
min at 3000g and resuspended in 200ǋl cold EDTA (50mM). All remaining 
steps were performed in a fume hood. Cells were transferred to 1.5ml 
microfuge tubes before adding 100ǋORI0 sorbitol, 0.1 M sodium citrate, 
50mM EDTA pH 5.8, 25ǋO PO- ǃ-mercaptoethanol, 3mg ml-1 Zymolase 
20T. This was mixed with 500ǋO RI ZDUP 1% (w/v) low melting point 
agarose, made up with 0.125M EDTA and heated in a microwave until 
dissolved. Agarose aliquots (~100ǋO) were added to pre-sealed and cooled 
plug moulds (Biorad) and allowed to set for 1h. Set plugs were removed 
from the moulds and incubated overnight at 37°C ZLWK ǋO RI 0
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EDTA, 0.1M Tris, 5ǋO PO- ǃ-mercaptoethanol, in 1.5ml microfuge tubes 
covered with Saran wrap. The solution was removed and the plugs overlaid 
with 500ǋO RI  Zv) Sarkosyl, 0.4M EDTA, 1mg ml-1 Proteinase K, 
0.1mg ml-1 RNase, before a further overnight incubation at 37°C. Plugs 
were cooled to room temperature and the solution overlay removed. This 
was followed by rinsing the plugs with 500ǋORI0FROG('7$, which was 
removed before the plugs were overlaid with 500ǋl of 0.45 M EDTA, 0.1 M 
Tris. Plugs were stored at 4°C until use in restriction digest reactions.  
2.18.2 Digestion of DNA Isolated in Agarose Plugs 
 Approximately one third of a plug (2.18.1) was used for each 
digestion. Each plug was equilibrated in 500ǋO 1x Tris-EDTA (TE) buffer 
(10mM Tris pH7.5, 1mM EDTA pH8) for 3 x 1h incubations at 37°C.  This 
was followed by 3 x 1h incubations in 500ǋl of a buffer comprising 50mM 
potassium acetate, 20mM Trizma acetate, 1mM (DTT), 0.1 mg ml-1 bovine 
serum albumin (BSA), pH 7.9. Samples were placed on ice before transfer 
to an equivalent volume of fresh buffer and addition of 60U PmeI or StuI. 
After 1KRQ LFH WKHYROXPHZDVPDGHXS WRǋOZLWK WKH VDPHEXIIHU
including a final concentration of 10mM magnesium acetate and incubated 
overnight at 37°C. Digested plugs were rinsed with TE buffer and then 
stored in 500ǋO 7( EXIIHU DW °C prior to separation of DNA by field 
inversion gel electrophoresis (FIGE). 
2.18.3 Field Inversion Gel Electrophoresis (FIGE) 
Conventional electrophoresis can effectively separate DNA 
fragments up to 20 kb. Pulsed field gel electrophoresis (PFGE) can resolve 
larger fragments by alternating the electrical field between spatially distinct 
pairs of electrodes. During field inversion gel electrophoresis (FIGE) the 
electrical field is fixed at 180° and inverted in the forward and reverse 
directions enabling sample resolution in the 0.1-250 kb size range.   
Agarose plugs were loaded into individual wells of a 1% (w/v) agarose gel 
(2.7) made up with 0.5% TBE buffer. MidRange PFG marker I (NEB UK) 
(Fig. 18) was also added to a well. Digested-DNA was separated by FIGE, 
using 0.5% (w/v) TBE as running buffer and a Biorad FIGE mapper 
programmed to resolve fragments of 20-50 kb.  Digested DNA was 
visualised by staining the gel in ǋJPO-1 ethidium bromide (in dH2O) for 
30 min and photographed using a Biorad Gel Doc 2000. 
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Figure 18 ± MidRange PFG Marker I (NEB UK) 
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2.18.4 Southern Transfer and Probing for EPA1  
 Southern transfer was performed according to the standard capillary 
action protocol whereby DNA molecules are transferred from the gel to a 
porous nylon membrane (Biorad zeta-probe GT membrane) using 
absorbent paper to draw solution through the gel and the membrane 
(Southern, 2006).  
 Bands of interest were detected using a 416bp probe specific to 
EPA1, amplified by PCR from genomic DNA using Phusion® high-fidelity 
polymerase (2.4.1) and primers ¶-
GTTCGTTCAACACTTCCTTCATCAGCAGGC-¶ and ¶-
CTTTGTGATAAGCTGGTCATGATAATGCCTGC-¶ DQG ODEHOOHG ZLWK G&732P 
using a HighPrime labelling kit (Roche) according to the manufacturers¶ 
instructions. Prior to probe hybridisation the nylon membrane containing 
transferred DNA was neutralised for 5 min in 500ml 2x SSPE before being 
placed in a hybridisation tube and prehybridised for >3h at 65°C in the 
presence of 40ml prehybridisation solution (Table. 8). The dCT32P-labelled 
SUREHZDVDGGHGWRǋOGHQDWXUHGILVK'1$PJPO-1) and the solution 
boiled for 4 min before being chilled on ice and added to 30ml of 
hybridisation solution (Table. 8). This hybridisation solution was added to 
the hybridisation tube immediately after removal of the prehybridisation 
solution and incubated overnight at 65°C. Hybridisation solution was 
removed and the membrane washed, with incubation at 65°C, by the 
addition of 50ml wash solution I (Table. 8) for 10 min. A second wash with 
the same solution was performed for 30 min, followed by 2x 30 min 
washes with 50ml of wash solution II (Table. 8). Finally the membrane was 
removed from the hybridisation tube and excess liquid blotted off before 
imaging electronically (Biorad Developer) to detect dCT32P-labelled probe 
binding. Resulting bands were sized against a standard curve constructed 
in Excel, according to the distances migrated by DNA ladder fragments of 
known size.  
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Table 8 ± Solutions for dCT32P-Labelled Probe Hybridisation 
 Components for the solutions described below were obtained from 
Sigma.  
 
Solution Components 
20x SSPE NaCl - 175.3g  
NaH2PO4-H2O ± 27.6g 
EDTA 7.4g  
pH 7.4 
Make up to 1L with dH2O 
Autoclave 
['HQKDUGW¶V Ficoll® 400 - 1g 
Polyvinylpyrrolidone (PVP360) ± 1g 
BSA (fraction V) ± 1g  
Make up to 50ml with dH2O 
Filter sterilize 
Store at -20°C 
Prehybridisation 
Solution 
SSPE ± 6x (above) 
SDS ± 1% 
'HQKDUGW¶V± 5x (above) 
Denatured Fish DNA* - ǋJPO-1 
Make up to 40ml with dH2O heated to 50°C 
Hybridisation Solution Dextran Sulphate ± 1.5g 
SSPE ± 6x (above) 
SDS ± 1% 
Make up to 30ml with dH2O heated to 50°C 
Wash Solution I SSPE ± 2x 
SDS ± 0.5% 
Wash Solution II SSPE ± 0.2x 
SDS ± 0.5% 
*Fish DNA (10mg ml-1) was denatured by boiling for 5 min before being 
chilled on ice.  
2.19 Statistical Analysis 
6WDWLVWLFDODQDO\VLVRIGDWDZDVSHUIRUPHGE\6WXGHQW¶VW-test using 
excel order to indicate if observed differences were statistically significant. 
Statistical significance was inferred when resulting p values were below 
0.05 (p=<0.05) while p=>0.05 indicated a lack of significance.    
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Chapter 3 - Heterogeneity 
in Rad6 Expression 
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3.1 Introduction 
The genes responsible for DNA damage tolerance in S. cerevisiae 
are grouped into the RAD6 pathway, named after its founding and most 
prominent member. Members of this pathway have been classified into 
either the TLS branch, also known as the error prone pathway, or the error 
free branch of damage tolerance, both of which have been discussed more 
fully in the introduction to this thesis (1.6). Briefly, however, these 
pathways enable DNA lesions occurring at ssDNA to be bypassed without 
the need for lesion removal. The majority of repair mechanisms act via 
excision of the damaged region followed by resynthesis based on sequence 
information from the complementary strand. Consequently DNA damage 
bypass is important at regions of ssDNA, such as those found at the 
replication fork, where no complementary strand exists to allow resynthesis 
of an excised region. The DNA damage tolerance pathways therefore allow 
DNA replication to be completed and ssDNA gaps to be filled in the 
presence of damage (Ulrich, 2005, Andersen et al., 2008, Ulrich, 2009, 
Waters et al., 2009). Despite their different mechanisms, initiation of both 
damage tolerance pathways requires the Rad6 ubiquitin conjugating 
enzyme (E2) and the ubiquitin ligase (E3) Rad18. The two proteins form a 
heterodimeric complex which is recruited to sites of ssDNA damage, likely 
through the ssDNA binding activity of Rad18, and acts to monoubiquitinate 
PCNA (Andersen et al., 2008, Ulrich, 2009).  Such monoubiquitinated PCNA 
promotes the TLS pathway of damage tolerance which is proposed to act 
via a polymerase switching model making use of one of more damage 
tolerant TLS polymerases (Ulrich, 2009, Waters et al., 2009). Further 
polyubiquitination of PCNA by Mms2-Ubc13-Rad5 activates error free lesion 
bypass which is thought to occur by a template switching model (Andersen 
et al., 2008, Branzei et al., 2008, Ulrich, 2009).    
DNA damage tolerance constitutes the central and best 
characterised role of S. cerevisiae Rad6, however, the protein appears to 
be a multifunctional ubiquitin conjugating enzyme and is known to interact 
with two additional ubiquitin ligases, Bre1 and Ubr1 (Andersen et al., 2008, 
Game and Chernikova, 2009). The Rad6-Bre1 heterodimer acts to 
monoubiquitinate histone H2B at the Lys-123 residue. This modification 
facilitates histone H3 di- and tri-methylation at Lys-4 and Lys-79 (Game 
and Chernikova, 2009), which subsequently affects numerous cellular 
functions including transcriptional regulation and silencing as discussed in 
the introduction to this thesis (1.5) (Verzijlbergen et al., 2009, Norris and 
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Boeke, 2010, Takahashi et al., 2011). Indeed RAD6 mutant strains have 
been identified to exhibit deficiency for Sir-dependent silencing (Huang et 
al., 1997). In addition the Rad6-Bre1 complex is involved in a less well 
known aspect of Rad6-mediated DNA repair as H3 methylation, particularly 
at Lys-70, can substantially influence DNA damage checkpoint activation 
and repair. In S. cerevisiae this pathway is required for G1 checkpoint 
activation and contributes to the homologous recombination pathway of 
DNA repair in G2 cells (Game and Chernikova, 2009). The interaction of 
Rad6 with Ubr1, on the other hand, is required for Rad6-mediated N-end 
rule ubiquitination and protein degradation (Ulrich, 2002, Andersen et al., 
2008, Game and Chernikova, 2009).  
Previous work in the Avery lab indicated, through the use of an S. 
cerevisiae strain expressing a Rad6-GFP translational fusion (Invitrogen) 
and subsequent analysis by flow cytometry, that Rad6 protein expression 
was bimodal: apparent high- and low-expressing subpopulations were 
distinguishable. This observation seemed independent of cell size since 
normalization of GFP fluorescence by forward scatter (FSC), which provides 
a measure of cell size, did not result in loss of the two subpopulations (Fig. 
19). In contrast, deletion of either SIR2 or SWI6 did abolish the two 
subpopulations which were replaced with one high expressing population 
(Fig. 19). Deletion of SIR2 is known to cause loss of transcriptional 
silencing (Huang, 2002, Liou et al., 2005) suggesting that the different 
Rad6 expression levels could reflect differing silencing capacities of 
individual cells. Furthermore Rad6, along with the Sir proteins, is required 
for silencing at both telomeres and the HM loci in budding yeast, (Huang et 
al., 1997), thus raising the question of whether Rad6 may regulate its own 
expression. Sir2 function impacts a number of processes including cell 
aging, cell cycle progression and, interestingly, regulation of cellular 
response to DNA damage (North and Verdin, 2004) which could be related 
to the observed induction of Rad6 in the sir2Ʃ mutant.   
Swi6 on the other hand was initially targeted for study here due to 
its role in S. pombe, where the protein binds histone H3 and is a crucial 
silencing component with silencing being predominately mediated by Swi6 
containing complexes (Bannister et al., 2001, Huang, 2002, Buhler and 
Gasser, 2009). By contrast S. cerevisiae Swi6 acts as a transcription 
cofactor that does not bind DNA directly but rather forms the SBF and MBF 
complexes via interaction with either Swi4p or Mbp1p, respectively. The 
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Figure 19 ± Analysis of Rad6 expression (AU=arbitrary units) by flow cytometry 
through use of a Rad6-GFP translational fusion containing strain in wild type 
(WT), sir2Ʃ and swi6Ʃ cells, (Data from A. L.  Bishop). 
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transcription factor complexes activate transcription maximally in late G1, 
with down-regulation occurring during G2 and M phases, both actions 
appearing to require SWI6 (Lowndes et al., 1992, Sedgwick et al., 1998, 
Breeden, 2003). The SBF complex may have an additional role in the 
transcriptional response to cell wall stress (Kim et al., 2010). Swi6 is 
known to contain at least four ankyrin repeat (ANK) motifs which have 
been shown to have an antagonistic effect on transcription. Such 
transcriptional attenuation may have a role in modulating the periodic 
transcriptional activation mediated by Swi6 during the cell cycle (Sedgwick 
et al., 1998). One possible explanation for the Rad6 results could be that 
Swi6 exerts some partial repression on Rad6 expression, which is 
subsequently lost upon deletion of the genes. Alternatively, SWI6 deletion 
may affect Rad6 expression indirectly. 
This chapter set out to corroborate the above observations through 
complementation of both the SIR2 and SWI6 deletions and to elucidate 
further the basis for the apparent heterogeneity in Rad6 expression. 
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3.2 Complementation of the sir2Ʃ and swi6Ʃ 
Deletions in Rad6-GFP Expressing Cells 
In order to corroborate that loss of the two Rad6-GFP expression 
subpopulations following deletion of either SIR2 or SWI6 (see introduction 
to this chapter) genuinely resulted from loss of either gene, these deletions 
were complemented. The complementation strategy required construction 
of single copy plasmids containing the genes expressed under the control 
of their respective promoters and terminators.  
3.2.1 Construction of SIR2 and SWI6 Single Copy Plasmids 
 Both SIR2 and SWI6 were initially amplified from genomic DNA from 
S. cerevisiae BY4741 utilising primers SIR2-FWD-PstI/SIR2-REV-XbaI and 
Swi6-Fwd-BamHI/Swi6-Rev-SacII (Materials and Methods) to generate 
PstI/XbaI and BamHI/SacII fragments respectively. These fragments 
encompassed sufficient upstream and downstream sequence to include 
both native promoters and terminators. The amplified PCR fragments were 
ligated into appropriately digested yeast single copy vector pRS315 to 
create pRS315-SIR2 and pRS315-SWI6 (Fig. 20).  
3.2.2 Complementation of Rad6-GFP sir2Ʃ and Rad6-GFP 
swi6Ʃ Strains does not restore Bimodal Rad6-GFP Expression 
 In order to complement Rad6-GFP sir2Ʃ and swi6Ʃ deletion strains 
pRS315-SIR2 or pRS315-SWI6 were transformed into the appropriate 
strain to reintroduce the relevant wild type gene. As discussed earlier, 
these deletion strains exhibit loss of one of the Rad6-GFP subpopulations 
previously identified in wild type cells. Assuming that such a phenotype is 
genuinely attributable to loss of either SIR2 or SWI6, reintroduction of 
these genes would be expected to restore bimodal Rad6-GFP expression. 
However, introduction of pRS315-SIR2 or pRS315-SWI6 did not accomplish 
this, as demonstrated by flow cytometry (Fig. 21A, B), although 
reintroduction of SWI6 did induce a slight decrease in Rad6-GFP levels. 
This lack of complementation argued against a role for Sir2 or Swi6 in the 
generation of bimodal Rad6-GFP expression. Moreover, in parallel analysis 
wild type cells were observed not to demonstrate two Rad6-GFP 
subpopulations, but rather either a high- or low-Rad6-GFP expressing 
phenotype was seen in different wild type cultures (Fig. 21C). High 
expressing cultures exhibited similar Rad6-GFP expression to that seen in 
the sir2Ʃ and swi6Ʃ deletion strains. In the low expressing cultures, many 
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Figure 20 ± Single copy plasmids pRS315, pRS315-SIR2 and pRS315-SWI6. 
Plasmids pRS315-SIR2 and pRS315-SWI6 were used for complementation of 
Rad6-GFP sir2Ʃ and Rad6-GFP swi6Ʃ respectively. 
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Figure 21 ± Flow cytometric analysis of Rad6-GFP expression (AU) in 
exponential (A) Rad6-GFP sir2Ʃ and (B) Rad6-GFP swi6Ʃ cells with and without 
pRS315-SIR2 or pRS315-SWI6 respectively and (C) wild type Rad6-GFP cells 
exhibiting (top) low- (autofluorescence from unlabelled cells is indicated in 
grey) and (bottom) high-Rad6-GFP expression (AU).   
97 
 
cells fell into the region of autofluorescence exhibited by unlabelled wild 
type cells, indicating that Rad6-GFP expression within these cells can be 
considered minimal. The Low-expressing Rad6-GFP phenotype was 
identified with greater frequency, being seen in ~71% of the 35 cultures 
tested. These observations suggested that Rad6-GFP expression did not 
occur as two subpopulations within a culture derived from a single colony, 
although expression levels can differ markedly between cultures derived 
from different colonies. It appeared that the previous data (see 
introduction to this chapter) had been derived from cultures inoculated 
with cells from mixed colonies. 
 
3.3 Rad6 Expression Levels are Maintained for Many 
Generations  
If the two Rad6-GFP expression levels observed in cultures derived 
from different colonies is indeed due to some form of epigenetic regulation, 
rather than genetic mutation, then it is logical to expect cells to switch 
between the 2 states. In order to identify any switching, three cultures of 
each expression state were maintained in exponential phase by daily 
subculture with analysis by flow cytometry at one, four, and ten days (Fig. 
22). No switching was observed in any culture up to four days and after ten 
days only one of three low expressing cultures began to show any signs of 
switching towards a higher expression state (Fig. 23A). Subsequent 
analysis revealed high-Rad6 expressing cells to demonstrate a slightly 
quicker growth rate of ~1.4 hours compared to the ~1.5 hours for 
equivalent low expressing cells (Fig. 23B). It was thus suggested that the 
one culture to demonstrate an apparent switching capacity after ten days 
may have arisen due to initial contamination with some cells of a high 
expressing colony. It may have taken up to ten days outgrowth for the 
faster growing contaminant to become detectable by flow cytometry.  
Retention of the expression state over such extended periods of 
time was not indicative of phenotypic heterogeneity that did not have a 
genotypic basis. Rather it would suggest the existence of inherited 
genotypic differences between cells demonstrating the 2 expression states. 
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Figure 22 ± Flow cytometric analysis of high- and low-expressing Rad6-GFP 
cells. Three cultures of each expression state were maintained in exponential 
phase during growth in YPD medium and analysed at one, four, and ten days.  
Figure 23 ± (A) One of three low-Rad6-GFP expressing cultures, maintained in 
exponential phase in YPD and analysed by flow cytometry, demonstrated an 
apparent switching capacity after ten days growth. (B) Growth rates of high- 
and low-Rad6-GFP expressing cells. Data indicate the mean of three 
independent experiments ± SEM.  
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3.4 Rad6 Does Not Exhibit Bi-stable Gene or Protein 
Expression 
 The observation that individual yeast cultures do not exhibit bi-
stable Rad6-GFP expression was in contrast to previous results obtained 
prior to this study. Rather in this instance cultures were shown to either 
demonstrate high or low expression, these expression states being 
inheritable over extended periods of time.   
It was decided to confirm that both types of population did indeed 
contain tagged Rad6 constructs, and that low-expressing cells were not 
untagged contaminants. The Rad6-GFP cassette in genomic DNA of 
different clones was detected by PCR using primers RAD6-FWD and ADH1-
term-REV (Materials and Methods). Both types of culture did indeed contain 
the Rad6-GFP construct, evident as a ~2.4kb band that was absent in 
unlabelled strains (Fig. 24). This indicated the low expressing population 
does not originate from an unlabelled contaminant. Furthermore, 
sequencing across the Rad6-GFP region, using primers RAD6-SEQ 1-5 
(Materials and Methods) confirmed the presence of an identical Rad6-GFP 
construct in both high and low cells.   
Given that strong inheritance of the Rad6 expression state seems to 
indicate the occurrence of a genetic difference between high- and low-
expressing cells, either around the RAD6 locus or elsewhere, it was decided 
to re-construct Rad6-GFP expressing yeast.     
3.4.1 Analysis of a RAD6-GFP Transcriptional Fusion 
Initially a RAD6-GFP transcriptional fusion was constructed by 
amplification of the GFP cassette from pSVA12 (Avery et al., 2000) using 
primers Rad6GFP-TF-Fwd and Rad6GFP-TF-Rev (Materials and Methods) 
which include 50bp regions of homology to either side of the RAD6 ORF. 
The resulting fragment was transformed into S. cerevisiae BY4741 and 
successful integration in selected transformants confirmed by diagnostic 
PCR using primers RAD6-FED and RAD6-REV (Materials and Methods). 
These primers recognise regions outside of the inserted cassette and 
produce a ~3.5kb band to indicate correct integration whereas 
unsuccessful transformants yielded a PCR product of ~1.8kb (Fig. 25).  
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Figure 25 ± Diagnostic PCR for successful generation of a RAD6-GFP 
transcriptional fusion using primers RAD6-FWD and RAD6-REV. A PCR product 
of ~3.5kb indicates the presence of the RAD6-GFP constructs whilst untagged 
strains produced a band at ~1.8kb.  
Figure 24 ± PCR for the Rad6-GFP construct using DNA isolated from both high 
and low expressing cells and primers RAD6-FWD and ADH1-term-REV. The 
presence of the construct is indicated by a PCR product at ~2.4kb  
101 
 
Analysis of the RAD6-GFP transcriptional fusion strain, in triplicate 
experiments, revealed expression of the gene to occur as a single 
population, similar to the constitutively expressed ACT1-GFP used as a 
control (Fig. 26). To rule out the possibility of colonies being present that 
give rise to alternative levels of RAD6 expression, numerous colonies were 
pooled and analysed together. A similar strategy does indeed reveal the 
two Rad6-GFP populations identified through flow cytometric analysis of 
the original translational fusion strain from invitrogen (Fig. 19). This, 
analysis, however, again revealed only one RAD6-GFP expression 
population as shown for single colony analysis (Fig. 26). 
3.4.2 Analysis of a Newly Constructed Rad6-GFP Translational 
Fusion     
 In Addition to the RAD6-GFP transcriptional fusion described above, 
a Rad6-GFP translational fusion was remade. Primers RAD6-TLF-FWD and 
RAD6-TLF-REV (Materials and Methods) were utilised to amplify the Rad6-
GFP cassette from the Invitrogen translational fusion strain. This cassette 
was then transformed into the BY4741 background with appropriate 
integration being confirmed by diagnostic PCR using primers RAD6-FWD 
and RAD6-REV (Materials and Methods). These primers recognise regions 
outside of the inserted cassette, with successful transformants producing a 
band of ~4kb whereas unsuccessful integration results in a ~1.8kb band. 
Triplicate successful transformants were analysed by flow cytometry using 
cells obtained from single colonies. These exhibited an expression level 
roughly intermediate between the two expression levels previously 
identified in the Invitrogen translational fusion strain (Fig. 27). In a similar 
strategy as employed for the transcriptional fusion strain (above), many 
colonies were pooled and analysed together. This approach did not reveal 
two different levels of Rad6 expression but rather exhibited an 
intermediate expression level as seen for single colony analysis (Fig. 27). 
Thus both the transcriptional and translational fusion strains created during 
this study are in agreement that only one population of cells could be 
distinguished according to RAD6 expression level. 
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Figure 26 ± Exponential cells of a newly generated RAD6-GFP transcriptional 
fusion strain grown in YPD and analysed by flow cytometry. A constitutively 
expressed ACT1-GFP strain grown under the same conditions was analysed for 
comparison.  Histograms are representative of three independent experiments. 
Figure 27 ± Flow cytometric analysis of a remade Rad6-GFP translational 
fusion strain. Cells were grown to exponential phase in YNB prior to analysis. 
(A) Rad6-GFP expression (AU) (black) along with Autofluorescence from an 
untagged strain (grey). (B) Comparison of Rad6-GFP expression (AU) from the 
remade translational fusion (black) and the high- (blue) and low- (green) 
expression levels obtained by analysis of the Invitrogen translational fusion. 
Histograms are representative of three independent flow cytometry 
experiments utilising the remade Rad6-GFP translational fusion.    
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3.5 Discussion 
 This chapter aimed to elucidate further a previous observation in 
the Avery laboratory that the Rad6 protein of S. cerevisiae appeared to 
exhibit bi-stable expression. Initial results suggested a role for differential 
transcriptional silencing and regulation between cells, according to the 
phenotypes obtained via either SIR2 or SWI6 deletion. During the course of 
this study, however, complementation of sir2Ʃ or swi6Ʃ did not re-
establish bi-modal Rad6 expression. These observations suggested the 
apparent roles of Sir2 and Swi6 in controlling bi-stable Rad6 expression to 
be artifactual. Indeed it is worth noting that the RAD6 gene does not reside 
in a subtelomeric location but rather ~400kb from the left end of 
chromosome VII, supporting the lack of a direct role for Sir2 in controlling 
Rad6 expression. Additionally, although Swi6 of fission yeast is known to 
function in transcriptional silencing at centromeres, telomeres and the 
silent mating type, Swi6 function in S. cerevisiae is rather different. Swi6 of 
S. cerevisiae acts as a transcriptional cofactor forming complexes with 
either Swi4 or Mbp1 to activate and subsequently repress gene expression 
during cell cycle progression (Lowndes et al., 1992, Sedgwick et al., 1998, 
Huang, 2002). These points, along with the lack of complementation, add 
further weight to the likelihood that preliminary conclusions based on the 
deletion strain phenotypes were not reliable. In addition I was unable to 
distinguish two subpopulations according to Rad6 expression in cells 
derived from any single colony in the present study. Rather cultures either 
exhibited high or low Rad6 expression. Prior identification of two Rad6 
expressing subpopulations may have arisen due to inoculation of cultures 
with more than one colony, thus encompassing cells expressing both high- 
and low- levels of Rad6-GFP. Inoculation of cultures with many colonies 
was indeed observed to, in the present study, suggest the occurrence of 
two Rad6 expressing subpopulations within one culture. It seems logical to 
suggest that the results obtained prior to this study indicating a role for 
both Sir2 and Swi6 in regulating Rad6 expression may have resulted from 
construction of the deletion strains in high-Rad6 expressing variant 
colonies.  
Further analysis of Rad6 expression through the creation of new 
RAD6-GFP transcriptional- and Rad6-GFP translational-fusion strains did 
not support the observation of two Rad6-GFP expression states with the 
original Invitrogen strain. The one Rad6 expressing subpopulation identified 
in the newly generated Rad6-GFP translational fusion strain occupied an 
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intermediate position between the high and low expression levels identified 
previously. Considering that both of the original high- and low-Rad6 
expressing populations were confirmed to contain identical Rad6-GFP 
constructs, it seems likely that the two distinct Rad6 expression levels 
initially observed reflected some genetic heterogeneity elsewhere in the 
genome, possibly due to a mutation, in the Invitrogen strain. This was 
substantiated by the fact that different Rad6 expression states were 
inherited indefinitely consistent with a genotypic basis (Avery, 2006). 
 The further investigation performed here indicated that initial results 
suggesting that Rad6 is expressed bi-stably in S. cerevisiae were 
misleading. As the main aim of this thesis was the analysis and further 
characterisation of heterogeneity in yeasts, it was decided not to take the 
Rad6 part of the studies any further.   
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glabrata exhibits Strain 
Background-Dependent 
Heterogeneous Epa1 
Expression 
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4.1 Introduction 
Adhesion is an important step in the infection process of any human 
pathogen. The genome of the pathogenic yeast C. glabrata contains 
sequences that encode a family of GPI-anchored CWPs that function as 
adhesins. This group of GPI-CWPs is known as the EPA family of adhesins, 
the majority of which reside in subtelomeric clusters (De Las Penas et al., 
2003, Castano et al., 2005, de Groot et al., 2008). The C. glabrata genome 
encodes approximately 67 adhesin-like GPI proteins, with 17 and 23 of 
these being allocated to the EPA family in two commonly used laboratory 
strains, ATCC2001 and BG2 respectively (de Groot et al., 2008, Kaur et al., 
2005). Despite this large adhesin repertoire EPA1 remains, to date, the 
best characterized member of the EPA family. EPA1, which itself encodes a 
Ca2+-dependent lectin (Cormack et al., 1999), forms part of a subtelomeric 
cluster containing three EPA genes (EPA1-3) adjacent to the right telomere 
of chromosome E (De Las Penas et al., 2003). As with other GPI-cell wall 
adhesins  the Epa1 protein precursor has been shown to possess an N-
terminal signal sequence, C-terminal Ser/Thr rich domain and a C-terminal 
GPI addition signal. The N-terminal region also contains the ligand binding 
domain responsible for recognition of host-encoded N-acetyl lactosamine-
containing glucoconjugates (Cormack et al., 1999, Frieman et al., 2002). 
In vitro adherence appears to be largely dependent upon Epa1, with 
deletion of the gene reducing adherence to human epithelial cells by 95% 
(Cormack et al., 1999). In addition, a chimeric construct of EPA1 
containing the GPI anchor signal of ScCWP2, was able to confer adherence 
of normally non-adherent S. cerevisiae to cultured human epithelial cells 
(Frieman et al., 2002). Interestingly, and likely due to the expression of 
additional adhesins, deletion of EPA1 does not result in a significant 
virulence phenotype in murine models of mucosal infection (Cormack et al., 
1999). By contrast deletion of the entire EPA1 gene cluster (HYR1/EPA1-3) 
does cause a significant reduction in kidney colonization lending support for 
the importance of additional adhesins in vivo (De Las Penas et al., 2003). 
Further to this two additional (3$¶V(3$and EPA7, have been implicated 
as important for kidney colonization (Castano et al., 2005).    
It has previously been demonstrated in the Avery laboratory, that 
EPA1 exhibits marked variation in its expression levels within a genetically 
identical population of cells (Fig. 28) (M.C. Smith and S.V. Avery, 
Unpublished). That result prompted further investigation as to whether 
variation in EPA1 expression was able to manifest as variation in adhesion 
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(ii) 
Figure 28 - FACS analysis of C. glabrata EPA1-GFP transcriptional fusion 
strain (BG198) shown in red. For comparison a S. cerevisiae ACT1-GFP 
construct is shown in black. Autofluorescence from cells containing no 
GFP construct is shown in grey.  The vertical axis demonstrates cell 
numbers while the horizontal axis represents GFP fluorescence levels. 
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capacity to cultured epithelial cells. C. glabrata strain BG2-Epa1-HA, 
expressing functional, human influenza hemagglutinin (HA) epitope-
tagged, Epa1 enabled cells to be sorted based on their cell surface Epa1-
HA expression levels. Subsequent adhesion assays to human Hep2 
epithelial cells illustrated that cells expressing high levels of Epa1 exhibited 
more than threefold greater adherence than observed for the low Epa1 
sub-population (Fig. 29A) (M.C. Smith and S.V. Avery, Unpublished). This 
data indicated a functional consequence of heterogeneity that may be 
related to the virulence of this yeast pathogen. Additional previous analysis 
of BG2-Epa1-HA revealed the Epa1 expression level of single cells to be 
transient and therefore consistent with a non-genotypic rather than a 
genotypic basis for variation (Fig. 29B). Cells were again sorted to obtain 
sub-populations of high and low Epa1-HA expressing cells. Sorted cells 
were sub-cultured into fresh medium and analysed at intervals. In both 
instances sorted populations reverted back to demonstrate a mixed 
population of Epa1-HA expression within 20hrs. Such reversion indicates 
that after a few cell generations no further inheritance of the Epa1-HA 
expression state is discernible (M.C. Smith and S.V. Avery, Unpublished).         
The following chapter aims to confirm the existence of 
heterogeneity in both EPA1 transcriptional expression and Epa1-HA cell 
surface expression. In addition I aimed to generate another Epa1-HA 
FRQVWUXFW LQ DQ DOWHUQDWLYH VWUDLQ EDFNJURXQG &* +78Ʃ 7KLV VWUDLQ
would provide a greater variety of possible selection markers for 
subsequent genetic manipulations in addition to enabling comparison of 
Epa1-HA expression in two commonly used C. glabrata strain backgrounds. 
In addition I wanted to further analyse inheritance of the Epa1 expression 
state in single cells through the exploitation of fluorescence microscopy. 
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Figure 29 ± (A) Adhesion of high and low Epa1-HA subpopulations to human 
Hep2 epithelial cells. (B) Reversion of high and low Epa1-HA cells to a mixed 
population over time. (M.C. Smith and S.V. Avery, Unpublished). 
110 
 
4.2 Cell-to-Cell Heterogeneity in Epa1 Expression is 
observed at the C. glabrata Cell Surface and appears 
to depend upon Strain Background 
4.2.1 Confirmation of EPA1 Expression Heterogeneity 
           As described in the introduction to this section, heterogeneity of 
EPA1 has previously been demonstrated in the BG2 strain background 
through use of an EPA1-GFP transcriptional fusion. Comparison with the S. 
cerevisiae ACT1 gene, also through use of a GFP transcriptional fusion to 
the ACT1 promoter, indicated a significant difference between the spread of 
expression levels for the two genes (Fig. 28). Although this comparison 
was performed between genes of different species, the S. cerevisiae and C. 
glabrata genomes are highly related. In fact, of the almost 6000 S. 
cerevisiae 25)¶VURXJKO\RQO\KDYHQRREYLRXVRUWKRORJLQC. glabrata, 
(Domergue et al., 2005). In addition there is an average of 65% amino 
acid identity between orthologous proteins of these two species, (Kaur et 
al., 2005). It was thought appropriate here to further substantiate the 
observed heterogeneity by additional means. This was done by calculation 
of the Coefficient of Variation (CV) according to the criteria used by 
Newman et al (2006). Briefly, a circular gate, containing 500 cells, was 
placed around the forward scatter (FSC) and side scatter (SSC) medians 
(Fig. 30). Consequently this method enables the analysis of CV from a 
gated population of cells containing more uniform properties of cell size 
and granularity. This method generated an EPA1-GFP CV value of 106.3, 
higher than the value obtained for 2,212 other S. cerevisiae yeast genes, 
ZKHUH&9¶VUDQJHGIURP-77.3. A much lower CV of 13.1 was obtained 
by this method for ACT1-GFP from the present data. The CV obtained for 
EPA1-GFP expression by this accepted method is therefore indicative of a 
high level of expression heterogeneity for EPA1. 
           An additional method used during CV analysis was division of the 
fluorescence signal by FSC, which can be used as a measure of cell size, for 
individual cells. This takes into account the differences in cell size that are 
encountered during the analysis process and provides a similar CV level 
(107) as that obtained by the Newman method (106.3) for EPA1-GFP. This 
method has been favoured throughout this study as it encompasses data 
from a greater proportion of the population rather than such a small 
subset. 
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Figure 30 ± (A) Gating of 500 cells around the forward scatter (FSC) and side 
scatter (SSC) medians. The light blue colour within gate R4 illustrates the 
remaining cell population following removal of the top and bottom 5% FSC and 
SSC values. The FSC and SSC medians for this population were calculated, 
demonstrated by the point at which the two lines cross, around which a circular 
gate, R5, encompassing 500 cells was placed. (B) GFP fluorescence from cells 
within the R5 circular gate in (A) is represented by the dark blue region in (B). 
&9¶V RI*)3 H[SUHVVLRQZHUH WKHQ FDOFXODWHG XVLQJ RQO\ FHOOV IURPZLWKLQ WKLV
region. (C) EPA1-GFP CV values, calculated according to the gating described in 
(A) and (B), error bars are representative of triplicate experiments.    
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4.2.2 Heterogeneity of Epa1 Protein Expression at the Cell 
Surface 
Analysis of a previously constructed C. glabrata strain, BG2-Epa1-
HA, enabled visualisation of Epa1 protein expression at the cell surface 
through use of the HA epitope tag. BG2-Epa1-HA contains a functional 
triple-HA tagged EPA1 construct (Frieman et al., 2002), under the control 
of its native promoter, at the EPA1 locus in the BG2 C. glabrata strain 
background (Fig. 31A). The HA epitope tag (YPYDVPDYA) is recognised by 
commercially-available antibodies raised against this sequence. 
Consequently Epa1-HA protein expression at the cell surface can be 
measured by staining cells with the anti-HA, Alexa Fluor® 488 conjugate 
antibody. Analysis by flow cytometry of C. glabrata cells stained with this 
antibody revealed that a high level of heterogeneity, as also seen using the 
EPA1-GFP transcriptional fusion in the same strain background, is also 
evident at the protein level. This produced a CV of ~94. This is also the 
same strain background as that used previously to demonstrate that the 
extent of Epa1 has a functional consequence for adherence, and such 
variation appears non-genotypic (Fig. 29).   
4.2.3 Construction of CG2001-Epa1-HA 
The previous experiments, discussed above, utilised C. glabrata 
strain BG2. Although used regularly, the complete sequence for this strain 
is unavailable. In addition there are limited options for the type and 
number of available selection markers. 
In order to create a strain containing triple-HA tagged EPA1 along 
with more selectable marker options it was decided to use C. glabrata 
VWUDLQ&*+78Ʃ(Kitada et al., 1995). This strain is a derivative of the 
C. glabrata type strain (ATCC2001) for which complete subtelomere-to-
subtelomere genome sequence is available (Sherman et al., 2006). In 
addition this strain provides more flexibility in the choice of selection 
markers for future genetic manipulations. Triple-HA tagged EPA1, under 
control of its own promoter and contained within pMS15, a plasmid 
constructed prior to the initiation of this study, was utilised. Digestion of 
the plasmid with XbaI-PacI released a ~6.8kb EPA1-HA fragment, which 
included URA3 as a selection marker, targeted to the EPA1 locus by 1kb 
regions of flanking homology (Fig. 31A). This provided a strain expressing 
a functional EPA-HA with more selectable marker options and consequently 
more scope for genetic manipulation. Transformed cells were selected for  
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Figure 31 ± (A) The 6.8kb fragment containing a triple HA-tagged EPA1 
construct transformed in to CG2001 +78Ʃ generating CG2001-Epa1-HA. This 
fragment is also expressed in BG2-Epa1-HA. (B and C) Diagnostic PCR products 
generated IURPJHQRPLF'1$RI &*+78Ʃ DQG&*-Epa1-HA strains. 
(A and B) Primers WIEPA1-FWD and EPA1-REV-OSHOM produce a band of 
~4.5kb demonstrating successful integration of the EPA1-HA fragment. By 
contrast &*+78Ʃcontaining untagged EPA1 produces a band of ~3.4kb. 
(A and C) To confirm that homologous recombination of the transforming 
fragment had occurred in such a way as to include the HA tag diagnostic PCR 
was performed using the primers HAtag-FWD and EPA1-REV-OSHOM. 
Successful transformants, generating CG2001-Epa1-HA, produce a band at 
NEZKLOH&*+78ƩFHOOVGHPRQVWUDWHQRDPSOLILFDWLRQ 
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on URA- YNB medium, and confirmed to contain EPA1-HA at the correct 
locus by diagnostic PCR utilising genomic DNA and primers WIEPA1-
FWD/HAtag-FWD and EPA1-REV-OSHOM which recognise regions within 
and outside of the transforming fragment respectively (Fig. 31). In 
addition, through use of anti-HA, Alexa Fluor® 488 conjugate, flow 
cytometry and microscopy were employed to confirm expression of the HA 
tagged Epa1 protein at the cell surface (Fig. 32). Expression of Epa1-HA is 
cleaUO\LOOXVWUDWHGZKHQFRPSDUHGWRDQXQWDJJHG&*+78Ʃ control. In 
addition fluorescence can be identified at the surface of cells analysed by 
fluorescence microscopy. 
4.2.4 Heterogeneity of Epa1 Expression at the Cell Surface 
appears to be Strain Dependent 
Construction of BG2-Epa1-HA and CG2001-Epa1-HA, both of which 
contain triple-HA tagged EPA1 (Fig. 31 LQ %* DQG &* +78Ʃ
backgrounds respectively, enabled comparison of Epa1 expression and 
heterogeneity at the cell surface in two separate strain backgrounds. As 
described earlier, analysis was performed using an anti-HA, Alexa Fluor® 
488 conjugate antibody followed by flow cytometry. Interestingly this 
revealed that the level of heterogeneity in Epa1 expression was markedly 
different between the two strains, with BG2-Epa1-HA exhibiting a CV value 
of ~94 compared with a value of just ~53 for CG2001-Epa1-HA (Fig. 33). 
The increased level of heterogeneity was accompanied by a 15.8% 
decrease in overall population-averaged Epa1 expression level (Fig. 33). 
Such a decrease can be attributed to an increase in the number of cells 
expressing lower levels of Epa1. A large proportion of these low expressing 
Epa1 cells are seen to overlap with the Autofluorescence recorded for 
unstained cells (Fig. 33). This may suggest that such cells are exhibiting 
very low and possibly no expression of Epa1 at their surface. 
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Figure 32 ± Following staining with anti-HA, Alexa Fluor® 488 conjugate 
(Materials and Methods) both analysis by (A) flow cytometry together with (B) 
fluorescence microscopy confirmed expression of Epa1-HA at the cell surface. 
(i) Black line, stained CG2001-Epa1-+$ FHOOV JUH\ OLQH &* +78Ʃ FHOOV
expressing untagged Epa1. Cell number is depicted along the vertical axis while 
the horizontal axis represents Epa1-HA fluorescence 
(ii) 
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Figure 33 ± (A) Histogram depicting Epa1-HA expression differences between 
the two strains analysed by flow cytometry. BG2-Epa1-HA (blue), CG2001-HA 
(green) and unstained control (grey). Number of cells is represented by the 
vertical axis while Epa1-HA expression is shown along the horizontal axis.  (B) 
Population averaged Epa1-HA expression as calculated by flow cytometric 
analysis. BG2-Epa1-HA is represented in blue while green represents CG2001-
Epa1-HA. (C) Epa1-HA CV values, representing cell-to-cell heterogeneity, 
calculated by flow cytometric analysis. BG2-Epa1-HA and CG2001-Epa1-HA are 
again depicted by blue and green respectively.  
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4.3 Heterogeneity and Expression of Epa1-HA Varies 
During Growth in Batch Culture 
In order to determine if Epa1 heterogeneity levels fluctuate during 
batch culture, time course experiments were performed (Fig. 34). BG2-
Epa1-HA and CG2001-Epa1-HA cells were inoculated in to fresh medium 
from stationary phase starter cultures and sampled regularly for a period of 
12 hours. Sampled cells were stained with anti-HA, Alexa Fluor® 488 and 
Epa1-HA expression levels analysed by flow cytometry. Previous work in 
the BG2 strain background utilised a polyclonal antibody raised against the 
N-terminal domain of Epa1, (Kaur et al., 2007). During this study highest 
expression levels were identified at 2 hours post inoculation with 
background levels being reached by 10 hours.    
In agreement with the above mentioned study, Epa1-HA levels at 
the cell surface were found to peak in the hours immediately following 
inoculation. The highest level of expression in both strains tested was 
observed at 1hr post inoculation; this high expression also correlated with 
the lowest level of heterogeneity in both strains. Most variation in 
expression levels occurred between 1-5 hours following inoculation into 
fresh medium, with lowest levels being reached between 7-10 hours as 
cells progress into stationary phase. At this point expression levels appear 
to remain relatively constant. Epa1 CV values remained higher in BG2-
Epa1-HA at every time-point when compared to values at the equivalent 
time-point for CG2001-Epa1-HA. Interestingly, the highly heterogeneous 
BG2-Epa1-HA strain also demonstrated marked fluctuation in Epa1-HA CV 
levels during the course of the experiment. CV values ranged from 51 to 
almost 126 in BG2-Epa1-HA meaning that the highest heterogeneity level 
was more than double the lowest heterogeneity value. By contrast, Epa1-
HA heterogeneity levels were relatively constant in CG2001-Epa1-HA, 
suggesting that Epa1 expression may be under tighter control in CG2001-
Epa1-HA than in BG2-Epa1-HA during growth in batch culture.    
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Figure 34 ± Time course flow cytometry analysis of Epa1-HA expression (blue) 
and CV (green) in (A) BG2-Epa1-HA and (B) CG2001-Epa1-HA over a period 
of 12 hours during growth in batch culture. In both instances the left vertical 
axis corresponds to Epa1-HA expression and the right vertical axis corresponds 
to Epa1-HA CV. Time in hours is depicted along the horizontal x-axis.   
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4.4 Inheritance of Epa1 
A previously performed reversion assay using BG2-Epa1-HA cells 
sorted according to Epa1-HA expression has been discussed earlier (Fig. 
29B). This assay revealed that cells expressing high- or low- levels of 
Epa1-HA reverted back to mixed levels of expression over a period of 
20hrs. This timescale was rather long compared to timescales that are 
relevant when considering many forms of heterogeneity (e.g. those that 
are cell cycle or rhythm driven) (Smith et al., 2007, Sumner et al., 2003). 
Initial time-points suggested a partial inheritance of the Epa1 expression 
state over a limited time period. This was further tested by analysis of 
Epa1-HA expression of parent cells and their offspring by fluorescence 
microscopy, as described below.   
4.4.1 Epa1-HA Expression in Daughter Cells represents De 
Novo Synthesis of Epa1 
Differential partitioning of molecules during cell division may 
contribute towards measured fluctuations in protein abundance between 
cells, (Huh and Paulsson, 2011). Time-lapse fluorescent microscopy was 
used to determine by what extent, if any, Epa1 levels are dictated by 
partitioning of already synthesised Epa1 protein from the mother cell to the 
daughter bud during cell division. Anti-HA, Alexa Fluor® 488 antibody 
stained Epa1-HA cells were followed through the process of cell division by 
imaging at 10 min intervals for a period of 3 hours. This enabled the fate of 
pre-synthesised parental Epa1-HA to be tracked. Captured images revealed 
no partitioning of pre-stained cell wall Epa1 from a mother to a daughter 
cell (Fig. 35). The observations suggest that pre-synthesised Epa1 protein 
itself remains associated with the mother cell during division and any 
subsequent expression in the daughter cell occurs de novo. This was found 
to be true for both the BG2-Epa1-HA and CG2001-Epa1HA strain 
backgrounds.    
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Figure 35 ± Time-lapse fluorescence microscopy of anti-HA, Alexa Fluor® 488 
conjugate stained cells. Brightfield (left) and fluorescent (right) images were 
captured every 10 minutes in order to follow the process of cell division and any 
partitioning of parental cell wall Epa1-HA protein. 
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4.4.2 Newly Budded Cells Exhibit a Variety of Expression 
States 
The above time-lapse microscopy data provides information on the 
fate of parental Epa1-HA, however it does not provide information on the 
subsequent bud cell Epa1-HA expression. The observation that Epa1-HA 
synthesis likely occurs de novo in newly budded cells substantiates that 
antibody probing provides a snapshot of Epa1-HA synthesised in a 
particular cell. This, along with bud cell size as an indicator of the daughter 
cell development, can provide information about Epa1-HA expression 
during cell cycle progression of new cells.  
Fluorescence microscopy, in the form of static snapshots, was used 
to compare the mean Epa1-HA expression of individual budded cells with 
the corresponding bud cell area for 100 cells (Fig. 36). Analysis of these 
data revealed low correlation between bud cell size and subsequent Epa1-
HA expression level. I was able to show that large and small buds alike 
demonstrated a variety of Epa1-HA expression levels. Correlation 
coefficients of bud cell size against Epa1-HA expression were -0.334 and -
0.068 for CG2001-Epa1-HA and BG2-Epa1-HA strains respectively, thereby 
indicating virtually no relationship between the two parameters particularly 
in the latter strain. CG2001-Epa1-HA cells demonstrate a slightly greater 
correlation, however, -0.334 is still rather low given that a value of, 0, 
indicates no correlation while +1/-1 indicate strong positive and negative 
correlations respectively. Furthermore, a large proportion of small (below 
ǋ0 &*-Epa1-HA buds can be seen to demonstrate low levels of 
fluorescence, relative to high expressing buds of an equivalent size, despite 
this possible correlation. It is also possible that a limited number of small 
buds with very high expression have skewed results towards suggesting a 
correlation, this may be rectified by increasing sample size. Such results 
suggest that Epa1 expression at the cell surface occurs independently of 
the daughter cell progression through the cycle. Rather, expression occurs 
at various points or rates, and sometimes not at all, in newly formed C. 
glabrata cells. Such immediate heterogeneity between daughter cells will 
thereby contribute to heterogeneity in the wider population. It may be 
interesting to note that BG2-Epa1-HA buds demonstrate both a lower mean 
Epa1-HA expression (~11.3) and a higher CV (~59.0) than that seen for 
CG2001-Epa1-HA cells which give values of ~21.56 and ~44.84, 
respectively. Such differences between the strains are in general  
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Figure 36 ± The relationship EHWZHHQEXGFHOODUHDǋ02) and mean Epa1-HA 
expression (AU) for individual (A) CG2001-Epa1-HA and (B) BG2-Epa1-HA 
cells. Scatter graphs demonstrate results for 100 bud cells analysed from static 
fluorescence image snapshots following staining with anti-HA, Alexa Fluor® 488 
conjugate. In both instances mean Epa1-HA expression is illustrated by the 
vertical axis while bud cell area is shown along the horizontal axis. Correlation 
coefficients are indicated for each strain. 
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agreement with the trends demonstrated by previous flow cytometry 
described in this thesis (4.2.4) and (Fig. 33). 
4.4.3 Cell Surface Epa1-HA Expression State may be partially 
Inherited 
The method of bud cell analysis described above also enabled Epa1-
HA expression to be measured specifically in mother cells. Ultimately this 
allowed a direct comparison between expression in the mother and the 
corresponding bud, this was performed for 100 cells. For both strain 
backgrounds, high and low expressing mothers gave rise to both low 
expressing and high expressing daughters irrespective of the mothers 
Epa1-HA expression level (Fig. 37A). This indicated that the level of Epa1-
HA expression developed in daughters is not dictated by cell surface Epa1-
HA expression in the mother. A correlation coefficient value of 0.12 
confirmed the lack of a marked relationship between mother and daughter 
cell fluorescence in CG2001-Epa1-HA cells (Fig. 37B). Interestingly, 
however, there was some correlation between mother and daughter cell 
fluorescence in BG2-Epa1-HA cells, as a correlation coefficient of 0.54 was 
obtained. The observed ability of BG2-Epa1-HA mother cells to produce 
daughters of a different Epa1 level does however indicate that daughter 
cell expression levels are not absolutely governed by the mother. Such 
results suggest that in this particular strain background there may be at 
least some partial heritability of the Epa1-HA expression state (Fig. 37C).  
This method also enabled a comparison of the expression levels of 
individual mother cells in the two strains. In agreement with previous flow 
cytometry and microscopy data, BG2-Epa1-HA mother cells demonstrated 
a higher Epa1-HA CV value (~69) than that seen for equivalent cells of 
CG2001-Epa1-HA (~44).  
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Figure 37 ± (Non) heritability of Epa1-HA expression state. (A) Fluorescence 
microscopy images showing examples where a low Epa1-HA expressing 
mother produces a bright bud (i), or a high Epa1-HA expressing mother gives 
rise to low (ii) or high (iii) expressing buds. Scatter plots illustrate the 
relationship between mother and bud mean Epa1-HA expression as analysed 
by anti-HA, Alexa Fluor® 488 staining and fluorescence microscopy of 100 
cells for (B) CG2001-Epa1-HA and (C) BG2-Epa1-HA. Mother cell Epa1-HA 
expression is represented by the horizontal x-axis while bud cell Epa1-HA 
expression is demonstrated along the vertical Y-axis. Correlation coefficients 
are indicated for both strains.   
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4.5 Discussion 
I investigated Epa1 expression at both the transcription and protein 
levels in order to elucidate the degree of heterogeneity present during 
expression of this cell wall adhesin. Initial results using an EPA1-GFP 
transcriptional fusion strain enabled confirmation that heterogeneity in 
expression of this gene does indeed exist. Calculation of the coefficient of 
variation (CV) according to the method described by Newman et al. (2006) 
yielded a value for EPA1-GFP expression than was higher than the CVs 
obtained for 2,212 other yeast genes (Newman et al., 2006). Such a result 
indicated that EPA1 expression in this pathogenic yeast is indeed highly 
heterogeneous. The fact that the calculated CV value for EPA1 however 
was markedly higher than any of the other yeast genes tested could reflect 
some difference in heterogeneity regulation between S. cerevisiae and C. 
glabrata. However, it should be noted that the Newman study was not 
comprehensive, and excluded members of the S. cerevisiae FLO gene 
family. Like the C. glabrata EPA family, the FLO genes encode a group of 
GPI-CWPs that confer adhesion to agar, plastic and to other yeast (Guo et 
al., 2000). Inclusion of these genes in the Newman study would have 
provided a useful comparison. The FLO10 and FLO11 genes, in particular, 
are known to demonstrate variegated expression due to metastable 
silencing (Halme et al., 2004, Octavio et al., 2009). It is unlikely that the 
high level of heterogeneity observed with the EPA1-GFP construct is 
artifactual since subsequent tagging of Epa1 by a separate method, using 
the HA epitope, in the same strain background also indicated a high CV 
value.   
Subsequent use of two Epa1-HA tagged strains allowed a 
demonstration that the extent of Epa1 expression heterogeneity appears to 
be dependent upon strain background. The results provided evidence that 
strain BG2-Epa1-HA, has a markedly higher level of Epa1-HA expression 
heterogeneity than CG2001-Epa1-HA. The increased heterogeneity is 
accompanied by an overall decrease in expression level due to an increase 
in the proportion of low Epa1-HA expressing cells. Differences pertaining to 
adhesion capacity of C. glabrata according to strain background have been 
previously identified (de Groot et al., 2008). ATCC2001 was shown to be 
strongly adherent when compared to cells of the ATCC90876 strain 
background. This difference was accompanied by increased surface 
hydrophobicity in ATCC2001, a state that is seen to coincide with 
incorporation of additional cell surface adhesins not present in ATCC90876 
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(de Groot et al., 2008). Indeed increased incorporation of hydrophobic cell 
wall adhesins is likely related to increases in cell surface hydrophobicity 
(Ishigami et al., 2006, de Groot et al., 2008, Hoyer and Hecht, 2001). The 
observation of high Epa1-HA expression in an ATCC2001 derivative strain 
background is consistent with the hydrophobicity and adherence properties 
of this strain. In vitro adhesion to epithelial cells is known to be mediated 
by Epa1 (Cormack et al., 1999). Therefore, based on the present data, it 
may be logical to assume that the CG2001-Epa1-HA strain would also 
demonstrate both increased population-averaged adherence and population 
averaged hydrophobicity when compared to BG2-Epa1-HA.   
In agreement with previously reported data (Kaur et al., 2007) Epa1 
was expressed at its highest levels during early stages of growth in both 
tested strains. This expression decreased as cells progressed through to 
stationary phase, again in agreement with previous data that suggested 
EPA1 expression to be low in stationary phase cells (Castano et al., 2005, 
De Las Penas et al., 2003). Such experiments also enabled any changes in 
Epa1 heterogeneity that may be occurring during growth in a batch culture 
to be tracked. It was interesting to note that strain CG2001-Epa1-HA, 
which demonstrates lower levels of Epa1 heterogeneity than BG2-Epa1-HA, 
also exhibited less fluctuation in these heterogeneity levels during growth. 
Results suggested that Epa1 expression may be under tighter control in the 
CG2001-Epa1-HA strain. 
As cell surface Epa1 protein generated in single cells was retained 
by those cells during division and not partitioned into an emerging bud, it 
could be inferred that any Epa1 protein detected at the cell surface had 
been synthesised de novo in that particular cell. Although Epa1 already 
present in the cell wall is not partitioned into new daughter cells this is not 
to say that Epa1 protein at other stages of the maturation process, or 
indeed EPA1 mRNA, does not undergo differential partitioning (Huh and 
Paulsson, 2011). Maturation of GPI-anchored CWPs requires a series of 
post-translational modifications. Initially these proteins are targeted to the 
endoplasmic reticulum (ER) where addition of the GPI anchor occurs. Newly 
synthesised GPI-anchored proteins are segregated from other secretory 
proteins and transported to the Golgi in COPII-coated vesicles. The 
proteins must move through the Golgi before further transportation to their 
final destination of the cell wall (Castillon et al., 2009, Doering and 
Schekman, 1996, Muniz et al., 2001, Rivier et al., 2010, Verstrepen et al., 
2004). Such vesicles and the ordered partitioning of the relevant organelles 
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themselves provide additional means by which protein may be segregated 
from mother to daughter cells (Shima et al., 1997, Huh and Paulsson, 
2011). In addition stochastic partitioning has been shown to contribute to 
non-genetic heterogeneity (Huh and Paulsson, 2011).  
The transcript levels of many S. cerevisiae CWP-encoding genes are 
cell cycle dependent leading to some S. cerevisiae CWPs being 
preferentially incorporated either in small buds or large buds or found in 
mother cells only. Temporal regulation of CWP incorporation has also been 
described in C. albicans, with the GPI-CWP Csa1 only being observed in 
growing yeast buds while it is absent from mother cells (Smits et al., 2006, 
Klis et al., 2009). By contrast, the data presented here, using bud cell size 
as an indicator of cell cycle progress, revealed very little correlation 
between bud cell size and Epa1 expression in either tested strain 
background. Rather Epa1 was found to be incorporated into the cell walls 
of mother cells and large and small bud cells alike. The results indicated 
that Epa1 protein expression is regulated independently of the cell cycle. In 
addition the variation in Epa1 protein arising at the cell surface of new 
buds resulted in immediate heterogeneous Epa1 expression in the newly 
formed population of cells.  
Incorporation of the S. cerevisiae CWPs Tip1 and Cwp2 into mother 
cells and small/medium bud cells respectively can be determined by the 
timing of transcription during the cell cycle (Smits et al., 2006). 
Heterogeneous incorporation of Epa1 protein into bud cells of equivalent 
size may thus indicate variation in EPA1 transcription between such cells. 
Indeed such variation in gene expression between single cells is evident for 
both S. cerevisiae FLO10 and FLO11 due to metastable silencing (Halme et 
al., 2004). Lack of consistent inheritance of the expression state, in either 
strain background, corroborates a non-genetic mechanism underlying 
heterogeneous Epa1 expression. Additionally the ability of cells sharing 
such close proximity to exhibit differential expression indicates that 
observed Epa1 variation does not result from differing environmental 
inputs. Nevertheless, a slight relationship between mother and daughter 
cell fluorescence in BG2-Epa1-HA Epa1 protein expression level was 
observed. The partial heritability in the BG2-Epa1-HA strain would be 
consistent with an epigenetic basis for heterogeneity in this strain (Avery, 
2006),QFRQFXUUHQFHZLWKIORZF\WRPHWULFGDWDFDOFXODWHG&9¶VSURYHGWR
be higher in both BG2-Epa1-HA mothers and buds than the corresponding 
CG2001-Epa1-HA cells. The differential expression observed in cells sharing 
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such close proximity during microscopy analysis also indicates variation is 
not the result of differing environmental inputs.  
The possible mechanisms for such varied Epa1 expression, both 
within a clonal population and between various genetic backgrounds, will 
be further investigated in the following chapter.   
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Chapter 5 - Regulation of 
Epa1 Expression in Candida 
glabrata 
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5.1 Introduction 
Similar to the ALS and FLO adhesin families in C. albicans and S. 
cerevisiae respectively, the EPA family consists of genes and proteins which 
share significant sequence identity. Such similarity may create functional 
redundancy, a possible explanation for the lack of a discernible epa1Ʃ 
phenotype in vivo where additional adhesins may compensate. 
Nevertheless, despite such sequence similarity the different adhesin 
proteins do appear to confer distinct cell surface properties allowing 
adhesion to a variety of substrates (Guo et al., 2000, Hoyer et al., 2008, 
Zupancic et al., 2008). One appealing hypothesis, borne out of the diverse 
range of niches occupied by pathogenic organisms, suggests that different 
adhesins are expressed under different conditions appropriate to their 
binding specificities. It has been proposed that differential gene expression 
driven by signals associated with different niches may regulate the varied 
expression of such adhesins (De Las Penas et al., 2003, Castano et al., 
2005). Indeed subtelomeric silencing in S. cerevisiae may be regulated in 
response to cell stresses (Ai et al., 2002). Regulation of cell wall adhesins 
may therefore be highly regulated with such regulation being integral to 
niche adaptation and/or host infection.   
Both the EPA and FLO family genes are predominately located in 
subtelomeric clusters, and close proximity to the telomere has been 
demonstrated to be important in regulating expression of both adhesin 
families (De Las Penas et al., 2003, Halme et al., 2004, Verstrepen et al., 
2004, Castano et al., 2005). In a C. glabrata BG2 strain background the 
EPA1 cluster (HYR1, EPA1-3) resides at the right telomere of chromosome 
E, EPA4 and EPA5 are present in the genome as an inverted repeat located 
at the right telomere of chromosome I, and EPA6 and EPA7 are located at 
either telomere on chromosome C (Fig. 38) (De Las Penas et al., 2003, 
Castano et al., 2005). With the exception of EPA4/5, which appears to be 
absent, these EPA genes have been identified at equivalent positions in C. 
glabrata ATCC2001 (de Groot et al., 2008, Thierry et al., 2008, Muller et 
al., 2009). The available genomic sequence for the type strain ATCC2001 
runs from subtelomere to subtelomere but with gaps at the telomere 
regions (Sherman et al., 2006). Telomeric sequence for some chromosome 
ends in strain BG2 is available however, therefore it is known that the EPA1 
start codon is located approximately 24.6kb from its respective telomere in 
this strain. Consequently the EPA1 ORF occupies a position markedly 
distanced from the telomere when compared to any of EPA2-7. Indeed EPA 
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Figure 38 ± Schematic representation of the positions of EPA1-to-EPA7 in the 
genome of C. glabrata strain BG2 at four telomeres. The EPA1 cluster is located 
at the right telomere of chromosome E (chr E-R), the EPA4/EPA5 cluster resides 
at the right telomere of chromosome I (chr I-R), and EPA6 and EPA7 are located 
at either ends of chromosome C (chr C-L and chr C-R). Slightly modified from 
(Rosas-Hernandez et al., 2008). 
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2-5 are known to be subjected to SIR3-dependent, transcriptional silencing 
when exponential cells are grown in vitro. Conversely, and likely due to its 
increased distance from the telomere, EPA1 is expressed under such 
conditions (De Las Penas et al., 2003). Nevertheless EPA1 levels are 
increased in a sir3Ʃ BG2 background indicating that although not efficiently 
silenced the EPA1 locus is subject to some repressive chromatin effects (De 
Las Penas et al., 2003). Silencing of EPA1 appears to be particularly 
relevant in stationary phase BG2 cells where the transcript is weakly 
detectable and greatly increased in a sir3Ʃ background (Castano et al., 
2005). EPA6 and EPA7 also appear to be subject to position dependent 
transcriptional silencing. Studies using URA3-based insertion assays have 
demonstrated a requirement for all three C. glabrata Sir proteins; Sir2, 
Sir3 and Sir4, in silencing at the EPA1-7 loci (Rosas-Hernandez et al., 
2008). The Sir complex mediates silencing at both the silent mating type 
loci and telomeres in S. cerevisiae and is recruited to DNA via the action of 
a number of DNA binding proteins including Rap1. Identification of 
consensus Rap1 binding sites at C. glabrata telomeres suggests a similar 
function in this organism and indeed disruption of RAP1 does de-repress 
transcription of silenced EPA genes (De Las Penas et al., 2003, North and 
Verdin, 2004, Castano et al., 2005). 
The apparent degree of silencing exerted at telomeres appears to 
differ between chromosome ends (De Las Penas et al., 2003). URA3 
insertion assays demonstrated that unlike the EPA4/5 cluster, where 
silencing occurred at all integration sites, there was graduated silencing 
across the EPA1-3 cluster and the EPA7 telomere (De Las Penas et al., 
2003, Castano et al., 2005). Rather silencing decreased across the EPA1-3 
cluster and EPA7 telomere as insertion sites became more and more 
centromeric. This is in agreement with previous data that EPA1, which has 
a relatively centromeric location compared to other EPA genes, is subject 
to only weak silencing. Different genetic requirements for silencing 
identified at these telomeres may contribute to such observed differences. 
The yKu70/yKu80 heterodimer, essential for S. cerevisiae silencing at all 
tested telomeres where it is known to regulate telomere length and aid in 
recruitment of Sir3 and Sir4, (Boulton and Jackson, 1996, Porter et al., 
1996, Laroche et al., 1998), is not required for telomere position effect 
(TPE) silencing at the right end of chromosome E which includes the EPA1-
3 cluster (Rosas-Hernandez et al., 2008). In addition Rif1, likewise required 
for telomere length regulation in C. glabrata (Castano et al., 2005), has 
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been seen to exert various degrees of silencing at the different telomeres 
tested, with a discontinuous contribution to silencing observed across the 
EPA1-3 telomere. Nevertheless EPA1, EPA2 and EPA3 are all induced in a 
rif1Ʃ background as measured by RT-PCR (Rosas-Hernandez et al., 2008). 
A proposed model for such differential telomere silencing suggests that 
certain C. glabrata telomeres encode cis-acting elements comparable to the 
silencer and proto-silencer elements described in S. cerevisiae (Fourel et 
al., 1999, Pryde and Louis, 1999, Rosas-Hernandez et al., 2008). Such 
elements may provide additional mechanisms to recruit silencing 
complexes and thus render telomeres more or less sensitive to changes in 
telomere length, such as was seen with ykuƩ and rif1Ʃ mutants. 
Furthermore such a cis-acting element has been identified between EPA3 
and its telomere (Rosas-Hernandez et al., 2008). Silencing mediated by 
this element requires Sir3. However, analogous to EPA1-3 expression, this 
does not appear to be dependent upon yKu70/80. In fact the silencing 
effect of this element increases with loss of yKu70 or yKu80, a likely 
consequence of shortened telomeres resulting in more available Sir 
complex. Indeed longer telomeres observed in rif1 deletion strains do 
result in a partial release of this silencer mediated silencing (Rosas-
Hernandez et al., 2008). Such results indicate that telomeres in C. glabrata 
are by no means equivalent (an observation mirrored in S. cerevisiae), and 
that the level of TPE and expression regulation is complex and differs 
between chromosome ends.     
The above-mentioned observations highlight the potential 
complexity that may exist in the regulation of the subtelomeric EPA genes. 
This ranges from TPE to the contribution of silencer elements, and does not 
exclude possible promoter specific points of control and post-translational 
regulation of the product. The differing genetic interactions at different 
chromosome ends only add further to this complex arrangement. Such a 
level of complexity may be particularly important for a pathogenic 
organism such as C. glabrata by enabling individual modulation of EPA 
gene expression during the infection process. This chapter aims to 
elucidate mechanisms of regulation that impact on the heterogeneity of 
EPA1 expression.  
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5.2 Impact of Virulence Related Environmental 
Conditions on Epa1 Expression and Heterogeneity 
Adaptation to changing environments is a requirement for the 
survival of many microorganisms. Such adaptation is important for 
pathogens such as C. glabrata due to the wide range of host niches, with 
differing niche-specific conditions, that are encountered during the process 
of infection. While C. glabrata is a commensal of the gastrointestinal tract, 
it is capable of causing a wide range of diseases ranging from superficial 
mucosal infections to severe systemic candidiasis (Pfaller et al., 1998, Fidel 
et al., 1999, Kaur et al., 2005, Richter et al., 2005). C. glabrata can be 
isolated from the oral cavity, stomach, vaginal tract, bloodstream, kidney, 
liver and spleen (Fidel et al., 1999, De Las Penas et al., 2003, Castano et 
al., 2005, Schmidt et al., 2008). In addition, this pathogenic yeast occurs 
in environmental niches outside any mammalian host, having been 
isolated, for example, from rotten fruit (Nyanga et al., 2007, Schmidt et 
al., 2008). The ability of C. glabrata to survive and persist in such a diverse 
range of habitats indicates an efficient ability to adapt to changing 
environments.  
Given the large repertoire of EPA adhesins that exist in this 
organism, and the attractive theory that different adhesins may be 
expressed in response to different environmental signals and at different 
times during infection, the effect of a number of infection-relevant 
conditions on expression of Epa1 was investigated.  
5.2.1 Effect of Temperature 
As mentioned above C. glabrata is an opportunistic human fungal 
pathogen that is commonly found in association with its host. Human body 
temperature is regulated to maintain an optimum of 37°C and, as 
expected, C. glabrata grows well at this temperature. I hypothesised that 
temperature could be a signal detected as a change of environment by C. 
glabrata, for example during entry to a host organism, leading to an 
alteration in expression profile accordingly. An elevated temperature of 
37°C is a general requirement of hyphal induction in C. albicans (Sudbery, 
2011) with several genes known to be expressed in a hyphal specific 
manner including the adhesins HWP1 and ALS3 (Hoyer et al., 1998, Hoyer 
et al., 2008). Since adhesion is believed to be an important stage in the 
infection process it was decided to determine if a switch in temperature 
from a standard laboratory growth temperature of 30°C to a host-
resembling 37°C would modify Epa1 expression.  
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The effect of temperature change was analysed in both Epa1-HA 
tagged strains, CG2001-Epa1-HA and BG2-Epa1-HA. Cells were grown at 
the appropriate temperature for at least 15 hours before exponential phase 
cells were stained with anti-HA, Alexa Fluor® 488 antibody and analysed by 
flow cytometry. The results demonstrated that in the highly heterogeneous 
BG2-Epa1-HA strain a change in temperature from 30 to 37°C had only a 
small effect on Epa1-HA expression with a ~16.6% increase observed. This 
was accompanied by a small alteration in CV from 84 to 94 (Fig. 39). 
Conversely, the same temperature switch to 37°C in CG2001-Epa1-HA 
resulted in a more marked ~33.1% increase in Epa1-HA expression. In 
addition this increased expression was accompanied by a ~21% decrease 
in the CV value (Fig. 40). Despite temperature having a more marked 
effect on Epa1-HA expression in strain CG2001-Epa1-HA the observed 
increase was not associated with any marked difference in adhesion to 
Hep2 epithelial cells with only a ~6% increase being observed (Fig. 41).  
5.2.2 Response to Nitrogen Limitation 
Upon entry to the host environment access to certain nutrients may 
become limiting. Nitrogen limitation has previously been reported to induce 
morphological changes leading to invasive growth in pathogenic yeasts, 
including C. glabrata (Gimeno et al., 1992, Csank et al., 1998, Csank and 
Haynes, 2000). Invasive growth may be an important modification in 
response to environmental conditions that contributes to pathogenesis. 
Due to host conditions and possible implications for virulence, I decided to 
analyse the effect of nitrogen starvation on Epa1-HA expression in C. 
glabrata.  
Previous studies involving nutrient limitation in C. glabrata utilised a 
5% synthetic complete (SC) medium for which all SC components, 
including ammonium sulphate ((NH4)2SO4), were at 5% of the standard 
concentration (Domergue et al., 2005). Therefore, in order to limit cells for 
nitrogen specifically both BG2-Epa1-HA and CG2001-Epa1-HA were grown 
in SC medium at 100% (37.8mM) and 5% (1.89mM) of the standard 
nitrogen concentration used for the medium in the form of (NH4)2SO4, 
which constitutes the predominant nitrogen source, for at least 15 hours. 
Limiting nitrogen with the 5% condition had little effect on either mean 
Epa1-HA expression or heterogeneity (CV) in the BG2-Epa1-HA strain  
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Figure 39 ± The effect of Temperature on Epa1-HA expression in BG2-Epa1-
HA. Cells were maintained at the appropriate temperature in YPD medium for at 
least 15 hours prior to analysis. In each instance, blue indicates expression at 
30°C while green illustrates expression at 37°C. (A) Epa1-HA expression (AU) 
was analysed by flow cytometry following staining of exponential phase cells 
with anti-HA, Alexa Fluor® 488 conjugate antibody. (B) Mean Epa1-HA 
expression levels (AU) are shown and (C) heterogeneity is illustrated by Epa1-
HA CV values. Data presented (B, C) are means of independent triplicate 
experiments ±SEM.  
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Figure 40 ± The effect of Temperature on Epa1-HA expression in CG2001-
Epa1-HA. Cells were maintained at the appropriate temperature in YPD medium 
for at least 15 hours prior to analysis. In each instance, blue indicates 
expression at 30°C while green illustrates expression at 37°C. (A) Epa1-HA 
expression (AU) was analysed by flow cytometry following staining of 
exponential phase cells with anti-HA, Alexa Fluor® 488 conjugate antibody. (B) 
Mean Epa1-HA expression levels (AU) are shown and (C) heterogeneity is 
illustrated by Epa1-HA CV values. Data presented (B, C) are means of 
independent triplicate experiments ±SEM.  
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Figure 41 ± The effect of temperature on adhesion of CG2001-Epa1-HA cells to 
Hep2 epithelial cell. Cells were grown overnight in YPD medium at either 30°C or 
37°C, before dilution into fresh YPD medium and further growth at the 
appropriate temperature to exponential phase. Adhesion assays to Hep2 
epithelial cells were performed, after which adhesive cells were removed and 
plated on YPD agar. The resulting number colony forming units (cfu) was used to 
determine adherent cell numbers. Data presented are means of adherent cell 
number calculated from independent triplicate experiments ±SEM. 
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background (Fig. 42). An effect of nitrogen was slightly more apparent in 
the CG2001-Epa1-HA strain background, which demonstrates tighter 
heterogeneity regulation. In this instance limitation for nitrogen resulted in 
a 15.8% increase in mean Epa1-HA expression and 8.7% decrease in CV 
from 68.1 to 62.2 (Fig. 43).  
5.2.3 Response to pH Level 
The diverse niches occupied by C. glabrata within the host 
environment vary greatly in terms of their ambient pH. Within the human 
host such pH levels can range from the relatively acidic regions of the 
stomach and vaginal tract through to the more neutral and basic regions 
found in the bloodstream and many organs. In addition pH changes over 
time within a single niche have also been documented, for example in the 
oral cavity where pH can vary markedly due to changes in diet, the 
metabolism of other microflora and salivary flow. In addition pH of the 
vaginal tract can vary from its usual acidic level to slightly alkaline during 
the menstrual cycle (Davis, 2009, Davis, 2003). Pathogenic fungi must 
therefore be able to adapt to pH changes within the host and survival in 
such diverse pH environments suggests that C. glabrata possess an 
effective pH adaptation strategy (Schmidt et al., 2008).  
The effect of pH on Epa1-HA expression and heterogeneity was 
analysed by flow cytometry, following anti-HA antibody staining, in both 
strain backgrounds; BG2-Epa1-HA and CG2001-Epa1-HA. Three different 
physiologically relevant pH values were tested; an acidic pH of 4 such that 
is found in the human vaginal cavity, pH7.4 which represents the pH of 
human blood and many tissues, and a pH of 8 similar to the more alkaline 
conditions of the gastrointestinal tract (Schmidt et al., 2008, Davis, 2009). 
These experiments were performed using Pan Fungal Medium (PFM) which 
was developed specifically for the standardisation of experiments involving 
the analysis of pH responses in yeasts and filamentous fungi (Schmidt et 
al., 2008). Cells were maintained at the appropriate pH for at least 15 
hours prior to analysis. This investigation revealed pH to have little effect 
on either Epa1-HA mean expression or heterogeneity in the BG2-Epa1-HA 
strain background, although lowest mean Epa1-HA expression levels were 
evident at pH7.4. Heterogeneity levels also remained quite similar in BG2-
Epa1-HA cells grown at the three pHs (Fig. 44). Alteration of growth 
medium pH had a greater effect on mean Epa1-HA expression and 
heterogeneity in a CG2001-Epa1-HA strain background (Fig. 45). In this 
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Figure 42 ± The effect of Nitrogen limitation on Epa1-HA expression in BG2-
Epa1-HA. Cells were grown in SC medium supplemented with the relevant 
concentration of ammonium sulphate ((NH4)2SO4) for at least 15 hours prior to 
analysis.  In each instance, blue indicates 100% Nitrogen ((NH4)2SO4) while 
green illustrates 5% Nitrogen ((NH4)2SO4) in otherwise unmodified SC medium. 
(A) Epa1-HA expression (AU) was analysed by flow cytometry following staining 
of exponential phase cells with anti-HA, Alexa Fluor® 488 conjugate antibody. 
(B) Mean Epa1-HA expression levels (AU) are shown and (C) heterogeneity is 
illustrated by Epa1-HA CV values. Data presented (B, C) are means of 
independent triplicate experiments ±SEM.  
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Figure 43 ± The effect of Nitrogen limitation on Epa1-HA expression in 
CG2001-Epa1-HA. Cells were grown in SC medium supplemented with the 
relevant concentration of ammonium sulphate (gL-1 (NH4)2SO4) for at least 15 
hours prior to analysis. In each instance, blue indicates 100% Nitrogen (gL-1 
(NH4)2SO4) while green illustrates 5% Nitrogen (gL
-1 (NH4)2SO4) in otherwise 
unmodified SC medium. (A) Epa1-HA expression (AU) was analysed by flow 
cytometry following staining of exponential phase cells with anti-HA, Alexa 
Fluor® 488 conjugate antibody. (B) Mean Epa1-HA expression levels (AU) are 
shown and (C) heterogeneity is illustrated by Epa1-HA CV values. The 
differences in Epa1-HA expression and CV observed between the two growth 
conditions were deemed to be either, significant (p=<0.05), or not significant 
(p=> DFFRUGLQJ WR WKH 6WXGHQW¶V W-test (Materials and Methods). Data 
presented (B, C) are means of independent triplicate experiments ±SEM. 
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Figure 44 ± The effect of ambient pH on Epa1-HA expression in BG2-Epa1-
HA. In each instance, red indicates pH4, yellow indicate pH7.4, and blue 
indicates pH8. Cells were grown in PFM at the appropriate pH for at least 15 
hours prior to analysis.  (A) Epa1-HA expression (AU) was analysed by flow 
cytometry following staining of exponential phase cells with anti-HA, Alexa 
Fluor® 488 conjugate antibody. (B) Mean Epa1-HA expression levels (AU) are 
shown and (C) heterogeneity is illustrated by Epa1-HA CV values. Data 
presented (B, C) are means of independent triplicate experiments ±SEM. 
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Figure 45 ± The effect of ambient pH on Epa1-HA expression in CG2001-Epa1-
HA. In each instance, red indicates pH4, yellow indicate pH7.4, and blue 
indicates pH8. Cells were grown in PFM at the appropriate pH for at least 15 
hours prior to analysis. (A) Epa1-HA expression (AU) was analysed by flow 
cytometry following staining of exponential phase cells with anti-HA, Alexa 
Fluor® 488 conjugate antibody. (B) Mean Epa1-HA expression levels (AU) are 
shown and (C) heterogeneity is illustrated by Epa1-HA CV values. Differences 
RIVWDWLVWLFDOVLJQLILFDQFHZHUH LGHQWLILHGXVLQJD6WXGHQW¶VW-test (see text and 
Materials and Methods).  Data presented (B, C) are means of independent 
triplicate experiments ±SEM. 
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instance the lowest level of Epa1-HA expression was seen at pH7.4, with 
mean Epa1-HA expression being significantly (24% and 16%) lower than 
that observed at pH4 and pH8 respectively DFFRUGLQJ WR WKH6WXGHQW¶V W-
test.  The highest expression level, at pH4, corresponded to the lowest 
level of heterogeneity, (CV=40.4), in this strain background. By contrast 
CVs for Epa1-HA expression at pH7.4 and pH8 are very similar at 55.2 and 
55.8 respectively. Thus heterogeneity at these latter pH values was 
approximately 37% higher than at pH4, a difference that was indeed 
deemed statistically significant (Fig.45). 
 
5.3 Transcriptional Silencing affects EPA1/Epa1 
Expression and Heterogeneity 
As discussed in the main introduction to this chapter a number of 
studies have demonstrated that inhibition of transcriptional silencing, both 
directly, including SIR3 deletion, and indirectly, can release telomeric 
silencing and de-repress EPA expression including EPA1 (De Las Penas et 
al., 2003, Castano et al., 2005, Rosas-Hernandez et al., 2008). 
Consequently I wanted to determine whether transcriptional silencing 
contributed to the heterogeneity of Epa1 expression in our two strains.   
5.3.1 Sir3-Dependent EPA1 Transcription in a BG2 Strain 
Background 
Analogous to BG2-Epa1-HA, which enables visualisation of Epa1-HA 
protein expression at the cell surface in a BG2 strain background the EPA1-
GFP transcriptional fusion (BG2-EPA1-GFP), demonstrated a high level of 
expression heterogeneity in a BG2 background as demonstrated in chapter 
4 (Fig. 29, 30). Flow cytometric analysis of a sir3Ʃ mutant constructed in 
this EPA1-GFP BG2 background (Materials and Methods) indicated EPA1 
heterogeneity to be markedly dependent on Sir-mediated transcriptional 
silencing (Fig. 46). Loss of transcriptional silencing at the telomeres via 
deletion of SIR3 resulted in a 57% decrease in the observed EPA1-GFP 
heterogeneity, from CV ~107 to ~46 (Fig. 46A, C). In addition, the results 
demonstrated that the decreased heterogeneity observed following loss of 
transcriptional silencing was accompanied by a ~53% increase in mean 
EPA1-GFP expression (Fig. 46A, B). These changes in Epa1-HA expression 
and CV demonstrated p YDOXHVDFFRUGLQJWRWKH6WXGHQW¶VW-test and 
were thus deemed statistically significant. The increase in EPA1-GFP 
expression seemed attributable to the loss of a subpopulation of low GFP   
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Figure 46 ± The role of Sir3-dependent transcriptional silencing on cell surface 
Epa1 expression in the BG1-EPA1-GFP strain. Wild type (WT) and sir3Ʃ mutant 
cells were grown to exponential phase in YPD medium before analysis by flow 
cytometry. In each instance WT cells are represented in blue while sir3Ʃ mutant 
cells are indicated in green. (A) EPA1-GFP expression (AU) was analysed by flow 
cytometry. (B) Mean EPA1-GFP expression levels (AU) are shown and (C) 
heterogeneity is illustrated by EPA1-GFP CV values. The differences in Epa1-HA 
expression and CV observed between WT and sir3ƩPXWDQWFHOOVZHUHdeemed 
to be either, significant (p=<0.05), or not significant (p=>0.05) according to 
WKH6WXGHQW¶VW-test (Materials and Methods). Data presented (B,C) are means 
of independent triplicate experiments ±SEM. 
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expressing cells that was present in the wild type (Fig 46A). Loss of this 
highly silenced population of cells would also be expected to be a major 
contributing factor to the decreased heterogeneity exhibited by EPA1-GFP 
sir3Ʃ mutant cells. The results thus indicate that transcriptional silencing 
plays a major role in the regulation of EPA1 expression and its 
heterogeneity.   
5.3.2 Sir3-Dependent Transcriptional Silencing in CG2001-
Epa1-HA 
In order to identify the effect of Sir-dependent transcriptional 
silencing on cell surface Epa1 protein expression, which is more relevant 
for infection, a sir3Ʃ mutant was initially constructed in the Epa1-HA 
tagged strain CG2001-Epa1-HA (Materials and Methods). Subsequent flow 
cytometric analysis of this CG2001-Epa1-HA sir3Ʃ mutant strain, following 
anti-HA, Alexa Fluor® 488 conjugate antibody staining, revealed 
unexpected results. The CG2001-Epa1-HA sir3Ʃ mutant demonstrated a 
~28% decrease in mean Epa1-HA expression compared to the wild type 
(Fig. 47). In addition, and in contrast to results obtained in a BG2 strain 
above, inhibition of transcriptional silencing had virtually no effect on Epa1-
HA heterogeneity in CG2001-Epa1-HA, with wild type and sir3Ʃ mutant CV 
values of ~55 and ~53 respectively (Fig. 47). This result may be related to 
the much lower level of Epa1-HA heterogeneity that is already present in 
wild type cells of this strain background compared to the BG2 strain 
background (4.2.4). The population of low expressing cells evident in the 
BG2 strain background (BG2-Epa1-HA and BG2-EPA1-GFP) is absent from 
CG2001-Epa1-HA and it is this sub-population that was found to be 
eliminated upon sir3 deletion in BG2-EPA1-GFP. It is noted that this 
comparison is between strains expressing an EPA1-GFP transcriptional 
fusion and Epa1-HA translational fusion, which in itself creates the potential 
for differing results. Nevertheless, one possible explanation for the results 
is that an already-tight regulation of Epa1-HA expression across a CG2001-
Epa1-HA cell population (i.e. low heterogeneity) relates to weak silencing 
in this background (addressed further in 5.3.5).   
A single copy plasmid containing the SIR3 ORF under the control of 
its native promoter and terminator was constructed to complement the 
sir3Ʃ mutant. This involved amplification of the SIR3 region as a SacI 
fragment which was then inserted into the single copy C. glabrata plasmid 
pCgACT-14 (Kitada et al., 1996) to yield pCgACT-14-SIR3 (Materials and  
Methods). This plasmid includes tryptophan as a selection marker and 
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Figure 47 ± The role of Sir3-dependent transcriptional silencing on cell surface 
Epa1 expression in the CG2001-Epa1-HA strain. Wild type (WT) and sir3Ʃ 
mutant cells were grown to exponential phase in YPD medium before analysis by 
flow cytometry. In each instance wild type cells are represented in blue while 
sir3Ʃ mutant cells are indicated in green. (A) Epa1-HA expression (AU) was 
analysed by flow cytometry following staining of exponential phase cells with 
anti-HA, Alexa Fluor® 488 conjugate antibody. (B) Mean Epa1-HA expression 
levels (AU) are shown and (C) heterogeneity is illustrated by Epa1-HA CV 
values. The differences in Epa1-HA expression and CV observed between WT 
and sir3ƩPXWDQWFHOOVZHUHGHHPHGWREHHLWKHUVLJQLILFDQWp=<0.05), or not 
significant (p !DFFRUGLQJWRWKH6WXGHQW¶VW-test (Materials and Methods).  
Data presented (B, C) are means of independent triplicate experiments ±SEM. 
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could therefore be transformed into CG2001-Epa1-HA sir3Ʃ mutant cells.  
Analysis of transformed cells by flow cytometry demonstrated that 
introduction of functional SIR3 successfully complemented the sir3Ʃ 
mutant, with Epa1-HA expression reverting back to wild type levels (Fig. 
48A). Heterogeneity levels, as expected, remained relatively unaffected 
(Fig. 48B). Unfortunately, the tryptophan selection marker made pCgACT-
14-SIR3 inappropriate for complementation of BG2-EPA1-GFP. The limited 
available selection markers ultimately resulted in multiple genetic 
manipulations proving difficult in a BG2 background. 
5.3.3 Corroboration of Strain Dependent Sir-Mediated 
Transcriptional Silencing of Epa1-HA 
The results presented above suggest a strain dependent regulation 
of EPA1/Epa1 expression by transcriptional silencing. This mechanism of 
regulation appeared to be more influential in the BG2 background (BG2-
EPA1-GFP). By contrast, loss of Sir3 activity in the CG2001-Epa1-HA strain 
actually produced a decrease in mean Epa1-HA expression. Despite such 
indications that Sir-dependent EPA1 silencing may differ according to strain 
background it must be considered that these experiments were performed 
using different reporters of expression. The effects of SIR3 deletion were 
determined using an EPA1-GFP transcriptional fusion in the BG2 
background while the C. glabrata &*+78ƩDGHULYDWLYHRI WKH W\SH
strain, was analysed through use of an Epa1-HA construct. A corresponding 
EPA1-*)3WUDQVFULSWLRQDO IXVLRQ LQ WKH&*+78ƩEDckground was not 
available. Construction of such a strain, using a GFP fragment flanked by 
50bp regions of EPA1 homology, was ineffective. It was, however, 
determined to focus on cell surface Epa1 expression which is more 
functionally relevant in terms of infection. Attempts were made to create a 
sir3Ʃ mutant of the BG2-Epa1-HA strain, but these proved unsuccessful 
mainly due to the difficulty of having limited available selection markers. 
Non-specific growth was evident when using selection markers that were 
available, such as hygromycin, and resulted in large numbers of colonies to 
be tested by diagnostic PCR, no successful transformants were detected. 
As discussed in chapter 4 (4.2.3) the EPA1-HA transforming fragment 
included URA3 as a selection marker. Attempts were made to remove this 
URA3 marker and select for successful transformants on 5FOA, which 
inhibits growth of Ura+ cells, thus allowing the URA3 marker to be utilised 
in BG2-Epa1-HA for deletion of Sir3. Non-specific growth again proved   
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Figure 48 ± Complementation of CG2001-Epa1-HA sir3Ʃ cells with pCgACT-14-
SIR3. Cells were grown to exponential phase in YNB without tryptophan to 
ensure retention of pCgACT-14-SIR3 prior to staining with anti-HA, Alexa Fluor® 
488 conjugate antibody and analysis by flow cytometry. Wild type (WT) cells are 
shown in dark blue, sir3Ʃ cells are shown in green, and cells complemented with 
pCgACT-14-SIR3 are shown in light blue. (A) Mean Epa1-HA expression levels 
(AU) are shown and (B) heterogeneity is illustrated by Epa1-HA CV values. Data 
presented (A, B) are means of independent triplicate experiments ±SEM.   
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problematic, possibly due to the sub-set of cells that demonstrate silencing 
at the EPA1 locus in this strain background which may mask the presence 
of URA3.   
In order to substantiate that Sir-mediated regulation of Epa1 does 
differ according to strain background I needed to compare strains in which 
Epa1 expression was measured by the same method. Consequently it was 
decided to use Epa1-HA tagged strains, BG2-Epa1-HA and CG2001-Epa1-
HA, in which transcriptional silencing would be inhibited by some other 
method, namely nicotinic acid (NA) limitation (Domergue et al., 2005). 
Further to this, sir3Ʃ mutants were constructed in untagged BG2 and 
&*+78ƩVWUDLQVZLWKFHOOVXUIDFH(SDH[SUHVVLRQPHDVXUHGXVLQJDQ
anti-Epa1 antibody (Kaur et al., 2007) kindly donated by B. Cormack (John 
Hopkins University).   
5.3.3.1 Inhibition of Silencing in CG2001-Epa1-HA and BG2-
Epa1-HA by Nicotinic Acid Limitation 
C. glabrata is auxotropic for NA and as a result requires an external 
supply in order to assimilate NAD+ and enable function of the NAD+-
dependent histone deacetylase Sir2, an essential component of the 
transcriptional silencing machinery. Previous studies have successfully 
repressed transcriptional silencing of EPA genes in C. glabrata by limiting 
growth media for NA (Domergue et al., 2005). These authors also 
demonstrated that gene de-repression by NA limitation was specifically 
caused by inhibition of Sir2 activity and thus inhibition of Sir-mediated 
silencing. By limiting cells for NA it was possible to inhibit transcriptional 
silencing and analyse the effects on Epa1-HA expression in the two 
different strain backgrounds.     
Cells were limited for NA as previously described, by growth in SC 
medium supplemented with either the standard amount RI 1$ ǋ0
RU1$ǋ0(Domergue et al., 2005). Cells were grown 
overnight in the experimental medium before re-inoculation into 
appropriate SC medium and further growth to reach exponential phase. 
The results obtained with Sir-dependent transcriptional silencing by NA 
limitation broadly agreed with the data from sir3Ʃ mutants, indicating Sir-
dependent regulation of Epa1 indeed to be dependent upon strain 
background. Thus, NA limitation had a greater effect on Epa1-HA 
expression in strain BG2-Epa1-HA, with CV values decreasing from ~88 to 
~63 upon inhibition of silencing (Fig. 49). By contrast, inhibition of  
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Figure 49 ± Inhibiting transcriptional silencing by NA limitation and its effect 
on Epa1-HA heterogeneity (CV) in BG2-Epa1-HA cells. Results obtained from 
growth in 100% NA are shown in blue, while those from 5% NA are depicted in 
green. Cells were grown overnight in SC medium with either 100% or 5% NA 
before being re-inoculated into the appropriate fresh SC medium and grown to 
exponential phase. (A) Epa1-HA expression (AU) was analysed by flow 
cytometry following staining of cells with anti-HA, Alexa Fluor® 488 conjugate 
antibody. (B) Heterogeneity of Epa1-HA expression is demonstrated by Epa1-
HA CV values. Data presented are means of independent triplicate experiments 
±SEM.   
152 
 
silencing by limiting NA availability had no effect on Epa1-HA expression 
heterogeneity in a CG2001-Epa1-HA background with CV values remaining 
at ~35 (Fig. 50). Mean Epa1-HA expression analysis was also in agreement 
with the results obtained with sir3Ʃ mutants. The decreased heterogeneity 
in strain BG2-Epa1-HA was accompanied by ~37% increase in mean Epa1-
HA expression when cells were limited for NA (Fig. 51A). Similarly, as seen 
for the CG2001-Epa1-HA sir3Ʃ mutant, wild type cells of this background 
demonstrated ~27% decreased mean Epa1-HA expression when limited for 
NA (Fig. 51B). The latter observation, while unexpected, was therefore 
corroborated with a sir3Ʃ mutant and NA limitation. Control experiments 
utilising CG2001-Epa1-HA sir3Ʃ mutant cells grown in SC medium 
supplemented with either 100% or 5% NA revealed no marked additional 
phenotype in mean Epa1-HA expression or Epa1-HA heterogeneity (CV) 
following growth in NA limited SC medium (Fig. 52). This result is in 
concordance with the previous identification that NA limitation induced EPA 
de-repression is specifically due to an inhibition of transcriptional silencing 
(Domergue et al., 2005).              
5.3.3.2 ± Analysis of Cell Surface Epa1 Expression in sir3Ʃ 
Mutant Cells via an Anti-Epa1 Antibody     
The construction of sir3Ʃ deletion mutants in untagged-Epa1 BG2 
DQG &* +78Ʃ VWUDLQV 0DWHULDOV DQG 0HWKRGV HQDEOHG FHOO VXUIDFH
Epa1 expression to be measured in both backgrounds through use of an 
anti-Epa1 antibody (Kaur et al., 2007) kindly donated by B. Cormack (John 
Hopkins University). This antibody was not mono-specific for Epa1 but also 
capable of recognising Epa6 and Epa7 and possibly other Epa adhesins. 
Consequently, in order to obtain antibodies with a higher specificity for 
Epa1, pre-absorption was performed using an epa1Ʃ deletion strain grown 
under conditions of limited NA to induce expression of other EPA genes 
(Domergue et al., 2005), (Materials and Methods). Specificity of the pre-
absorbed antibody for Epa1 was checked using the wild type BG2 and 
epa1Ʃ deletion strains, again grown in limited NA, along with a secondary 
Alexa Fluor® 488 conjugate antibody and analysis by flow cytometry. This 
revealed that the pre-absorbed antibody was indeed specific for Epa1 as 
virtually no staining was observed in epa1Ʃ cells compared to its non-pre-
absorbed counterpart or compared to staining observed for wild type cells. 
 
 
153 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50 ± Inhibiting transcriptional silencing by NA limitation and its effect 
on Epa1-HA heterogeneity (CV) in CG2001-Epa1-HA cells. Results obtained 
from growth in 100% NA are shown in blue, while those from 5% NA are 
depicted in green. Cells were grown overnight in SC medium with either 100% 
or 5% NA before being re-inoculated into the appropriate fresh SC medium and 
grown to exponential phase. (A) Epa1-HA expression (AU) was analysed by 
flow cytometry following staining of cells with anti-HA, Alexa Fluor® 488 
conjugate antibody. (B) Heterogeneity of Epa1-HA expression is demonstrated 
by Epa1-HA CV values. Data presented are means of independent triplicate 
experiments ±SEM. 
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Figure 51 ± Inhibiting transcriptional silencing by NA limitation and its effect on 
mean Epa1-HA expression (AU) in (A) BG2-Epa1-HA and (B) CG2001-Epa1-HA 
strain backgrounds. Results obtained from growth in 100% NA are shown in 
blue, while those from 5% NA are depicted in green. Cells were grown overnight 
in SC medium with either 100% or 5% NA before being re-inoculated into the 
appropriate fresh SC medium and grown to exponential phase. Cells were then 
stained with anti-HA, Alexa Fluor® 488 conjugate antibody and analysed by flow 
cytometry. Data presented are means of independent triplicate experiments 
±SEM. 
Figure 52 ± Inhibiting transcriptional silencing by NA limitation and its effect on 
Epa1-HA expression in the CG2001-Epa1-HA sir3Ʃ mutant. Results obtained 
from growth in 100% NA are shown in blue, while those from 5% NA are 
depicted in green. Cells were grown overnight in SC medium with either 100% 
or 5% NA before being re-inoculated into the appropriate fresh SC medium and 
grown to exponential phase. Following anti-HA, Alexa Fluor® 488 conjugate 
antibody staining cells were analysed by flow cytometry. (A) Mean Epa1-HA 
expression (AU) levels and (B) Epa1-HA heterogeneity (CV) values are shown. 
Data presented are means of independent triplicate experiments ±SEM. 
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Analysis of Epa1 cell surface expression in BG2-sir3Ʃ and CG2001-
sir3Ʃ deletion strains by flow cytometry using this pre-absorbed anti-Epa1 
antibody was in agreement with previous data obtained for sir3Ʃ deletion 
mutants (5.3.1 and 5.3.2) and following NA limitation (5.3.3.1) (Fig. 53, 
54). Inhibition of silencing in the BG2 strain background by this method 
again caused a marked decrease in Epa1 expression heterogeneity of 
~48% accompanied by a more than two-fold increase in mean Epa1 level 
(Fig. 53). By contrast, and as expected according to previous data, Epa1 
expression heterogeneity in the CG2001-sir3Ʃ deletion mutant remained 
virtually unchanged compared to wild type cells with CV values of ~58 and 
~56 being obtained respectively. In further corroboration of the earlier 
results obtained during this study, mean Epa1 expression levels were seen 
to decrease by ~11% upon sir3Ʃ deletion (Fig. 54).        
5.3.4 The Effect of Transcriptional Silencing on EPA1 Transcript 
Levels also depends on Strain Background 
As EPA1-GFP transcriptional fusions were not available in the two 
strains being tested, EPA1 transcript levels were determined by qRT-PCR 
following inhibition of transcriptional silencing, via NA limitation. In addition 
by using wild type strains expressing native (not HA-tagged) Epa1, it was 
possible to rule out any artifactual effect that insertion of such a tag may 
KDYH&HOOVRIWKHUHOHYDQWXQWDJJHGVWUDLQV%*DQG&*+78ƩZHUH
grown in the presence of standard and limited NA concentrations as 
described above (5.3.3.1). As discussed this method produces cells with 
³VWDQGDUG´ DQG OLPLWHG levels of Sir2-mediated transcriptional silencing, 
respectively (Domergue et al., 2005). Thus, extraction of RNA from such 
cells enabled comparison of EPA1 mRNA transcript levels in the two strains 
in response to inhibition of silencing. The results were similar to those for 
Epa1 protein expression at the cell surface in the two Epa1-HA tagged 
versions of these strains. Inhibition of silencing by NA limitation induced 
increased levels of EPA1 transcript in the BG2 background whilst EPA1 
WUDQVFULSW OHYHOV ZHUH GHFUHDVHG LQ WKH &* +78Ʃ VWUDLQ EDFNJURXQG 
(Fig. 55). The results are consistent with regulation at the transcript level 
determining the effects also seen at the protein level. 
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Figure 53 ± The role of Sir3-dependent transcriptional silencing on cell surface 
Epa1 expression in a BG2 strain background. Wild type (blue) and sir3Ʃ deletion 
mutant (green) cells were grown to exponential phase in YPD medium before  
probing for Epa1 using an anti-Epa1 antibody and a secondary Alexa Fluor® 488 
conjugate antibody before analysis by flow cytometry.  (A) Mean Epa1p 
expression levels (AU) are shown and (B) heterogeneity is illustrated by Epa1p 
expression CV values. Data presented are means of independent triplicate 
experiments ±SEM. 
Figure 54 ± The role of Sir3-dependent transcriptional silencing on cell surface 
Epa1 expression in a BG2 strain background. Wild type (blue) and sir3Ʃ deletion 
mutant (green) cells were grown to exponential phase in YPD medium before  
probing for Epa1 using an anti-Epa1 antibody and a secondary Alexa Fluor® 488 
conjugate antibody before analysis by flow cytometry.  (A) Mean Epa1p 
expression levels (AU) are shown and (B) heterogeneity is illustrated by Epa1p 
expression CV values. Data presented are means of independent triplicate 
experiments ±SEM. 
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Figure 55 ± EPA1 mRNA levels in (A) BG2 and (B) &*+78ƩIROORZLQJ1$
limitation to inhibit transcriptional silencing. Cells were grown overnight in SC 
medium containing either 100% NA (blue) or 5% NA (green) before re-
inoculation into the appropriate fresh SC medium and growth to exponential 
phase. RNA was extracted from ~1x107 cells grown under the relevant 
condition, and EPA1 mRNA quantified using standardised cDNA additions in all 
reactions. The data shown are means from three independent experiments 
(each analysed in triplicate) ±SEM.  
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5.3.5 Sir3 Mediated Silencing appears to be Less Efficient in a 
CG2001-EPA1-HA Background 
 
5.3.5.1 Addition of a Second SIR3 Copy Increases 
Heterogeneity in CG2001-Epa1-HA 
The observations discussed thus far pertaining to differences in 
Epa1-HA expression heterogeneity between the two tested strains, along 
with differences in Sir-mediated regulation of such heterogeneity and of 
mean expression levels, could suggest that there is weaker transcriptional 
silencing of EPA1 LQ&*+78ƩWKDQLQD%*JHQHWLFEDFNJURXQG6XFK
silencing differences could result from differences in the availability of 
components of the silencing machinery between strains, among other 
possibilities. Sir3 has been implicated in EPA1 regulation both by previous 
studies (De Las Penas et al., 2003, Castano et al., 2005, Rosas-Hernandez 
et al., 2008) and my own data (above). The larger distance of EPA1 from 
the telomere when compared to other EPA genes would be consistent with 
Sir3, in particular, being pivotal for the efficiency of silencing since it is this 
protein that propagates spreading of the Sir complex and silencing out and 
away from the telomere (Renauld et al., 1993, Talbert and Henikoff, 2006). 
These points, along with the fact that I had already constructed a single 
copy plasmid containing the SIR3 ORF, pCgACT-14-SIR3 (5.3.2), led me to 
study the effect that an additional copy of SIR3 may have on silencing of 
Epa1-HA in the CG2001-Epa1-HA strain. The pCgACT-14-SIR3 single copy 
plasmid was transformed into CG2001-Epa1-HA cells and the effect on 
Epa1-HA expression analysed by anti-HA, Alexa Fluor® 488 conjugate 
antibody staining and flow cytometry. This analysis showed that 
introduction of a second SIR3 copy resulted in an Epa1-HA expression 
profile in CG2001-Epa1-HA cells that resembled more closely that of the 
more heterogeneous BG2-Epa1-HA strain (Fig. 56). Introduction of 
pCgACT-14-SIR3 yielded a marked increase in Epa1-HA heterogeneity, 
from CV ~32 to CV ~62 accompanied by a ~37% decrease in mean Epa1-
HA expression (Fig. 56).  
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Figure 56 ± Effect of ectopic SIR3 expression on Epa1-HA expression among 
exponential phase cells of CG2001-Epa1-HA either transformed (green) or not 
(blue) with pCgACT-14-SIR3. (A) Flow cytometric histogram of Epa1-HA 
expression following cell staining with anti-HA, Alexa Fluor® 488 conjugate 
antibody. (B) Mean Epa1-HA expression levels (AU) are shown and (C) 
heterogeneity is illustrated by Epa1-HA CV values. Data presented (B, C) are 
means of independent triplicate experiments ±SEM.  
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5.3.5.2 SIR3 Transcript Level appears not to Contribute to the 
Weakened EPA1 Silencing Observed in CG2001HTUƩ 
As illustrated above, addition of a second copy of SIR3 to CG2001-
Epa1-HA led to an increase in Epa1-HA heterogeneity, more closely 
resembling Epa1-HA expression in BG2-Epa1-HA. This result added weight 
to the suggestion that EPA1 exhibits weakened silencing in a CG2001-
Epa1-HA background compared to BG2-Epa1-HA, partly corroborated by 
SIR3 expression. It was considered possible that strain dependent Sir3-
mediated EPA1 silencing may have its roots in SIR3 transcript level 
differences between the strains. In order to test this I measured the SIR3 
transcript level in both strain backgrounds by qRT-PCR, using the wild type 
VWUDLQV%*DQG&*+78Ʃ/HYHOVRIWKHSIR3 transcript were actually 
a IROG KLJKHU LQ WKH ZHDNO\ VLOHQFHG &* +78Ʃ VWUDLQ WKDQ LQ the 
BG2 strain where transcriptional silencing has been shown to be more 
influential upon EPA1 and Epa1-HA expression (Fig. 57). The results 
indicated that the strain dependency of EPA1 silencing was not determined 
by the transcript level of SIR3. It is possible that the higher levels of SIR3 
WUDQVFULSW LQ WKH&*+78ƩPD\ UHIOHFW VRPHFRPSHQVDWRU\ UHVSRQVH
for the apparent low silencing efficiency of this strain.  
5.3.6 Analysis of NA-Limitation and EPA1 Expression in a 
Range of Clinical C. glabrata Isolates   
As Sir-mediated transcriptional silencing of EPA1 appeared 
dependent upon strain background it was decided to test this across a 
larger range of C. glabrata isolates. Clinical isolates acquired from a variety 
of sources, (Table 9) and kindly donated by Michael Petrou (Imperial 
College London), were used in this particular study. Each isolate was grown 
in SC medium supplemented with either 100% or 5% NA to produce 
populations in which Sir-mediated silencing was either active or inhibited 
respectively (5.3.3.1). RNA was then extracted from exponential phase 
cells and EPA1 transcript levels analysed by qRT-PCR.  
Inter-strain differences for Sir-mediated regulation of EPA1 were 
evident across the tested clinical isolates (Fig. 58). Strains CI-21, CI-32, 
CI-146 CI-172, and NCYC388 (a laboratory strain) exhibited increased 
EPA1 transcript levels when limited for NA; in this regard, these isolates  
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Table 9 ± C. glabrata Clinical Isolatesa 
Clinical Isolate Source Sir-Mediated Silencingb 
CI-21 Blood BG2-Like 
CI-22 Urine No Effect 
CI-31 SPT &*+78Ʃ-Like 
CI-32 Urine BG2-Like 
CI-39 Pelvic Drain CG2001 +78Ʃ-Like 
CI-82 Blood &*+78Ʃ-Like 
CI-105 Bile No Effect 
CI-134 Wound (Sternum) No Effect 
CI-146 Lung Biopsy BG2-Like 
CI-172 Tongue BG2-Like 
NCYC388 NCYC Collection BG2-Like 
aIsolates were kindly supplied by Michael Petrou (Imperial College London) 
bOutcomes derived from Fig. 58 
Figure 57 ± SIR3 P51$ OHYHOV LQ &* +78Ʃ EOXH DQG %*
(green) strain backgrounds. Cells were grown in YPD under standard 
conditions to reach exponential phase. RNA was extracted from 
~1x107 cells, and SIR3 mRNA quantified using standardised cDNA 
additions in all reactions. The data shown are means from three 
independent experiments (each analysed in triplicate) ±SEM.  
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Figure 58 ± Classification of C. glabrata clinical isolates into either; BG2-like, 
QRHIIHFWRU&*+78Ʃ-like, according to the effect of silencing inhibition 
by NA limitation on EPA1 transcript level. Cells were grown overnight in SC 
medium containing either 100% NA (blue) or 5% NA (green) before re-
inoculation into the appropriate fresh SC medium and growth to exponential 
phase. RNA was extracted from ~1x107 cells grown under the relevant 
condition, and EPA1 mRNA quantified using standardised cDNA additions in all 
reactions. The data shown are means from three independent experiments 
(each analysed in triplicate) ±SEM.   
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were deemed to be µBG2-like¶. On the other hand, strains CI-31, CI-39, and 
CI-82, were more µ&* +78Ʃ-like¶, with decreased EPA1 transcript 
levels when silencing was inhibited. Of the eleven tested clinical isolates, 
three, CI-22, CI-105, and CI-134 showed no marked change in EPA1 
expression when limited for NA.  
The extent to which EPA1 expression is regulated by Sir-mediated 
silencing thus varies depending on strain background. The BG2-like clinical 
isolates apparently relied to a greater extent on such regulation to silence 
EPA1. It is tempting to speculate that these isolates may also resemble the 
BG2 strain background by demonstrating high levels of EPA1/Epa1-HA 
heterogeneity. The way in which each individual clinical isolate responded 
to inhibited silencing did not appear related to where the particular isolate 
was sourced from. For example, CI-21 and CI-82 were both isolated from 
blood but demonstrate µBG2-Like¶ and µ&*+78Ʃ-Like¶ EPA1 silencing 
respectively (Table 9). 
5.3.6.1 The Extent of EPA1 Silencing Correlates with Cell 
Surface Epa1 Heterogeneity in Clinical C. glabrata Isolates 
 3UHFHGLQJ GDWD IRU %* DQG &* +78Ʃ VWUDLQ backgrounds 
indicate that transcriptional silencing of EPA1 is linked to the level of Epa1 
heterogeneity. Based on this it was predicted that the apparent marked 
variation in silencing-dependent EPA1 expression across the range of 
tested clinical isolates (discussed above 5.3.6) should have implications for 
heterogeneity. This was tested by probing Epa1 cell surface expression 
with anti-Epa1 antibody (5.3.3.2) (Kaur et al., 2007), in exponential phase 
cells, grown under standard YPD conditions, and analysed by flow 
cytometry. Like the BG2 strain, all isolates in which EPA1 silencing was 
released under conditions of inhibited transcriptional silencing, by low NA, 
exhibited a broad Epa1 expression heterogeneity under standard conditions 
(Fig. 59). Both low- and high-Epa1 subpopulations were expressed, 
accompanied by a generally lower mean Epa1 level when compared to 
µ&* +78Ʃ-like¶ LVRODWHV )LJ  %\ FRQWUDVW LVRODWHV LQ ZKLFK 
inhibition of silencing caused a decrease in EPA1 expression exhibited lower 
Epa1 expression heterogeneity and higher mean Epa1 expression, thus 
resembling the CG2001 +78ƩVWUDLQEDFNJURXQG)LJ). Clinical isolates 
in which EPA1 expression appeared to be unaffected by silencing inhibition 
also resemblHGWKH&*+78ƩVWUDLQLQWHUPVRI(SDKHWHURJHQHLW\ 
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Figure 59 ± Flow cytometric analysis of (A) mean Epa1 expression (AU) and 
(B) Epa1 heterogeneity (CV) in C. glabrata clinical isolates classified into 
either; µBG2-like¶, µno effect¶, or µCG20+78Ʃ-like¶, according to the effect of 
silencing inhibition by NA limitation on EPA1 transcript level. µ%*-OLNH¶VWUDLQV
ZHUH %* 1&<& DQG LVRODWHV    DQG  µ&* +78Ʃ-OLNH¶
VWUDLQVZHUH&*+78ƩDQGLVRODWHVDQG7KHRWKer strains were 
isolates 22, 105 and 134. Cells were grown to exponential phase in YPD 
medium before probing with an anti-Epa1 antibody and a secondary Alexa 
Fluor® 488 conjugated antibody. Samples were then analysed by flow 
cytometry. Data presented are means of independent triplicate experiments 
±SEM. 
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their mean expression levels, however, were more varied (Fig. 59). 
Ultimately a positive relationship between silencing-dependent EPA1 
expression (low NA: high NA expression ratio) and heterogeneity (CV), was 
identified across the range of clinical isolates studies (Fig. 60), indicating 
that strain-specific gene silencing is likely a key determinant of strain-to-
strain variation in the heterogeneity of Epa1 expression.  
 
5.4 Variation in EPA1 Distance from the Chromosome 
End is not a Likely Cause of Strain Dependent Sir-
Regulation 
The C. glabrata W\SH VWUDLQ $7&& IURP ZKLFK &* +78Ʃ
and subsequently CG2001-Epa1-HA is derived has had its genome 
sequenced from sub-telomere to sub-telomere (Dujon et al., 2004, 
Sherman et al., 2006). Consequently this genome sequence contains gaps 
at each of the chromosome ends and it is not possible to determine the 
exact distance of the EPA1 ORF from the end of the chromosome using 
these data. By contrast, although a complete genome sequence is not 
available, sequence data for the EPA1 cluster at the right end of 
chromosome E, including the telomere, has been determined for strain BG2 
(De Las Penas et al., 2003). Thus it is known that the EPA1 ORF start site 
is at ~24.6kb from the chromosome end in a BG2 strain background.  
Results thus far in this project suggest that EPA1 in strain CG2001 
+78ƩH[SHULHQFHVZHDNHQHGVLOHQFLQJFRPSDUHG WR%* ,QDGGLWLRQ%*
displays greater Epa1-HA expression heterogeneity, which is suppressed by 
loss of transcriptional silencing. As these differences appear not to be a 
result of defective SIR3 H[SUHVVLRQ LQ&*+78Ʃ LWZDV K\SRWKHVLVHG
that the distance of EPA1 from the chromosome end may differ between 
these two strains. Indeed silencing at the right side of the EPA1 
chromosome is known to decrease as sites become more distant to the 
telomere (De Las Penas et al., 2003, Castano et al., 2005), similar to many 
other chromosomes and other organisms. In addition chromosomal 
rearrangements have been reported to create differences between C. 
glabrata strains in terms of chromosome number and by the creation of 
chimeric chromosomes (Muller et al., 2009, Polakova et al., 2009). 
Recombination can occur at high frequency at the subtelomeres resulting in 
polymorphism among different chromosome ends and between individuals; 
such recombination could lead to alterations in the distance of EPA1 from   
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Figure 60 ± Relationship between silencing and heterogeneity of Epa1 
H[SUHVVLRQ DFURVV DOO WHVWHG VWUDLQV µ%*-OLNH¶ VWUDLQV (green) were BG2, 
1&<&DQGLVRODWHVDQGµ&*+78Ʃ-OLNH¶ strains (blue) 
ZHUH&*+78ƩDQGLVRODWHVDQG7KHRWKHUVWUDLQV (grey) were 
isolates 22, 105 and 134. EPA1 expression ratio data is based on results 
obtained by qRT-PCR following inhibition of silencing by growth in limited NA 
medium (illustrated in Fig. 58). Heterogeneity (CV) values were obtained 
following probing with an anti-Epa1 antibody and a secondary Alexa Fluor® 
488 conjugated antibody followed by flow cytometry analysis, as presented in 
(Fig. 59B). 
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the end of its chromosome between strains (Louis and Vershinin, 2005, 
Verstrepen and Fink, 2009). Following this hypothesis, and owing to the 
weakened silencing observed, it was considered logical to test whether 
EPA1 LQ WKH &* +78Ʃ VWUDLQ LV ORFDWHG IXUWKHU IURP WKH HQG RI 
chromosome E than in BG2.    
5.4.1 Strategy to look for Differences in the Distance of EPA1 
from the Chromosome End in Two Strain Backgrounds 
Since telomere regions are absent from the complete genome 
sequence of the C. glabrata type strain I required an experimental method 
to allow comparison of EPA1 SRVLWLRQLQ&*+78ƩDQG%*7KLVZDV
achieved by digestion of genomic DNA (isolated from each strain in agarose 
plugs to prevent fragmentation of DNA) with a restriction enzyme cutting 
at a known distance centromere-proximal from the EPA1 start codon in 
both strains. Digested DNA was separated using field inversion gel 
electrophoresis (FIGE) and the resulting Southern blot probed for EPA1 
(Fig. 61). In order to ensure specific identification of the EPA1 containing 
fragment a 416bp probe recognising the 120bp repeat regions within the 
gene was utilised. These repeats are located within the ser/thr rich region 
of EPA1 and both the protein and nucleotide sequences are specific to EPA1 
(Frieman et al., 2002, De Las Penas et al., 2003). Corroboration of probe 
specificity was achieved using NCBI blast searches with EPA1 being the 
only hit. The size of the resulting EPA1 containing fragments could then be 
compared between straLQV%*DQG&*+78Ʃ. 
5.4.2 Distance of EPA1 from the Chromosome End does not 
appear to Differ between Strains  
Using the method described above, genomic DNA agarose plugs 
were digested with either PmeI or StuI. In each instance digestions were 
performed in triplicate with 3 separate agarose plugs being digested with 
each enzyme for each strain. Due to the lack of complete sequence data in 
BG2 only a limited selection of restriction sites with known positions in both 
strains were available. There is a 19bp difference in the location of the StuI 
restriction site upstream of EPA1, ZLWKWKHVLWHLQ&*+78ƩEHLQJES
further upstream than in BG2. This difference however is too small to be 
detected with this method of gel separation and thus should not affect the 
results. The PmeI restriction site is at 7458bp and 6853bp upstream of the  
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Figure 61 ± Strategy employed to identify differences in position of the 
EPA1 ORF from the chromosome end in two strain backgrounds.   
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EPA1 VWDUW FRGRQ LQ%* DQG&* +78Ʃ UHVSHFWLYHO\ $ GLIIHUHQFH RI
605bp will thus exist irrespective of any variation in chromosome length 
telomeric to EPA1, with BG2 being 605bp longer. This difference was taken 
into account during the examination for size variation between strains. 
Previous studies have determined the effect of distance from the 
telomere on transcriptional silencing through use of URA3 insertions. Such 
analyses at the right end of chromosome E (Chr-E-R) revealed a strong 
silencing effect up to 14.8kb from the telomere with weak silencing being 
identified by a distance of 20.6kb just downstream of EPA1 (De Las Penas 
et al., 2003, Rosas-Hernandez et al., 2008). Thus across a distance of 
5.8kb silencing appears to increase from weak to strong and although not 
quantified this increase seems to be in the region of ~2.5 fold (De Las 
Penas et al., 2003). A gradient of silencing has previously been observed 
across the EPA1-3 locus (Chr E-R) and is weakened as distance from the 
telomere increases (De Las Penas et al., 2003, Rosas-Hernandez et al., 
2008). Assuming that, following the initial region of high repression 
observed at the EPA1-3 telomere, silencing decreases continuously with 
distance from the telomere, this previous data indicates a distance of 
~2.9kb may be required to see even a 25% difference in silencing 
efficiency between two sites in the region of EPA1.  
Separation of digested genomic DNA followed by Southern blot and 
probing for EPA1 suggested the gene to be a similar distance from the 
chromosome end in both strain backgrounds (Fig . 62A). Individual band 
sizes were determined using a standard curve method with mean sizes 
being generated from the triplicate digests performed for each strain. After 
accounting for the 605bp and 19bp differences in PmeI and StuI restriction 
site positions respectively band sizes exhibited by the different strain 
backgrounds were compared. The results of PmeI digestion indicated the 
BG2 EPA1 to be located ~451bp further from the telomere than EPA1 in 
&*+78Ʃ)LJB). By contrast digestion with StuI suggested EPA1 
WR EH PRUH WHORPHUH GLVWDO LQ D &* +78Ʃ EDFNJURXQG ZLWK WKH
observed fragment being ~762bp longer than the equivalent fragment in 
BG2 (Fig. 62C). These contradictory differences are rather small and may 
be indicative of the margin of error for this experimental procedure. 
Furthermore, based on data from previous studies (De Las Penas et al., 
2003, Rosas-Hernandez et al., 2008) it seems unlikely that the small size 
of the differences detected would be sufficient to have a marked effect on 
EPA1 repression.  
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Figure 62 ± (A) Field inversion gel electrophoresis (FIGE) depicting sizes of 
bands released following digestion of genomic DNA isolated in agarose plugs 
with either PmeI or Stu, IRUERWK&*+78ƩDQG%*VWUDLQEDFNJURXQGV
Fragment size was determined using a standard curve method for (B) PmeI and 
(C) Stu,GLJHVWV LQ&*+78ƩEOXHDQG%*JUHHQEDFNJURXQGV IURP
three independent experiments ± SEM.  
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5.5 Contribution of Additional Post-Translational 
Factors to Epa1 Heterogeneity 
Epa1 expression heterogeneity in a BG2 background seems to be 
regulated primarily by Sir-dependent transcriptional silencing. Such a 
strong reliance on transcriptional silencing to regulate Epa1 heterogeneity 
may mask other possible factors contributing to heterogeneity. CG2001-
Epa1-HA provides a good model in which to elucidate such additional 
factors due to the Sir-independent regulation of Epa1 heterogeneity that is 
observed in this strain. The roles of a number of potential post-
translational factors in control of Epa1 heterogeneity were thus 
investigated in CG2001-Epa1-HA.  
5.5.1 Lipid Raft Heterogeneity does not contribute to Epa1 
Heterogeneity 
Lipid Rafts have been defined as nano-scale (10-200nm) dynamic 
membrane microdomains enriched for sterols and sphingolipids (Pike, 
2006). Protein localisation to these assemblies is primarily mediated by a 
GPI anchor, acylation, or certain transmembrane domains (Lingwood et al., 
2009). Indeed GPI-anchored proteins have been found to be enriched in 
lipid rafts (Martin and Konopka, 2004, Pike, 2004, Brown and Rose, 1992). 
In addition lipid rafts are known to be highly heterogeneous, exhibiting 
heterogeneity in both their composition and distribution (Pike, 2004, 
Mishra and Joshi, 2007).  During microscopic analysis it was noted that in 
many cells Epa1-HA expression was not distributed uniformly around the 
cell surface but rather occurred in patches, suggestive of possible lipid raft 
localisation (Fig. 63). Consequently I wanted to determine whether Epa1 
was localising to lipid rafts and if heterogeneity in the distribution and 
composition of these rafts could be contributing to Epa1 heterogeneity at 
the cell surface.  
Sterols and sphingolipids constitute the major lipid raft building 
blocks and thus inhibition of these components can also inhibit the 
formation of lipid rafts. In order to determine the role of lipid raft 
heterogeneity in Epa1-HA expression heterogeneity I inhibited both 
sphingolipid and sterol biosynthesis through treatment of cells with 
myriocin and ketoconazole respectively, and analysed the effects by flow 
cytometry and fluorescence microscopy. In all instances cells were grown 
overnight in appropriately supplemented YPD medium before re-inoculation 
and further growth to exponential phase prior to analysis.  
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Figure 63 ± Visualisation of Epa1-HA cell surface expression in exponential 
phase C. glabrata cells by fluorescence microscopy following staining with anti-
HA, Alexa Fluor® 488 conjugate antibody 
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5.5.1.1 Inhibition of Sphingolipid Biosynthesis to Disrupt Lipid 
Raft Formation 
Inhibition of sphingolipid biosynthesis was achieved through the use 
of myriocin which specifically inhibits the activity of serine 
palmitoyltransferase. This enzyme catalyses the first committed stage of 
sphingolipid biosynthesis and thus depletes the intracellular pool of 
sphingolipid intermediates (Miyake et al., 1995, Martin and Konopka, 
2004). Myriocin treated yeast exhibit depleted levels of both detergent 
resistant membranes and lipid rafts (Martin and Konopka, 2004). Myriocin 
inhibits serine palmitoyltransferase at picomole concentrations (Miyake et 
al., 1995) and has been successfully used as a lipid raft inhibitor in C. 
albicans EXGGLQJ FXOWXUHV DW D ILQDO FRQFHQWUDWLRQ RI ǋ0 (Martin and 
Konopka, 2004). I found, however, that a final myriocin concentration of 
ǋ0SURYLGHGPRUHGLVWLQFWHIIHFWVZLWKRXWDIIHFWLQJJURZWKDQGZDVWKH
concentration used in this study.  
0\ULRFLQǋ0 WUHDWHGFHOOVDQDO\VHGE\anti-HA, Alexa Fluor® 488 
conjugate antibody staining and flow cytometry, actually demonstrated a 
~39% increase in cell surface Epa1-HA (Fig. 64A). This result was 
unexpected since, as mentioned above, GPI-anchored proteins are often 
localised to lipid rafts and lipid raft inhibition might be expected to 
decrease cell surface Epa1-HA. Heterogeneity of Epa1-HA expression was 
largely unaffected, with CV values of ~47 and ~45 for untreated and 
myriocin treated cells respectively (Fig. 64B). To corroborate that the 
effects of myriocin were due to inhibition of sphingolipid synthesis, cells 
were exposed to both m\ULRFLQ DQG SK\WRVSKLQJRVLQH ǋ0
Phytosphingosine is an intermediate of sphingolipid synthesis downstream 
of serine palmitoyltransferase and has previously been shown to rescue 
cells from the effects of myriocin (Martin and Konopka, 2004).  
Phytosphingosine did largely rescue cells from the effect of myriocin here, 
with cell surface Epa1-HA levels returning closer to the level in untreated 
cells (Fig. 64A). Again heterogeneity remained similar to that in untreated 
cells (Fig. 64B). Consistent with phytosphingosine specifically 
compensating for sphingolipid loss in myriocin-treated cells, when cells 
were treated with phytosphingosine alone no decrease in cell surface Epa1-
HA expression occurred (Fig. 64A).    
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Figure 64 ± Mean cell surface Epa1-HA expression (AU) (A) and heterogeneity 
(CV) (B) following treatment of CG2001-Epa1-HA cells with; myriocin (light 
green), myriocin + phytosphingosine (PS) (dark green), and phytosphingosine 
(PS) alone (dark blue) compared to untreated cells (bright blue). Cells were 
grown overnight in appropriately supplemented YPD medium before re-
inoculation and further growth to reach exponential phase. Prior to analysis by 
flow cytometry cells were stained with anti-HA, Alexa Fluor® 488 conjugate 
antibody. The differences in Epa1-HA expression and CV observed in treated 
cells compared to the untreated control cells were deemed to be either, 
significant (p=<0.05), or not significant (p=>0.05) in each case according to 
WKH 6WXGHQW¶V W-test (Materials and Methods). Data presented are means of 
independent triplicate experiments ±SEM. 
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5.5.1.2 Inhibition of Sterol Biosynthesis to disrupt Lipid Raft 
Formation 
In order to inhibit sterol biosynthesis cells were grown in the 
presence of ketoconazole. Ketoconazole belongs to the azole family of 
antifungal agents and prevents the 14-Ƚ-demethylation of lanosterol in the 
ergosterol biosynthesis pathway (Ghannoum and Rice, 1999, Odds et al., 
2003, Martin and Konopka, 2004).HWRFRQD]ROHFRQFHQWUDWLRQVRIǋ0
DQGSDUWLFXODUO\ǋ0 have previously been demonstrated to block sterol 
polarization in C. albicans hyphae. Polarization of these sterol-rich regions 
was also dependent upon sphingolipid biosynthesis. It is thus likely that 
such domains are representative of lipid rafts and indicates that the 
ketoconazole concentrations used are sufficient to inhibit lipid raft 
formation (Martin and Konopka, 2004). I discovered, however, that a final 
NHWRFRQD]ROHFRQFHQWUDWLRQRIǋ0PDUNHGO\DIIHFWHGWKHJURZWKUDWHRI
cultures which could complicate interpretation of results, so this 
concentration was not used for this study. 
Cells grown in the presence of ketoconazole were analysed by anti-
HA, Alexa Fluor® 488 conjugate antibody staining followed by flow 
cytometry. The results indicated that, similar to the myriocin data, 
NHWRFRQD]ROHǋ0WUHDWPHQWEURXJKWDERXWDaLQFUHDVHLQ(SD-
HA at the cell surface (Fig. 65A). Similarly in support of the myriocin data, 
heterogeneity was largely unaffected with CV values of ~47 and ~50 for 
untreated and treated cells respectively (Fig. 65B). Ketoconazole treatment 
is thought to be a specific inhibitor of sterol biosynthesis (Martin and 
Konopka, 2004), and the similar effects on Epa1-HA expression seen 
following myriocin treatment seem to corroborate that this antifungal agent 
is exerting its effect on Epa1-HA via inhibition of the sterol component of 
lipid rafts.    
5.5.1.3 Inhibition of both Sphingolipid and Sterol Biosynthesis 
simultaneously caused increased Epa1-HA Expression 
Lipid rafts are believed to be heterogeneous in terms not only of 
their protein composition but also their lipid composition (Mishra and Joshi, 
2007). I considered whether inhibition of both sphingolipid and sterol 
biosynthesis combined was required to exert a major effect on lipid raft 
formation. I contemplated the possibility that reduced levels of sphingolipid 
may be compensated for by increased incorporation of sterols to raft 
domains, and vice versa. Indeed myriocin treatment in yeast has been  
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Figure 65 ± Mean cell surface Epa1-HA expression (AU) (A) and heterogeneity 
(CV) (B) following treatment of CG2001-Epa1-HA cells with; ketoconazole 
(green) compared to untreated cells (blue). Cells were grown overnight in 
appropriately supplemented YPD medium before re-inoculation and further 
growth to reach exponential phase. Prior to analysis by flow cytometry cells 
were stained with anti-HA, Alexa Fluor® 488 conjugate antibody. The differences 
in Epa1-HA expression and CV observed between untreated and ketoconazole 
treated cells were deemed to be either, significant (p=<0.05), or not significant 
(p=>0.05) aFFRUGLQJ WR WKH 6WXGHQW¶V W-test (Materials and Methods). Data 
presented are means of independent triplicate experiments ±SEM. 
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linked to increased ergosterol levels (Van Leeuwen et al., 2008).   
Combined treatment of cells with both myriocin and ketoconazole, 
inhibiting both major lipid rafts components, did not elicit any decrease in 
cell surface Epa1-HA. Rather Epa1-HA was increased to a greater extent 
(~60%) than when either drug was used alone (Fig. 66A). Cell surface 
Epa1-HA CV values were again largely unaffected (Fig. 66B). 
5.5.1.4 Inhibition of Lipid Rafts does not release the Patchy 
Expression Pattern Exhibited by Epa1-HA 
Based on the above observations I considered whether or not 
inhibition of lipid raft components actually liberated Epa1 and allowed the 
GPI-anchored protein to spread across the whole cell surface rather than 
being confined to patches. Cell surface Epa1-HA expression was analysed 
E\ IOXRUHVFHQFH PLFURVFRS\ IROORZLQJ WUHDWPHQW ZLWK P\ULRFLQ ǋ0
NHWRFRQD]ROHǋRUERWK7KHREVHUYDWLRQVUHYHDOHGWKDWORFDOLVDWLRQRI
Epa1-HA at the cell surface resembled that of untreated cells despite 
addition of the sphingolipid and sterol biosynthesis inhibitors. In all cases 
Epa1-HA expression often demonstrated irregular localisation with certain 
areas exhibiting stronger fluorescence than others. Inhibition of either 
sterol or sphingolipid biosynthesis, or both, did not make this localisation 
pattern more uniform (Fig. 67A-D). 
5.5.1.5 Epa1-HA Fluorescence does not Co-localise with Filipin 
Staining in C. glabrata 
An alternative approach, other than the use of sphingolipid/sterol 
inhibitors was employed to determine if Epa1-HA is localised to lipid rafts. 
Filipin staining was used to localise regions particularly enriched for sterols 
at the plasma membrane of C. glabrata. Filipin is a fluorescent polyene 
antibiotic that specifically binds sterols. This sterol dye absorbs ultraviolet 
light at 360nm while emitting visible blue light at 480nm and has been 
used to visualise membrane sterols in diverse cell types, from mammalian 
to yeast (Wachtler et al., 2003, Beh and Rine, 2004, Martin and Konopka, 
2004, Jin et al., 2008, Van Leeuwen et al., 2008). Filipin stained cells were 
analysed by fluorescence microscopy. This indicated that the majority of 
cells exhibited uniform membrane staining (Fig. 68). Dual staining with 
both anti-HA, Alexa Fluor® 488 conjugate antibody and Filipin illustrated 
that patches of Epa1-HA fluorescence did not correspond with any sterol 
enriched areas for individual cells.   
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Figure 66 ± Mean cell surface Epa1-HA expression (AU) (A) and heterogeneity 
(CV) (B) following treatment of CG2001-Epa1-HA cells with; myriocin and 
ketoconazole (green) compared to untreated cells (blue). Cells were grown 
overnight in appropriately supplemented YPD medium before re-inoculation and 
further growth to reach exponential phase. Prior to analysis by flow cytometry 
cells were stained with anti-HA, Alexa Fluor® 488 conjugate antibody. The 
differences in Epa1-HA expression and CV observed between untreated and 
myriocin + ketoconazole treated cells were deemed to be either, significant 
(p=<0.05), or not significant (p=>0.05) according to the StuGHQW¶V W-test 
(Materials and Methods). Data presented are means of independent triplicate 
experiments ±SEM. 
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Figure 67 ± Fluorescence microscopy of Epa1-HA expression in exponential 
phase cells of the CG2001-Epa1-HA strain in untreated (A), Myriocin ǋ0
treated (B), .HWRFRQD]ROHǋ0WUHDWHG(C), and Myriocin + Ketoconazole 
treated (D) cells.  
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enriched areas for individual cells (Fig. 35) 
  
Figure 68 ± Dual Staining of CG2001-Epa1-HA with anti-HA, Alexa Fluor® 488 
conjugate antibody and Filipin to visualise Epa1-HA expression and sterol rich 
regions of the membrane simultaneously. Cells were grown to exponential 
phase in YPD medium prior to staining and then analysed by fluorescence 
microscopy. The different fluorochromes, Alexa Fluor® 488 and Filipin, were 
imaged using the FITC and DAPI filters respectively 
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C. glabrata cells predominantly exist as budding yeast blastoconidia, 
with pseudohyphal growth only being identified under conditions of limited 
nitrogen (Csank and Haynes, 2000). The uniform filipin staining observed 
for C. glabrata cells may be a consequence of their bud morphology and 
indicate a lack of obvious lipid compartmentalisation. Indeed studies in C. 
albicans revealed that both budding and pseudohyphal cells exhibited 
uniform filipin staining with distinct patches only being identified at the 
hyphal tip during this highly polarised form of growth (Martin and Konopka, 
2004).  
5.5.2 Epa1-HA Localisation does not appear Dependent on the 
Actin Cytoskeleton 
The actin cytoskeleton can become tethered to the lipid membrane 
seemingly via its interaction with proteins that bind the inner-leaflet of the 
bi-layer. Such interactions are thought to play a pivotal role in membrane 
compartmentalisation and the control of membrane raft dynamics and 
composition (Mishra and Joshi, 2007, Viola and Gupta, 2007). A role for 
actin in the polarization of lipid rafts during hyphal growth in C. albicans 
has also been demonstrated (Martin and Konopka, 2004). In addition, 
clustered GPI-anchored proteins have been suggested to associate with 
transmembrane proteins that, in-turn, interact with a membrane 
associated complex attached to the actin cytoskeleton (Suzuki and Sheetz, 
2001). Consequently I wanted to determine if actin patches show a 
localisation pattern similar to that observed for Epa1-HA. Following staining 
with Alexa Fluor 488 conjugated phalloidin (Invitrogen), which specifically 
binds actin, exponential phase cells were analysed by fluorescence 
microscopy. The microscopy photographs obtained are not completely 
clear, however, they do indicate actin patches to be rather diffuse and 
often concentrated in the bud cell. Therefore this pattern of fluorescence 
localisation did not resemble that seen for Epa1-HA (Fig. 69). This is in 
agreement with data obtained for S. cerevisiae and C. albicans whereby a 
typical actin staining pattern includes discrete patches localised to the 
surface of the growing bud or hyphae consistent with the actin 
cytoskeleton mediating polarized growth (Martin and Konopka, 2004, 
Holland and Avery, 2009).  
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Figure 69 ± Visualisation of actin patches in the CG2001-Epa1-HA strain 
background. Cells were grown to exponential phase in YPD medium and fixed 
with formaldehyde (4% v/v). Following staining with Alexa Flour 488 phalloidin 
cells were imaged by fluorescence microscopy. (A) Bright field image is shown 
on the left or (B) top with the corresponding fluorescence image on (A) the 
right or (B) bottom.  
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5.5.3 Removal of Epa1 from the Cell Surface via Yps Proteases 
does not appear to have a Role in Heterogeneity 
The YPS genes, referred to as yapsins, encode GPI-linked aspartyl 
proteases that have been identified in a number of fungi and are known to 
have roles in cell wall integrity (Krysan et al., 2005, Albrecht et al., 2006, 
Kaur et al., 2007). C. albicans populations deleted for their respective YPS 
genes (SAP9 and SAP10) demonstrate modified adhesion properties and 
reduced virulence in an in vitro model of oral infection (Albrecht et al., 
2006). The C. glabrata genome encodes a family of eleven YPS genes 
(YPS1-11) which have been identified as an important virulence trait in this 
pathogen (Kaur et al., 2007). It has been proposed that GPI-anchored cell 
wall proteins may act as substrates for these proteases and the C. glabrata 
Yps-family, in particular Yps1 and Yps7, have been implicated in the 
proteolytic processing of Epa1 to remove it from the cell wall (Kaur et al., 
2007). Due to such roles in cell wall integrity and virulence in addition to 
the proteolytic processing of Epa1, it was decided to test whether the 
action of these proteases may contribute to Epa1 heterogeneity at the cell 
surface.  
5.5.3.1 The Yps Proteins do not appear to have a Role in 
Controlling Epa1 Heterogeneity 
Previous analysis of Epa1 cell surface expression over time revealed 
expression to be highest in the hours immediately after inoculation into 
fresh medium. Expression of the protein then began to decline as cells 
progressed into stationary phase with lowest levels being observed at 10 
hours post inoculation (Kaur et al., 2007). Time-course experiments 
performed during this study and described in chapter 4 were consistent 
with those observations (Fig. 34). By contrast to wild type cells, yps(1-
11)Ʃ and yps1Ʃyps7Ʃ mutant strains, created in a BG2 background, 
maintained their Epa1 cell surface expression at maximal levels throughout 
a 10hr time-course with yps1Ʃ and yps7Ʃ single mutants demonstrating 
only a 2-fold decrease (Kaur et al., 2007).  
As Yps1 and Yps7 appear to be particularly relevant in regard to 
Epa1 regulation at the cell surface it was decided first to analyse their 
effects on Epa1-HA heterogeneity. A yps7Ʃ deletion strain, CG2001-Epa1-
HA yps7Ʃ (Materials and Methods), was analysed by flow cytometry at both 
3 hours, where Epa1 expression is high, and 10 hours, by which time Epa1 
expression normally has declined (except in ypsƩ mutants) (Kaur et al., 
2007). Expression values 3 hours post-inoculation were very similar for 
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CG2001-Epa1-HA WT and CG2001-Epa1-HA yps7Ʃ mutant strains. At 10 
hours CG2001-Epa1-HA wild type levels had declined by ~70% in both the 
wild type and yps7Ʃ mutant. The results revealed that Epa1-HA levels were 
not maintained in the CG2001-Epa1-HA yps7Ʃ mutant over and above 
those in the wild type (Fig. 70A). Similarly Epa1-HA heterogeneity also 
remained virtually unchanged in the yps7Ʃ mutant, with CV values of ~47 
(3 hours) and ~63 (10 hours) compared to the corresponding wild type 
values of ~49 and ~63 respectively (Fig. 70B).  
This analysis indicated that YPS7 deletion in a CG2001-Epa1-HA 
background was not sufficient to exert a marked effect on Epa1-HA 
expression. Therefore, and owing to the more marked effect previously 
observed in an yps1Ʃyps7Ʃ double mutant (Kaur et al., 2007) I 
constructed (Materials and Methods), and studied the effect of this double 
deletion on Epa1-HA expression and heterogeneity. Flow cytometry 
analysis at the 3 hour time-point did reveal a ~22% higher Epa1-HA level 
in the CG2001-Epa1-HA yps1Ʃyps7Ʃ mutant strain (Fig. 71A). 
Heterogeneity, as with CG2001-Epa1-HA yps7Ʃ, again remained virtually 
unaffected in the double deletion strain compared to wild type, with CV 
values of ~59 and ~57, respectively (Fig. 71B). Although Cg2001-Epa1-HA 
yps1Ʃyps7Ʃ cells continued to exhibit cell surface Epa1-HA levels higher 
than in wild type cells at the 10 hour time-point, maximal (3 hour) Epa1-
HA levels were not maintained following further growth of the mutant to 10 
hours (Fig. 71A).  Heterogeneity in the CG2001-HA yps1Ʃyps7Ʃ strain 
again remained unaffected at this later time point with a CV value (~69), 
very similar to the wild type (Fig. 71B). Thus, the results indicated that 
neither Yps1 nor Yps7 have a role in controlling Epa1-HA heterogeneity in a 
CG2001-Epa1-HA background.     
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Figure 70 ± Mean Epa1-HA level (AU) (A) and heterogeneity (CV) (B) of 
CG2001-Epa1-HA wild type (blue) and yps7Ʃ (green) strains at both 3 hours 
and 10 hours post inoculation. Cells were grown in YPD medium and analysed 
by flow cytometry following staining with anti-HA, Alexa Fluor® 488 conjugate 
antibody. Data presented are means of independent triplicate experiments 
±SEM.    
Figure 71 ± Mean Epa1-HA level (AU) (A) and heterogeneity (CV) (B) of 
CG2001-Epa1-HA wild type (blue) and yps1Ʃyps7Ʃ (green) strains at both 3 
hours and 10 hours post inoculation. Cells were grown in YPD medium and 
analysed by flow cytometry following staining with anti-HA, Alexa Fluor® 488 
conjugate antibody. The differences in Epa1-HA expression and CV observed 
between the wild type and yps1Ʃyps7Ʃ  strains at each time-point were deemed 
to be either, significant (p=<0.05), or not significant (p=>0.05) according to 
WKH6WXGHQW¶VW-test (Materials and Methods). The p values indicated correspond 
to both timepoints on their respective bar chart (A or B). Data presented are 
means of independent triplicate experiments ±SEM. 
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5.5.4 Heterogeneity in Epa1 Expression Occurs Independently 
of Total Mannoprotein Level at the Cell Surface 
The major constituents of the C. glabrata cell wall are 1,3-ǃ-glucan, 
1,6-ǃ-glucan, chitin and mannoproteins. Despite having similar cell wall 
organisation to S. cerevisiae, the mannoprotein content of C. glabrata cell 
walls is ~50% higher than that observed in either S. cerevisiae or C. 
albicans (de Groot et al., 2008). GPI-anchored proteins, such as Epa1, 
which are often heavily mannosylated during the glycosylation stage of 
their maturation process, form the largest mannoprotein group (de Nobel 
et al., 1990, Brul et al., 1997, Levitz and Specht, 2006, de Groot et al., 
2008, Lommel and Strahl, 2009). I considered whether heterogeneity 
exists generally for mannoprotein expression, and whether any such 
heterogeneity could contribute to Epa1 expression heterogeneity. 
5.5.4.1 Visualisation of Total Mannoprotein Levels and 
Comparison with Epa1-HA Expression 
Cell-to-cell variation in mannoprotein content was tested by probing 
cells with a fluorescent concanavalin-A conjugate, ConA-Alexa Fluor® 647 
(Invitrogen), which binds mannose (Biondo et al., 2005) followed by flow 
cytometry. Mannoprotein levels were shown to be markedly uniform across 
a cell population with a CV of ~30. In contrast Epa1-HA was quite 
heterogeneous (CV ~53) even in this CG2001-Epa1-HA strain. 
Furthermore, dual staining for both Epa1-HA and Con-A, utilising both anti-
HA, Alexa Fluor® 488 conjugate antibody and ConA-Alexa Fluor® 647 
respectively, revealed that the highest and lowest 13% of Epa1-HA 
expressing cells had a similar level of mannoprotein staining (Fig. 72A, B). 
The evidence indicated that there was no relationship between the Epa1-
HA and total-mannoprotein content of single cells.  
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Figure 72 ± Dual staining of CG2001-Epa1-HA for Epa1-HA expression (AU) 
with anti-HA, AlexaFluor® 488 conjugate antibody (A) and mannoprotein levels 
(AU) with ConA-Alexa Fluor® 647 conjugate (B) at the cell surface. Cells were 
grown to exponential phase prior to staining with one or both fluorescent 
conjugates. Analysis was performed by flow cytometry using FITC and APC-A 
filters to measure AlexaFluor® 488 and ConA-Alexa Fluor® 647 fluorescence 
respectively. Cells single stained with anti-HA, AlexaFluor® 488 only, and ConA-
Alexa Fluor® 647 only, were used to create compensation controls on the flow 
cytometer which account for any overlap between the two fluorochromes. High 
expressing Epa1-HA cells are shown in red while low expressing Epa1-HA cells 
are shown in blue (A). Red and blue peaks (B) represent the corresponding 
mannoprotein level for high- and low-expressing Epa1-HA cells respectively. 
The above data are representative of three independent experiments.  
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5.6 Heterogeneity of Epa1 Expression is Primarily 
Determined at the mRNA Level 
Heterogeneity in EPA1 expression is evident at both the cell surface 
protein level (Epa1-HA) and at the mRNA level (EPA1-GFP) in the BG2 
strain background. This evidence alongside such heterogeneity being Sir-
dependent strongly suggested that the variation is determined primarily at 
the mRNA level. Although CG2001-Epa1-HA does not exhibit the same 
level of heterogeneity or Sir-dependence, heterogeneity regulation could 
still occur at the transcriptional level. Indeed with a number of post-
translational factors being ruled out in section 5.5 regulation at the mRNA 
level seems plausible even in this strain. I wanted to corroborate that 
regulation occurs at the mRNA level in both strains, by testing whether the 
level of transcript directly correlates with the heterogeneous amount of 
Epa1-HA at the cell surfaces of individual cells.  
5.6.1 Epa1 Cell Surface Expression Level Correlates with EPA1 
Transcript Level 
In order to test whether EPA1 transcript level is directly correlated 
to expression of Epa1 protein at the cell surface, cells from each strain 
were sorted into high- and low-Epa1-HA expressing subpopulations. 
Initially exponential phase cells were stained using anti-HA, AlexaFluor® 
488 conjugate antibody, sorting of the highest and lowest 13% Epa1-HA 
expressing subpopulations was then performed by flow cytometry 
fluorescence-activated cell sorting (FACS). Extraction of RNA from these 
sub-populations followed by qRT-PCR allowed the level of transcript to be 
related to the level of Epa1-HA protein at the cell surface in individual cells. 
The results illustrated that cells with high levels of Epa1-HA at their cell 
surface also exhibited a higher level of EPA1 transcript than low Epa1-HA 
expressing cells. This was true for both BG2-Epa1-HA and CG2001-Epa1-
HA strains (Fig. 73). The greater heterogeneity of Epa1-HA in BG2-Epa1-
HA was illustrated by a ~7-fold increase in EPA1 mRNA from low to high 
Epa1-HA cells, compared to an increase of almost half this in CG2001-
Epa1-HA. These results demonstrated that transcript level is directly 
related to cell surface protein level and support the suggestion that Epa1-
HA expression heterogeneity is controlled at the mRNA level in both strain 
backgrounds.   
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Figure 73 ± Correlation between Epa1-HA protein and EPA1 mRNA levels of 
individual C. glabrata (A) BG2-Epa1-HA and (B) CG2001-Epa1-HA cells. 
Exponential phase cells grown in YPD medium were gated and sorted by FACS, 
according to Epa1-HA expression level (as indicated with anti-HA, Alexa Fluor® 
488 conjugate antibody). The gates shown were set to sort cells within the 
same forward scatter (cell size) range. RNA was isolated from ~1 x 106 cells of 
the high- (blue) and the low-Epa1-HA (green) expressing subpopulations, and 
EPA1 mRNA was quantified with qRT-PCR using standardized cDNA additions in 
all reactions. The data shown are means from three independent experiments 
(each analysed in triplicate) ± SEM. 
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5.7 Analysis of the EPA1 Promoter 
The data presented thus far suggest that Epa1-HA heterogeneity in 
both tested strain backgrounds is controlled at the mRNA level. With BG2-
Epa1-HA, the predominant form of transcriptional EPA1 regulation is 
mediated by Sir-regulated silencing. This however is not the case for 
CG2001-Epa1-HA. Additional factors such as the binding of activators or 
other repressors to the EPA1 promoter may also contribute to Epa1-HA 
heterogeneity. For instance FLO11 expression in S. cerevisiae appears to 
be both position and promoter dependent (Halme et al., 2004). Regulation 
from the promoter may be particularly important in the CG2001-Epa1-HA 
background, where Sir-dependent silencing seems less influential. 
Promoter analysis was therefore performed in order to identify any possible 
binding sites that may impact on EPA1 expression.     
5.7.1 The EPA1 Predicted Promoter Region Contains an 
Alpha2-Repressor Consensus Sequence 
It was decided to characterise the likely EPA1 promoter region, 
performing a bioinformatic analysis to ascertain the location of any putative 
transcription factor binding sites. A predicted promoter region was located 
at 73bp-122bp upstream of the EPA1 start codon using the BGDP Neural 
Network Promoter Prediction (NNPP) version 2.2 tool for Eukaryotes 
(Reese, 2001) (http://www.fruitfly.org/seq_tools/promoter.html). The 
promoter sequence identified was identical in both strain backgrounds. 
Analysis of this predicted promoter region using the S. cerevisiae promoter 
data base (Zhu and Zhang, 1999), which has previously been applied to C. 
glabrata (Srikantha et al., 2003), revealed a MATalpha2 and a Gcn4 
consensus sequence within the identified promoter region. Gcn4 has a role 
in the activation of amino acid biosynthetic genes in response to amino 
acid starvation (Hinnebusch and Natarajan, 2002). Epa1 has not been 
identified in such processes. Furthermore as discussed in section 5.2.2 
nutrient starvation in the form of nitrogen limitation appeared to have no 
marked effect on Epa1-HA expression. Consequently, efforts were focused 
on identifying a possible role for C. glabrata Alpha-2 in EPA1 regulation.     
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5.7.2 Alpha2 Repressor Level appears not to Control EPA1 
Expression 
In S. cerevisiae Ƚ2 functions as a repressor and is able to repress a-
specific genes within alpha cells and thus aid in mating type regulation 
(Herskowitz, 1989, Zhong et al., 1999). Three mating type loci similar to 
the MAT, HML and HMR loci in S. cerevisiae have been identified in C. 
glabrata and termed MTL1, MTL2 and MTL3. C. glabrata has also been 
shown to maintain distinct a and Ƚ mating types despite no observable 
sexual cycle (Srikantha et al., 2003, Muller et al., 2008). In addition, S. 
cerevisiae genes known to be repressed by the a1/Ƚ2 repressor are 
decreased in SIR2, SIR3, and SIR4 mutants (Wyrick et al., 1999). This 
may also implicate the repressor in regulation of Epa1 in the CG2001-
Epa1-HA strain background, where decreased Epa1-HA expression is 
observed when Sir activity is inhibited. The two predominant strain 
EDFNJURXQGV XVHG LQ WKLV VWXG\ &* +78Ʃ DQG %* KDYH EHHQ
identified as mating  type Ƚ and a respectively (Muller et al., 2008, 
Ramirez-Zavaleta et al., 2010). Based on the evidence discussed above 
and provided by the promoter analysis it was postulated that any variation 
in Ƚ2 repressor levels may contribute to Epa1-HA heterogeneity, 
particularly in strain CG2001-Epa1-HA. 
 In order to characterise potential variation in the levels of Ƚ2 
transcript in relation to Epa1 expression, cells were sorted by flow 
cytometry FACS according to Epa1-HA level and RNA extracted from these 
sorted cells was used for qRT-PCR (as described in 5.6.1). If Ƚ2 was indeed 
a direct repressor of EPA1, with the extent of repression being linked to Ƚ2 
mRNA expression, we would expect higher levels of Ƚ2 mRNA to be present 
in low Epa1-HA expressing cells, and vice versa. However, the analysis 
revealed that CG2001-Epa1-HA cells expressing low Epa1-HA also 
demonstrated lower levels of Ƚ2 mRNA compared to those of for high 
Epa1-HA expressing cells (Fig. 74). Thus, Ƚ2 expression does not correlate 
with Epa1 repression suggesting that the repressor may not be responsible 
for controlling Epa1 expression and heterogeneity. Since Ƚ2 transcript 
levels were actually found to positively correlate with Epa1-HA expression 
it is possible that the repressor may act on an alternative EPA1 repressor 
to affect expression of the adhesin indirectly. However, the promoter 
analysis did not reveal any obvious candidates. Furthermore if such a  
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Figure 74 ± Correlation between Epa1-HA protein and Ƚ2 mRNA levels of 
individual C. glabrata CG2001-Epa1-HA cells. Exponential phase cells 
grown in YPD medium were gated and sorted by FACS, according to Epa1-
HA expression level (as indicated with anti-HA, Alexa Fluor® 488 conjugate 
antibody). Cells were sorted within the same forward scatter (cell size) 
range. RNA was isolated from ~1 x 106 cells of the high- (blue) and the 
low-Epa1-HA (green) expressing subpopulations, and Ƚ2 mRNA was 
quantified with qRT-PCR using standardized cDNA additions in all reactions. 
The data shown are means from three independent experiments (each 
analysed in triplicate) ± SEM. 
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mechanism did exist, loss of silencing, known to de-repress silent Ƚ2 in C. 
glabrata (Ramirez-Zavaleta et al., 2010), may be expected to increase 
Epa1-HA expression in CG2001-Epa1-HA cells, however, the opposite is 
seen. Not surprisingly, Ƚ2 transcript could not be detected in sorted BG2-
Epa1-HA cells owing to the a-mating type of this strain, although leakiness 
in Ƚ2 expression has been inferred (Ramirez-Zavaleta et al., 2010). 
 
5.8 Alignments of EPA1 Sequence from Two Strain 
Backgrounds   
In order to substantiate that differences in Epa1 regulation between 
the two C. glabrata strains are not due to sequence differences in and 
around the EPA1 ORF, sequence alignments were performed using the 
NCBI Blast Alignment tool. EPA1 is the same length in both strains and 
alignment revealed only 14bp to be different between the two genes. These 
differences corresponded to nine amino acid substitutions throughout the 
length of the translated protein with four of these substitutions being to 
amino acids which are chemically similar in each strain (Fig. 75). None of 
the changes are in the region of the GPI-anchor, which begins at residue 
1010, nor are they present in the N-terminal domain (amino acids 1-332) 
which mediates ligand binding (Frieman et al., 2002). Consequently, such 
changes would not be expected to affect either ligand binding or, more 
importantly in terms of cell surface expression, attachment to the cell wall. 
Rather, amino acid substitutions were located in the C-terminal Ser/Thr 
rich domain. This region has been identified as important in the projection 
of Epa1 out from the cell wall, with changes in the length of this region 
leading to altered detection at the cell surface (Frieman et al., 2002). 
However since the proteins from each strain remain the same length such 
an effect is unlikely to create differences between our two strains and does 
not explain any differences in transcriptional regulation observed. 
Furthermore, differences in heterogeneity were seen with Epa1-HA in each 
strain: the Epa1-HA construct was derived from plasmid pMS15 for both 
strains, and therefore the sequence was the same. Upstream and 
downstream nucleotide sequences were also found to be highly similar 
between native EPA1 the two strains. Alignments demonstrated that 501bp 
of upstream sequence had 99% sequence identity between the two strains 
with 288bp upstream of the EPA1 start codon, encompassing the predicted 
promoter region, being 100% identical. The sequence up to 501bp down-   
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ATCC2001  1     MILNPALFLNKCVCIYTTLILLLLTNGGYATSSNDISLASKDPTTFPLGCSPDITTPKKG  60 
                MILNPALFLNKCVCIYTTLILLLLTNGGYATSSNDISLASKDPTTFPLGCSPDITTPKKG 
BG2       1     MILNPALFLNKCVCIYTTLILLLLTNGGYATSSNDISLASKDPTTFPLGCSPDITTPKKG  60 
 
ATCC2001  61    LSMELYSYDFRKKGSYPCWDAAYLDPNYPRTGYKSHRLLAKVDGVTGNINFYYHATKGCT  120 
                LSMELYSYDFRKKGSYPCWDAAYLDPNYPRTGYKSHRLLAKVDGVTGNINFYYHATKGCT 
BG2       61    LSMELYSYDFRKKGSYPCWDAAYLDPNYPRTGYKSHRLLAKVDGVTGNINFYYHATKGCT  120 
 
ATCC2001  121   PQLGHLPASYNYPKPLTMTNFTMLLYGYFRPKVTGFHTFTISADDLLFVNFGAGNAFDCC  180 
                PQLGHLPASYNYPKPLTMTNFTMLLYGYFRPKVTGFHTFTISADDLLFVNFGAGNAFDCC 
BG2       121   PQLGHLPASYNYPKPLTMTNFTMLLYGYFRPKVTGFHTFTISADDLLFVNFGAGNAFDCC  180 
 
ATCC2001  181   RRDSSADHFGNYQAYAIWGSKTAKDELTVHLDAGVYYPIRLFYNNREYDGALSFTFKTES  240 
                RRDSSADHFGNYQAYAIWGSKTAKDELTVHLDAGVYYPIRLFYNNREYDGALSFTFKTES 
BG2       181   RRDSSADHFGNYQAYAIWGSKTAKDELTVHLDAGVYYPIRLFYNNREYDGALSFTFKTES  240 
 
ATCC2001  241   NENTVSDFSEYFFSLDDTEEGCPGLISYDSSCASVKTSKIIGIDYHTETPNENLVPITKT  300 
                NENTVSDFSEYFFSLDDTEEGCPGLISYDSSCASVKTSKIIGIDYHTETPNENLVPITKT 
BG2       241   NENTVSDFSEYFFSLDDTEEGCPGLISYDSSCASVKTSKIIGIDYHTETPNENLVPITKT  300 
 
ATCC2001  301   IYHLGIPCTGTTTTPLCGSGFYDPLANKCVTINTSSTSSVTKTTSHTTSKEVSFHSSISS  360 
                IYHLGIPCTGTTTTPLCGSGFYDPLANKCVTINTSSTSSVTKTTSHTTSKEVSFHSSISS 
BG2       301   IYHLGIPCTGTTTTPLCGSGFYDPLANKCVTINTSSTSSVTKTTSHTTSKEVSFHSSISS  360 
 
ATCC2001  361   QKTLIPKSIPSPYGPIKSQSIPTEMETSSEISSSEYAFSDVISTPSHSPYTKKHSSLNSS  420 
                QKTLIPKSIPSPYGPIKSQSIPTEMETSSEISSSEYAFSDVISTPSHSPYTKKHSSLNSS 
BG2       361   QKTLIPKSIPSPYGPIKSQSIPTEMETSSEISSSEYAFSDVISTPSHSPYTKKHSSLNSS  420 
 
ATCC2001  421   SYTSTVIHSLTSYSISQGIFSTSLSEQNITSKSSTDKFSTATSMSNSITQSSIIISQSST  480 
                SYTSTVIHSLTSYSISQGIFSTSLSEQNITSKSSTDKFSTATSMSN+ITQSSIIISQ ST 
BG2       421   SYTSTVIHSLTSYSISQGIFSTSLSEQNITSKSSTDKFSTATSMSNNITQSSIIISQFST  480 
 
ATCC2001  481   NNENYTTTSMHTSSDKISTETLNNSISTTTSILFSNSSTILKNNTTIISSDKDTHYHPVN  540 
                NNENYTTTSMHTSSDKISTETLNNSISTTTSILFSNSSTILKNNTTIISSDKDTHYHPVN 
BG2       481   NNENYTTTSMHTSSDKISTETLNNSISTTTSILFSNSSTILKNNTTIISSDKDTHYHPVN  540 
 
ATCC2001  541   PTIVCSTNKTEIICASITQPSISNSNNHWSSSVLRFNSTTVRSTLPSSAGSNETSINVPF  600 
                PTIVCSTNKTEIICASITQPSISNSNNHWSSSVL+FNSTTVRSTLPSSAGSNETSINVPF 
BG2       541   PTIVCSTNKTEIICASITQPSISNSNNHWSSSVLKFNSTTVRSTLPSSAGSNETSINVPF  600 
 
ATCC2001  601   SSSTESNASTSSTSTSNSKTVRSTLPSSAGSNETSINVPFSSSTESNTSTSSTSTSNSKT  660 
                SSSTESN STSSTSTSNSK VRSTLPSSAGSNETSI+VPFSSSTESNTSTSSTSTSNSK  
BG2       601   SSSTESNTSTSSTSTSNSKMVRSTLPSSAGSNETSISVPFSSSTESNTSTSSTSTSNSKM  660 
 
ATCC2001  661   VRSTLPSSAGSNETSINVPFSSSTESNASTSSTSTSNSKTVRSTPFSSAGIIMTSLSQRN  720 
                VRSTLPSSAGSNETSINVPFSSSTESN STSSTSTSNSKTVRSTPFSSAGIIMTSLSQRN 
BG2       661   VRSTLPSSAGSNETSINVPFSSSTESNTSTSSTSTSNSKTVRSTPFSSAGIIMTSLSQRN  720 
 
ATCC2001  721   NKSASSYASSNSKCYNTADSCRKVHSTPSYLLTSSYTSEGVDYDCSLVSTKLKINDTNCL  780 
                NKSASSYASSNSKCYNTADSCRKVHSTPSYLLTSSYTSEGVDYDCSLVSTKLKINDTNC+ 
BG2       721   NKSASSYASSNSKCYNTADSCRKVHSTPSYLLTSSYTSEGVDYDCSLVSTKLKINDTNCV  780 
 
ATCC2001  781   NNKHTTKSCLKTSVTTTIPTLEIKTARKSSSNTIGLHSYPTSSPNKSISSAPIIGYISSF  840 
                NNKHTTKSCLKTSVTTTIPTLEIKTARKSSSNTIGLHSYPTSSPNKSISSAPIIGYISSF 
BG2       781   NNKHTTKSCLKTSVTTTIPTLEIKTARKSSSNTIGLHSYPTSSPNKSISSAPIIGYISSF  840 
 
ATCC2001  841   KTIKTASPSYQTSDLTTITTITSLNNPGSTAVENTHESNDKSRKTSSNDISSKHSVIKET  900 
                KTIKTASPSYQTSDLTTITTITSLNNPGSTAVENTHESNDKSRKTSSNDISSKHSVIKET 
BG2       841   KTIKTASPSYQTSDLTTITTITSLNNPGSTAVENTHESNDKSRKTSSNDISSKHSVIKET  900 
 
ATCC2001  901   KDAVESSNKSHQTNTLKCSSIIIASSSHNSYESLGGTTLTLTLSKVYSPQNNDTLPFLEI  960 
                KDAVESSNKSHQTNTLKCSSIIIASSSHNSYESLGGTTLTLTLSKVYSPQNNDTLPFLEI 
BG2       901   KDAVESSNKSHQTNTLKCSSIIIASSSHNSYESLGGTTLTLTLSKVYSPQNNDTLPFLEI  960 
 
ATCC2001  961   SEVNPSRTVLPESSKMMQYLTSTEERNKTARNTIATNIVSISTFHFEGEGNAIRMGYTQL  1020 
                SEVNPSRTVLPESSKMMQYLTSTEERNKTARNTIATNIVSISTFHFEGEGNAIRMGYTQL 
BG2       961   SEVNPSRTVLPESSKMMQYLTSTEERNKTARNTIATNIVSISTFHFEGEGNAIRMGYTQL  1020 
 
ATCC2001  1021  LLMLIGIIVMNIGT  1034 
                LLMLIGIIVMNIGT 
BG2       1021  LLMLIGIIVMNIGT  1034 
 
Figure 75 ± Protein alignment of Epa1 from ATCC2001 (top) and BG2 (bottom). 
$PLQRDFLGGLIIHUHQFHVDUHKLJKOLJKWHGLQUHGZLWKDµ¶LQGLFDWLQJDFKDQJHWRD
chemically similar amino acid.  
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-stream of the EPA1 ORF was also 99% identical between the two strains. 
 
5.9 Regulation of Other EPA Genes Relative to Epa1-
HA 
The hypothesis that different EPA genes may be expressed at 
different times during infection (De Las Penas et al., 2003, Castano et al., 
2005) led me to question whether this could reflect heterogeneity exhibited 
by cells, pre-infection, in order for subpopulations to be pre-equipped for 
VXUYLYDODWDQ\ORFDWLRQ,QWKLVFDVH³SUH-DGRSWHG´VXESRSXODWLRQVZRXOd 
EH ³VHOHFWHG´ RQ DUULYDO DW WKH VSHFLILF KRVW QLFKH UDWKHU WKDQ UHJXODWLRQ
occurring as a response. It may be that cells demonstrating low levels of 
Epa1 show high expression of other Epa adhesins and vice versa. Epa 
proteins have been shown to confer distinct cell surface properties 
(Zupancic et al., 2008) and heterogeneity generation could be a way of 
creating subpopulations of cells within the larger population that are 
primed for infection at specific sites.  
5.9.1 EPA6 and EPA7 mRNA Levels are Correlated with Cell 
Surface Epa1-HA Expression  
In order to test the hypothesis, cells that had been sorted by flow 
cytometry FACS according to their Epa1-HA expression were analysed for 
expression of EPA6 and EPA7 by qRT-PCR (as described in 5.6.1). Such 
analysis therefore allows a direct comparison between the level of Epa1 at 
the cell surface and the corresponding expression of additional EPA genes 
in the same cells. This analysis revealed that EPA6 and EPA7 mRNA 
expression correlated with cell surface Epa1-HA for both BG2-Epa1-HA and 
CG2001-Epa1-HA (Fig. 76). Although this method of analysis does not give 
a direct measure of heterogeneity the differences between high and low 
values may give an idea of what heterogeneity could exist. EPA6 and EPA7 
transcription varies ~17 fold and ~6 fold, respectively, between low-Epa1-
HA and high-Epa1-HA cells of the BG2-Epa1-HA strain. In comparison the 
differences were smaller (~3 fold for both genes) in CG2001-Epa1-HA. This 
is similar to the difference measured for EPA1 mRNA in such sorted cells 
(section 5.6.1). This may indicate higher levels of heterogeneity also for 
EPA6 and EPA7 in the BG2-Epa1-HA background. As a comparison, qRT-
PCR for ACT1 was also performed on sorted populations. Expression levels 
also appeared to be correlated to the Epa1-HA expression level, possibly  
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Figure 76 ± Correlation between Epa1-HA protein and EPA6 and EPA7 mRNA 
levels of individual C. glabrata (A) BG2-Epa1-HA and (B) CG2001-Epa1-HA 
cells. Exponential phase cells grown in YPD medium were gated and sorted by 
FACS, according to Epa1-HA expression level (as indicated with anti-HA, Alexa 
Fluor® 488 conjugate antibody). Cells were sorted within the same forward 
scatter (cell size) range. RNA was isolated from ~1 x 106 cells of the high- 
(blue) and the low-Epa1-HA (green) expressing subpopulations, and EPA6 (left) 
and EPA7 (right) mRNA was quantified with qRT-PCR using standardized cDNA 
additions in all reactions. The data shown are means from three independent 
experiments (each analysed in triplicate) ± SEM. 
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suggesting a more global effect on transcription that is not simply limited 
to the EPA genes. The variation in ACT1 expression across low- to high- 
Epa1 expressing cells was ~2 fold and ~3 fold for CG2001-Epa1-HA and 
BG2-Epa1-HA, respectively. This was less than the differences seen for 
EPA6 and EPA7 mRNA between low- and high-Epa1 expressing cells for the 
respective strains. It is possible that the differences seen for ACT1 may be 
indicative of the margin of error for the experiment, for instance loading 
differences and are thus artifactual. 
5.9.2 Sir-Regulated Transcriptional Silencing of Additional EPA 
Genes  
Results described earlier demonstrated an apparent difference in the 
dependence of EPA1 expression and heterogeneity on Sir-regulated 
transcriptional silencing according to strain background. In order to 
determine if this difference also applied to additional EPA genes the 
expression of EPA6 and EPA7 was measured by qRT-PCR under conditions 
RI µVWDQGDUG¶ and limited silencing for both strain backgrounds by limiting 
growth medium for NA (as described in section 5.3.3.1). This analysis was 
also performed in the CG2001-Epa1-HA sir3Ʃ strain in order to corroborate 
results obtained via NA limitation.  
 In the BG2 strain, data for both EPA6 and EPA7 agreed with the 
effect on EPA1, in that expression of both genes increased upon limitation 
of silencing (Fig. 77). IQ WKH &* +78Ʃ VWUDLQ E\ FRQWUDVW DOWKRXJK
EPA6 mRNA decreased upon loss of silencing by both limited NA and SIR3 
deletion, as is also seen for EPA1 in this strain, EPA7 expression was 
increased in both instances (Fig. 78). Thus for the latter strain at least 
these results indicate that different EPA genes within the same strain may 
depend to different extents on regulation by Sir-dependent transcriptional 
silencing. Indeed analysis of more EPA genes may reveal this also to be the 
case in the BG2 background.  
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Figure 77 ± EPA6 (left) and EPA7 (right) mRNA levels in BG2 following NA 
limitation to inhibit transcriptional silencing. Cells were grown overnight in SC 
medium containing either 100% NA (blue) or 5% NA (green) before re-
inoculation into the appropriate fresh SC medium and growth to exponential 
phase. RNA was extracted from ~1x107 cells grown under the relevant 
condition, and EPA6 and EPA7 mRNA quantified using standardised cDNA 
additions in all reactions. The data shown are means from three independent 
experiments (each analysed in triplicate) ±SEM. 
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Figure 78 ± EPA6 (left) and EPA7 (right) mRNA levels in (A) CG2001-Epa1-
HA (blue) and CG2001-Epa1-HA sir3Ʃ (green) cells grown to exponential phase 
in YPD and (B) &* +78Ʃ FHOOV following NA limitation to inhibit 
transcriptional silencing. Cells were grown overnight in SC medium containing 
either 100% NA (blue) or 5% NA (green) before re-inoculation into the 
appropriate fresh SC medium and growth to exponential phase. (A, B) RNA was 
extracted from ~1x107 cells grown under the relevant condition, and EPA6 and 
EPA7 mRNA quantified using standardised cDNA additions in all reactions. The 
data shown are means from three independent experiments (each analysed in 
triplicate) ±SEM. 
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5.10 Discussion 
During the course of the study described in this chapter, the 
contribution of various factors to Epa1 expression were studied in order to 
elucidate possible sources of cell-to-cell heterogeneity in expression of this 
adhesin. During the process of host infection, pathogens may encounter a 
wide range of host niches and therefore environmental conditions can be 
highly variable. The effect of several virulence related conditions on Epa1 
expression and heterogeneity were thus analysed; these included 
temperature, nitrogen limitation and ambient pH. Analyses demonstrated 
all three environmental conditions to have a greater effect on Epa1 
expression in the CG2001-Epa1-HA strain, which has lower heterogeneity 
than the BG2-Epa1-HA strain. However the effects were relatively small. 
Heterogeneity was minimally affected by the environmental variables for 
both strains, particularly BG2-Epa1-HA. In CG2001-Epa1-HA, temperature 
change and pH evoked the most marked effect on Epa1-HA expression and 
heterogeneity.  
In the case of ambient pH, CG2001-Epa1-HA exhibited the highest 
Epa1 expression and lowest heterogeneity at pH4. This acidic pH relates to 
the highly specific niche of the vaginal cavity and C. glabrata is known to 
be well adapted for colonisation in this environment (Schmidt et al., 2008, 
Davis, 2009). An attractive hypothesis is that different Epa1 proteins are 
expressed at different points during infection, possibly driven by signals 
associated with different host niches (De Las Penas et al., 2003, Castano et 
al., 2005). It may also be possible that heterogeneity occurs to different 
extents within the host as a survival mechanism. For example cells 
expressing low levels of Epa1 may be better adapted to disseminated blood 
stream infection, where adhesion may not be of primary importance, and 
avoidance of the immune system, possibly due to lower levels of 
immunogenic proteins at the pathogen surface. High expression on the 
other hand may be required when mucosal surfaces are encountered. 
Heterogeneity may allow C. glabrata populations to establish infection at 
any niche in addition to becoming systemic. As such the acidic pH of the 
vaginal cavity may serve as a useful signal identifying this particular niche 
as a specific site where adhesion is required causing reduced 
heterogeneity. By contrast growth pHs of 7.4 and 8, which represent a 
much broader range of host niches, did exhibit higher levels of 
heterogeneity.   
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Increasing growth temperature to that of mammalian hosts (37°C) 
has been linked to increased cell surface hydrophobicity in a number of C. 
glabrata isolates. This is thought to influence the adhesion properties of 
cells and be an indicator of increased adhesin incorporation at the cell wall 
(Hazen et al., 1986, Ishigami et al., 2006, de Groot et al., 2008). 
Increased Epa1-HA expression in CG2001-Epa1-HA, identified in this study, 
at 37°C is in agreement with increased incorporation of adhesins at the 
higher temperature, however this did not coincide with increased adhesion. 
It may be worth noting that Epa1-HA levels in CG2001-Epa1-HA are 
already high when compared to the BG2 background even when cells are 
grown at 30°C, indeed this strain has previously been shown to possess 
high cell surface hydrophobicity (de Groot et al., 2008). Consequently 
maximal adhesion to Hep2 epithelial cells may already be achieved at the 
lower temperature for this strain.  
The relative lack of environmental effects on Epa1-HA expression in 
BG2-Epa1-HA, compared to CG2001-Epa1-HA, may not be completely 
unexpected in that different isolates of C. glabrata have been shown to 
react differently to the same growth conditions (Hazen et al., 1986, Luo 
and Samaranayake, 2002). In addition the present study has shown Epa1-
HA expression and heterogeneity in BG2-Epa1-HA to be heavily dependent 
upon Sir-mediated transcriptional silencing. It may be logical to suggest 
that regulation exerted by the transcriptional silencing machinery could be 
sufficient to mask major environmental effects on Epa1 expression 
heterogeneity. In S. cerevisiae increased temperature has in fact been 
shown to increase transcriptional silencing at telomeres (Bi et al., 2004). 
Since transcriptional silencing is already active in BG2-Epa1-HA no 
additional silencing effect may be created by increased temperature. It is 
also possible that the active silencing in BG2-Epa1-HA, in addition to any 
increased silencing at 37°C, could simply counteract any increased 
expression induced directly by a switch in temperature. However, based on 
results observed for CG2001-Epa1-HA (which lacks EPA1 silencing), where 
only a small increase in Epa1-HA expression is observed, any hidden 
effects would likely be minimal.  
Increased Epa1-HA expression following the temperature shift in 
CG2001-Epa1-HA could be connected to an increase in silencing since 
inhibition of silencing in this strain results in a slight decrease in Epa1-HA 
expression. Introduction of an extra copy of SIR3, however, actually 
caused increased silencing. Nevertheless increased silencing seen in S. 
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cerevisiae at 37°C is not brought about by alterations in SIR3 expression. 
Rather, it was hypothesised that altered thermodynamics drive increased 
Sir-nucleosome and Sir-Sir interactions (Bi et al., 2004). Such effects may 
not be sufficient to facilitate silencing of EPA1 in CG2001-Epa1-HA cells 
grown at 37°C. By contrast, increasing the total level of SIR3, by 
introduction of an extra copy, may be sufficient to induce silencing of EPA1 
in this strain background. Sir3 overexpression is known to facilitate the 
spread of silent chromatin (Renauld et al., 1993, Talbert and Henikoff, 
2006). Consequently ectopic expression of SIR3 likely affects Sir-complex 
formation and spreading. This may be particularly pertinent to EPA1 which 
resides at >20kb from the chromosome end. Thus, addition of this second 
copy of SIR3 did bring observable Epa1 expression more in line with that 
seen for BG2-Epa1-HA, in which silencing appeared to be more efficient. 
 Although above results would be consistent with EPA1 residing at a 
position closer to the telomere in strain BG2-Epa1-HA than in CG2001-
Epa1-HA, any marked difference in the distance of EPA1 from the 
chromosome end between the two tested strain backgrounds could not be 
identified. Indeed, based on previous literature (De Las Penas et al., 2003, 
Rosas-Hernandez et al., 2008) it was estimated that an approximate size 
difference of ~2.9kb would be needed to see even a 25% alteration in 
transcriptional silencing at the EPA1 locus. Nonetheless, small differences 
were detected, with EPA1 in BG2 estimated to be ~451bp further from the 
telomere DQG aES FORVHU WR WKH WHORPHUH WKDQ LWV &* +78Ʃ
counterpart following PmeI and StuI digestion, respectively. Given the 
relatively small size differences compared to the total fragment sizes being 
measured and distances required to see an effect, in addition to their 
contradictory estimations, it is possible that they may be indicative of the 
margin of error for this experimental procedure. Lack of large size 
difference is consistent with insertion, deletion or recombination events 
within regions between EPA1 and the telomere not being responsible for 
the altered Sir-dependency observed in the two strains. In addition 
alignment of EPA1 between the two strains revealed them to be highly 
similar, and identical in length. EPA1 in these two particular strains was 
already known to contain the same number of 120bp minisatellite repeats 
(Thierry et al., 2008). Furthermore, studies have revealed no marked size 
difference in chromosome E, on which EPA1 resides, between a large 
number of C. glabrata strains (Muller et al., 2009).  Thus, other factors are 
likely necessary to reduce the efficiency of EPA1 transcriptional silencing in 
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CG2001-Epa1-HA. Such other factors did not include decreased levels of 
SIR3 WUDQVFULSWZKLFKZHUH DFWXDOO\ KLJKHU LQ &* +78Ʃ WKDQ LQ WKH
BG2 strain background where silencing was more efficient. It has also been 
shown elsewhere that the level of observable silencing is not necessarily 
related to the level of Sir transcript or protein (Bi et al., 2004). Taking 
these results in to account, silencing of EPA1 in CG2001-Epa1-HA may be 
due to inefficient propagation of silencing out towards the EPA1 locus. A 
genome wide screen in S. cerevisiae identified a number of negative 
regulators which were able to antagonize the spread of Sir activity (Raisner 
and Madhani, 2008). Such regulators could be one important factor for 
reduced silencing of EPA1 in CG2001-Epa1-HA, suppressible by SIR3 over-
expression. Along similar lines, heterogeneity in expression of such 
negative regulators could also have a role in controlling the heterogeneous 
Epa1 silencing observed for BG2-Epa11-HA. It is possible that the higher 
SIR3 mRNA levels recorded in a CG2001-Epa1-HA background represent a 
response of this strain to compensate, albeit inefficiently, for any reduction 
in the spread of silenced chromatin.   
The role of transcriptional silencing in EPA1 regulation was not only 
found to differ between the two predominant strains of this study; CG2001-
Epa1-HA and BG2-Epa1-HA, but also between a number of clinical C. 
glabrata isolates thus demonstrating inter-strain variation of Sir-
dependency of EPA1 heterogeneity. Epa1 expression in CG2001-Epa1-HA 
was affected by a loss of transcriptional silencing only in that there was a 
decrease in overall expression; heterogeneity was unaffected. The 
decrease observed, particularly since discounting a direct effect of the Ƚ2 
repressor, could represent a decrease in the level of available 
transcriptional machinery due to de-repression of previously silenced 
genes. By contrast Epa1 expression in BG2 was markedly increased by a 
reduction in transcriptional silencing. This resulted in decreased 
heterogeneity due to loss of the low expressing population of cells. 
Although the method of analysis used to determine the role of silencing in 
a number of clinical isolates by nicotinic acid limitation did not enable 
comparison of heterogeneity levels, it did enable identification of three 
distinct groups. 1) EPA1 is subject to transcriptional silencing which is 
released upon inhibition of silencing (BG2-like), 2) Inhibition of silencing 
has no marked effect on EPA1 expression, and 3) EPA1 expression 
GHFUHDVHV ZKHQ VLOHQFLQJ LV LQKLELWHG &* +78Ʃ-like). Such results 
underscore the propensity of different C. glabrata isolates to react 
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differently to the same stimulus (Hazen et al., 1986, Luo and 
Samaranayake, 2002). Furthermore, this study identified the Sir-
dependency of EPA1 expression to be correlated with Epa1 cell surface 
heterogeneity in these isolates being greatest in cells subject to silencing 
(BG2-like). The analyses did not suggest that the role of Sir-dependent 
silencing in EPA1 regulation was related to the source of each isolate. 
Isolates sourced from the same human niche exhibited different 
dependencies on transcriptional silencing in EPA1 regulation. Previous 
studies in C. albicans have indicated, with the exception of increased ALS4 
in vaginal specimens, that ALS transcriptional activity is relatively 
consistent despite the location from which specimens were collected (Hoyer 
et al., 2008). Rather than the most appropriate adhesin being expressed at 
a particular host site in response to environmental cues this indicated the 
presence of multiple adhesins at each niche (Hoyer et al., 2008). This could 
be consistent with a greater relative role for cell-to-cell heterogeneity in 
host infection.  
It was found that, however, although EPA1 expression in CG2001 
+78ƩLVQRWKHDYLO\UHOLDnt on Sir-mediated transcriptional silencing, EPA7 
within this strain is. Upon inhibition of silencing, expression of EPA7 was 
markedly increased, much in the same way as EPA1 expression increases 
under the same conditions in a BG2 background. Two different methods of 
regulation therefore seem to exist for EPA expression, at least in CG2001 
+78ƩDQG WKLVPD\HQDEOHGLIIHUHQWLDOEPA expression within the host at 
different sites. Similar differences in EPA gene regulation were not seen in 
a BG2 background however, but could possibly be revealed with the 
analysis of more EPA genes. Alternatively, BG2 which exhibits high EPA1 
heterogeneity, and possibly higher EPA6 and EPA7 variation (discussed 
further below) may be more reliant on silencing driven cell-to-cell adhesin 
heterogeneity as a mechanism to allow colonisation of whichever host site 
LVHQFRXQWHUHG&*+78ƩRQWKHRWKHUKDQGZKHUHKHWHURJHQHLW\ LV
markedly lower, may be more reliant on expression of the most 
appropriate EPA gene at a given site.    
The lack of Sir-mediated transcriptional silencing exerted on Epa1 in 
CG2001-Epa1-HA enabled the use of the strain to elucidate the effect of 
potential post translation factors on Epa1 expression and heterogeneity. 
The effects of lipid rafts, cleavage from the cell surface by the action of Yps 
aspartyl proteases and overall levels of mannoprotein at the cell surface 
were analysed. According to the results, although inhibition of lipid raft 
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components did lead to increased mean Epa1-HA expression, such domains 
do not appear to be involved in confinement of Epa1 to specific regions at 
the cell surface and heterogeneity of such lipid-enriched regions is not 
related to Epa1-HA heterogeneity. Similarly, removal of Epa1 from the cell 
surface by the action of Yps aspartyl proteases (Kaur et al., 2007) was 
found to have little role in the regulation of Epa1 heterogeneity. In addition 
the extent of heterogeneity exhibited by Epa1 was not mirrored by 
heterogeneity in total mannoprotein, indicating that Epa1 expression at the 
cell surface varies independently of this.  
In contrast to the lack of the above post-translational modes of 
control over Epa1 expression heterogeneity, it was apparent that cell 
surface Epa1 protein level was correlated with EPA1 transcript level in both 
strain backgrounds. Thus even in CG2001-Epa1-HA, in which Epa1 is not 
subject to Sir-mediated silencing and heterogeneity is lower than observed 
in BG2-Epa1-HA, heterogeneity in Epa1 expression appeared to be 
controlled at the transcriptional level. This is consistent with transcriptional 
regulation generally being a major contributor to gene expression noise 
(Avery, 2006). In line with this, cell-to-cell variation of adhesin-encoding 
FLO genes in S. cerevisiae is controlled at the transcriptional level by a 
combination of both global and promoter specific factors that contribute to 
gene silencing (Halme et al., 2004, Octavio et al., 2009). The transcription 
factors Flo8, Mss11, and Msn1 regulate FLO gene expression in S. 
cerevisiae (Halme et al., 2004, Verstrepen et al., 2004, Octavio et al., 
2009), with the corresponding Flo8 and Mss11 regulators in C. glabrata 
being implicated in EPA6 gene expression (Mundy and Cormack, 2009). 
Bioinformatic analysis, however, revealed a putative Ƚ2 repressor binding 
site within the promoter of EPA1. This repressor is known to have a role in 
decreased gene expression exhibited upon release of silencing in S. 
cerevisiae (Wyrick et al., 1999). Subsequent investigation in the present 
study revealed that increased expression of Ƚ2 transcript did not correlate 
with lower levels of Epa1-HA at the single cell level. Therefore, it is unlikely 
that Ƚ2 is responsible for Epa1 expression heterogeneity, or the decreased 
expression seen in CG2001-Epa1-HA upon inhibition of silencing. Evidence 
from previous studies supports the lack of a role for the Ƚ2 repressor in 
Epa1 expression regulation. Such studies have reported that silencing of 
the MTL3 locus, within which the C. glabrata Ƚ1 and Ƚ2 genes are located, 
is dependent on yKu70 and yKu80 (Ramirez-Zavaleta et al., 2010): 
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however, yKu deletion in C. glabrata has been shown to have no effect on 
EPA1 expression (Rosas-Hernandez et al., 2008). The Ƚ2 consensus 
sequence was identified in the promoters of both C. glabrata strain 
backgrounds. However, Ƚ2 is also unlikely to have a role regulating Epa1 
expression in the BG2 background since the a-mating type means that Ƚ2 
is transcriptionally silent in this strain. Although the transcript is eventually 
detectable due to leaky expression (Ramirez-Zavaleta et al., 2010), such 
low levels are unlikely to influence EPA1 expression in this background. In 
addition Sir-dependent silencing appears to be the primary mode of EPA1 
regulation in BG2 cells and the increased expression of Epa1 seen upon 
loss of silencing is also evidence against a role for the repressor in this 
strain.   
Like EPA1, expression of EPA6 and EPA7 was also found to be 
correlated with Epa1-HA cell surface levels in both strains. This suggested 
that control over expression of several EPA genes is exerted at the 
transcriptional level, possibly in a combined EPA regulation mechanism. An 
additional factor, however, that must be taken into account is the 
correlation also with ACT1 expression seen among the sorted populations. 
Despite this correlation the difference in ACT1 expression observed 
between high- and low-Epa1-HA expressing cells was lower than that 
observed for the EPA genes in either tested strain background. It is 
possible that the differences seen for ACT1 are artifactual and may be 
indicative of the margin of error for the experiment. Alternatively a more 
global regulation of heterogeneity may be occurring, which extends beyond 
just the EPA genes, i.e. the extremes of EPA1 expression also correlate 
with the extremes of expression for other genes, such as ACT1. Indeed, all 
genes demonstrate some heterogeneity even if the effect is small. An 
additional possible explanation for the correlated ACT1 expression may be 
that high Epa1 cells are primed not only for adhesion but also for the 
accompanying tissue invasion; the cytoskeleton is known to be important 
for polarized growth, thought to be involved in tissue invasion in C. 
albicans (Martin and Konopka, 2004), so higher expression of ACT1 may be 
beneficial in this regard. Further insights could be gained by a broader 
study including the analysis of many genes in high- and low-Epa1 
expressing subpopulations by transcriptomics analyses. This study into the 
expression EPA6 and EPA7 suggested that EPA6 and EPA7 in the BG2 strain 
may exhibit high heterogeneity, which might indicate that high EPA 
heterogeneity is a common trait of this strain.   
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Regulation of Epa1 heterogeneity thus seems to be complex and 
although the results discussed in this chapter indicate that control is 
exerted at the mRNA level, this could be part of a broader response 
influenced by several factors yet to be elucidated. Further complication 
stems from the fact that different strains, and indeed different EPA genes 
within these strains, seem to be differentially affected by the same stimuli. 
In particular, in the case of this study, a differential dependence of Epa1 
expression and heterogeneity on Sir-mediated transcriptional silencing was 
identified.   
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Chapter 6 - Concluding 
Remarks 
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6.1 Concluding Remarks 
 Research efforts in recent years have greatly improved our 
understanding of the molecular mechanisms that govern (fungal) 
pathogenesis, including the gene products that contribute to virulence. This 
understanding has been mirrored by the emergence of cell-to-cell 
heterogeneity as a major research area, with recognition of its likely role as 
a virulence determinant in pathogens (Avery, 2006, Verstrepen and Fink, 
2009). Indeed, in principle, it may take just a few virulent cells within a 
larger mostly-avirulent population to initiate infection. Importantly 
conventional microbiological analyses produce culture-averaged data which 
can mask variation within the population. This study aimed to identify and 
further characterise heterogeneity within yeast populations. Despite initially 
promising, but ultimately misleading, indications of bi-stable Rad6 
expression within S. cerevisiae, the major focus of this work became 
analysis of the well studied C. glabrata adhesin Epa1. The pathogenic yeast 
C. glabrata is responsible for a variety of mucosal and disseminated 
infections (Kaur et al., 2005), the latter of which can be associated with 
high levels of mortality (Wisplinghoff et al., 2004). Adhesion, being one of 
the first host-pathogen interactions to occur, is thought to be an important 
step in the initiation of infection and many pathogens produce adhesins to 
help mediate this process (de Groot et al., 2008, Hoyer et al., 2008, Silva 
et al., 2011). 
During the course of this study Epa1 gene and protein expression 
was observed to exhibit marked variation between individual cells. This 
phenotype appears to be primarily mediated by Sir-dependent 
transcriptional silencing. In agreement with this observation, Epa1 protein 
expression was controlled primarily at the mRNA level, consistent with 
transcriptional regulation being a major contributor to noise in gene 
expression generally (Avery, 2006). Indeed epigenetic gene silencing has 
been shown to regulate differential expression of the S. cerevisiae FLO 
genes which constitute functional homologues of the EPA gene family 
(Halme et al., 2004). Variation in the adhesion capacity of different C. 
glabrata strains has been reported previously (de Groot et al., 2008). In 
addition marked genome plasticity has been observed across isolates 
(Muller et al., 2009, Polakova et al., 2009). It may not be surprising then, 
that the existence of Sir-dependent Epa1 heterogeneity was related to 
strain background with the two predominant strains utilised during this 
study exhibiting different heterogeneity levels. Furthermore both high- and 
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low- heterogeneity phenotypes were evident across clinical isolates 
recovered from various host niches and appeared to correlate with the level 
of EPA1 silencing exhibited in those strains.  
It is tempting to speculate that different strains could have different 
virulences possibly due to their heterogeneity levels (heterogeneity may 
provide a virulence advantage). The incidence of both high- and low- 
heterogeneity isolates from patients, however, highlights the importance of 
additional factors in pathogenesis. This is not to say that Epa1 
heterogeneity would not confer any influence over virulence within the 
host. Indeed Epa1 expression of individual cells was shown to be correlated 
with adherence capacity, thus establishing a functional consequence of 
heterogeneity and a link to virulence potential. Moreover phenotypic 
heterogeneity is proposed to aid survival during times of stress and 
environmental fluctuation (Avery, 2006, Bishop et al., 2007, Smith et al., 
2007, Acar et al., 2008), such as may be encountered within the 
mammalian host as cells invade the bloodstream and/or colonise different 
epithelia and organs. To that end it might be predicted that isolates with 
the greatest heterogeneity (i.e., those exhibiting Sir-mediated EPA 
silencing), may have some survival advantage and possibly a greater 
virulence potential. For instance, low-Epa1 expressing cells could be better 
adapted for bloodstream infection where adhesion to a surface may be less 
important or better protected from immune recognition. For instance, C. 
glabrata BG2 cells deleted for the Yps proteases, which cleave Epa1 from 
the cell surface in this strain background, demonstrate increased activation 
of macrophages, alongside decreased survival within these phagocytic 
cells, and attenuated virulence (Kaur et al., 2007). These observations may 
suggest a survival advantage for cells expressing low levels of Epa1 
whereby lower levels of immunogenic proteins at the cell surface could 
suppress macrophage activation. Alternatively such cells may express 
higher levels of other proteins, such as other adhesins equipped for 
attachment to various surfaces; be it different host cell types, other yeast, 
or indwelling medical devices. Furthermore, the dynamic phenotypic 
changes identified, due to the fact that high- or low-expressing Epa1 cells 
revert to mixed populations within a few generations with mothers 
producing buds of different expression phenotypes, are predicted to be 
LQFUHDVLQJO\IDYRXUHGDVWKHIUHTXHQF\DWZKLFKDQRUJDQLVP¶VHQYLURQPHQW
changes increases (Acar et al., 2008). 
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An appealing hypothesis proposes that Epa proteins, which are 
known to vary in their ligand-binding specificities (Zupancic et al., 2008), 
are differentially regulated to facilitate adherence to different host surfaces 
during the course of infection. Such regulation may be driven by the 
various potential environmental cues encountered (De Las Penas et al., 
2003, Castano et al., 2005, de Groot et al., 2008, Zupancic et al., 2008). 
Certainly, environmental conditions such as NA limitation and exposure to 
weak acids commonly found in antifungals have been shown to affect 
expression of EPA genes such as EPA6 (Domergue et al., 2005, Mundy and 
Cormack, 2009). The impact of silencing on heterogeneity here results in a 
tendency towards increased numbers of cells expressing low rather than 
high-EPA1. Strains demonstrating high levels of Epa1 heterogeneity could 
be ones in which the dominant adhesin differs most between different cells. 
For instance, as alluded to above, cells demonstrating low levels of Epa1 
may produce high levels of an alternative adhesin in place of Epa1 at the 
cell surface, so adding another layer of diversity. This may allow the 
population as a whole to be pre-equipped for adhesion to more diverse 
surface types. Furthermore, such switching of the dominant Epa between 
subpopulations could aid in immune system evasion akin to the systems 
utilised by a number of parasites (Verstrepen and Fink, 2009). Indeed the 
ability to switch Epa1 expression state was demonstrated here. 
Transcriptional analysis performed during this study, however, suggests 
that alternative Epa proteins may not be expressed in place of Epa1, at 
least in the case of Epa6 and Epa7 where low levels of EPA1 mRNA 
appeared to correlate with low transcript levels for these other two 
adhesins. Nevertheless the BG2 and ATCC2001 strains encode 17 and 23 
EPA genes respectively (Kaur et al., 2005, de Groot et al., 2008), in 
addition to over 60 other adhesin-like GPI-proteins identified in C. glabrata 
(de Groot et al., 2008). Any one of these may have the potential to 
mediate adherence and thus replace Epa1 at the cell surface. Such non-Epa 
adhesins may include Pwp7p and Ade1p both of which have roles in 
adherence to endothelial cells and form members of a recently identified 
and characterized family of C. glabrata GPI-anchored CWPs, absent in S. 
cerevisiae and C. albicans (Desai et al., 2011). It is also plausible that low 
expressing cells exhibit relatively low levels of a high number of adhesins in 
RUGHU WR EURDGHQ ³VSHFLILFLW\´ UDWKHU WKDQ KLJK H[SUHVVLRQ RI RQH RU WZR
dominant adhesins. Alternately such cells may contain increased levels of 
non-adhesin cell wall proteins.   
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Interestingly, following exposure to weak acids that are used as 
preservatives in antifungal treatments (sorbic acid and paraben), EPA6 
expression increases (Mundy and Cormack, 2009). This increase, however, 
occurs only in a subset of cells, similar to the phenomenon observed for 
FLO11 of S. cerevisiae under conditions of N-limitation (Halme et al., 
2004). This establishes the possibility of heterogeneity existing in 
expression of Epa¶s other than Epa1. Furthermore the influence of the weak 
acid preservative treatments on expression differed between EPA6, EPA7, 
and EPA1 (Mundy and Cormack, 2009) thus providing an example of 
differential regulation not only of EPA6 but also between different EPA 
genes. EPA6 is also known to be induced during stationary phase, 
apparently due to the hypoxic environment (Mundy and Cormack, 2009). 
This environment is consistent with that found within biofilms and both 
EPA6 and EPA7 are expressed under biofilm conditions (Iraqui et al., 
2005). In contrast, Epa1 expression is maximal during exponential growth, 
the protein being cleaved from the cell wall as cultures enter stationary 
phase (Kaur et al., 2007), an observation confirmed in this study. Given 
the similar ligand-binding specificities of Epa1 and Epa7 (Zupancic et al., 
2008), differential regulation may ensure persistence of the adhesion 
properties of high-Epa1 cells upon the switch to stationary phase, such as 
during biofilm formation on host mucosa or on indwelling medical devices, 
a stage which often precedes candidiasis. It has been suggested that within 
the human host, adherent C. glabrata cells exist in a semi-stationary phase 
throughout most of their lifetime (de Groot et al., 2008). Results collected 
during this project indicate that a strain exhibiting high-Epa1 heterogeneity 
can extend such heterogeneous expression into stationary phase, 
irrespective of the accompanying decrease in mean expression. Thus Epa1 
heterogeneity could influence virulence even in stationary conditions.      
An important future challenge will include investigation in to how 
such heterogeneity in adhesin gene expression may impact survival within 
the host and ultimately virulence. Such studies may require the use of 
infection models, initially utilising both high-and low-Epa1 heterogeneity 
strains to identify possible differences in dissemination and the ability to 
colonise host sites following initial infection. Identification of a possible 
virulence advantage in highly heterogeneous strains would subsequently 
need to be linked specifically to Epa1 heterogeneity. This would likely 
require specific manipulation of Epa1 expression heterogeneity. SIR3 
deletion would be a non-specific approach as inhibition of transcriptional 
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silencing would have pleiotropic effects. Alternatively Epa1 heterogeneity 
could be manipulatable by introducing alternative promoters, as has been 
done with other genes (Blake et al., 2006, Smith et al., 2007). In addition, 
although both high- and low-Epa1 heterogeneity strains evidently occur in 
patients, analysis of larger numbers of such clinical isolates may provide 
some statistical data indicating whether one phenotype is dominant over 
the other within the host environment. A large analysis of this type could 
also provide more robust information on the relationship between source 
site and Epa1 heterogeneity. In addition, the hypothesis that individual 
cells express different dominant adhesins, enabling attachment to different 
surfaces could be tested through adhesion assays using sorted Epa1 
subpopulations and various host cell types as well as synthetic surfaces. 
Ultimately, several key questions concerning Epa1 heterogeneity in this 
pathogenic yeast still need to be answered, in particular, further 
characterisation of the mechanisms underlying such variation and the 
advantages that they may confer upon a population. 
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